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ABSTRACT 
PROTEIN DETECTION AND STRUCTURAL CHARACTERIZATION BY 
MASS SPECTROMETRY USING SUPRAMOLECULAR ASSEMBLIES AND 
SMALL MOLECULES 
 
SEPTEMBER 2019 
 
BO ZHAO, B.S., NANKAI UNIVERSITY 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Richard W. Vachet and Professor Sankaran Thayumanavan 
 
Mass spectrometry (MS) has played an increasingly prominent role in proteomics 
and structure biology because it shows superior capabilities in identification, quantification 
and structural characterization of proteins. To realize its full potential in protein analysis, 
significant progress has been made in developing innovative techniques and reagents that 
can couple to MS detection. This dissertation demonstrates the use of polymeric 
supramolecular assemblies for enhanced protein detection in complex biological mixtures 
by MS. An amphiphilic random co-polymer scaffold is developed to form functional 
supramolecular assemblies for protein/ peptide enrichment. The influences of charge 
density and functional group pKa on host-guest interactions within the assemblies are 
fundamentally investigated. In practice, these new materials enable specific isolation of 
target peptides from complex mixtures, as well as enhance MS detection/ quantification of 
protein biomarker in human breast milk. In parallel to protein detection, this dissertation 
also describes the development of a series of small-molecule covalent labeling (CL) 
reagents that are capable of studying protein higher order structure and protein-protein 
interactions when coupled with MS.  
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CHAPTER 1 
 
INTRODUCTION 
 Proteins are the most diverse class of biomolecules, their varying structure, 
expression, and function dictate biological homeostasis and cellular activities.1 Protein 
abnormalities including mutation and misfolding contribute to the development or directly 
cause many diseases.2-4 Therefore, it is extraordinarily valuable to appropriately analyze as 
well as predict protein structure and function to understand disease mechanisms and 
develop therapeutic agents. Efforts have been vigorously made to characterize proteins 
with the combination of theoretical simulations and experimental observations. In the past 
decades, remarkable progress has been made in mass spectrometry (MS) that shows 
superior capabilities in protein detection and structural characterization. Especially, the 
newly developed soft ionization methods such as matrix assisted laser desorption ionization 
(MALDI) and electrospray ionization (ESI) enable efficient but also reliable analyses in 
proteomics and protein structural biology.5-6 Due to the versatility of MS, it can be coupled 
with various techniques to further extend its analytical capabilities. For example, 
simplification and enrichment methods eliminate the complex matrices which in turn 
enables a more sensitive MS detection of targeted proteins in biological environments.5, 7-
9 In parallel to proteomics, a variety of approaches have also been applied to introduce 
structural information on protein topology, which consequently can be identified by MS.6, 
10-11 This dissertation demonstrates the application of polymeric supramolecular assemblies 
to enhance MS detection of targeted proteins in complex biological mixtures and the use 
of small molecule reagents to study protein structure and interactions when coupled with 
MS. 
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1.1 Protein mass spectrometry 
MS, an irreplaceable analytical tool for protein identification, quantification and 
structural characterization, has been widely used in biomedical research in recent years. 
MS measures the mass to charge ratio (m/z) of a given ion in the gas phase, which requires 
ionization of a given compound by different means (e.g. electron ionization).12 Previously, 
due to the lack of maintaining the integrity of peptides or proteins during ionization 
process, MS was not capable of measuring intact biomolecules, thereby failing to provide 
information of proteins or protein complexes both qualitatively and quantitatively.13 In the 
late 1980s, two soft ionization methods, MALDI and ESI, have emerged to become the 
most impactful tools in the realm of MS, which renders ionization of these biomolecules 
with minimal or no fragmentation.13-15 In addition to the development of new ionization 
methods, various types of mass analyzers have also advanced the detection of different 
molecule classes. With an appropriate instrument and MS method, a protein entity can be 
unambiguously identified via peptide mass fingerprinting as well as its corresponding 
fragmentation patterns.16-18 Since MS can provide information down to residue level, it can 
also differentiate protein isoforms, which is difficult for conventional methods with low 
resolution. Furthermore, when coupled with separation techniques such as liquid 
chromatography (LC), MS provides multiplex detection and quantification capabilities but 
without sacrificing its high throughput nature.9, 19-22 Except for revealing the primary 
structure of a given protein, MS has been utilized to decipher a protein’s higher order 
structures (HOS) and protein-protein interactions (PPI) as well.6, 10, 23-25 In general, various 
reagents have been developed to encode structural information to the protein sequence for 
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MS elucidation.26-29 Alternatively, native ESI also shows promising competency in 
assessing protein native structure and protein complexes structure at a global level.30-31 
1.1.1 Ionization method 
To measure the m/z of a specific compound in the mass spectrometer, an 
unavoidable reaction must happen that is the conversion of an analyte to an ion in the gas 
phase by different means. The advent of MALDI and ESI allows soft ionization of 
biomolecules, which have been the most commonly used techniques for peptide and protein 
MS analyses so far.  
 MALDI uses a pulsed laser irradiation to ionize solid analytes out of a co-
crystallized matrix (Figure 1-1a). Despite the fact that the ionization mechanism has not 
been fully understood, the ions are formed by a proton transfer reaction from matrix 
molecules that directly absorb laser energy. MALDI usually generates singly charged ions 
from a tiny amount of sample via pulsed laser irradiation events.32 The gas phase ions can 
be directly transferred to a mass analyzer (mostly coupled with time of flight mass 
analyzer) in vacuum systems. Furthermore, different analytes can be simultaneously 
ionized and rapidly analyzed using a multi-spot sample plate. Therefore, it can easily 
achieve high sensitivity and high throughput, especially analyzing relatively neat samples. 
In addition, MALDI ionization can tolerate certain level of salts, leading to convenient 
detection. However, MALDI also has some inherent limitations with regard to its inability 
to couple with some mass analyzers as well as to produce clean spectrums at low molecular 
range. Another limitation is critical as it typically caused by heterogeneous co-
crystallizations between analytes and the matrix which contributes to MALDI’s inability 
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to generate reproducible data, making it challenging for quantification and 
characterization. 
 
Figure 1-1. Schematic representation of (a) MALDI and (b) ESI ionization methods. 
 
ESI, as a complementary ionization method, can ionize analytes out of a solution, 
where gas phase ions are originated from the desolvation of charged droplets under a high 
voltage (Figure 1-1b).33 Since the analytes are ionized from a homogeneous solution, signal 
can be consistently produced, making quantification feasible. Other than this advantageous 
characteristic, ESI usually produces multiplet charged ions, which detects high molecular 
weight molecules within the working range of most mass analyzers. Moreover, this 
ionization can be very “soft” as it does not perturb the protein HOS and protein complex 
interactions. Most importantly, ESI is capable of coupling to liquid-based separation 
techniques such as liquid chromatography (LC) and capillary electrophoresis (CE), which 
allows MS to rapidly process complex samples without compromising high sensitivity. 
Nonetheless, drawbacks with regard to high sample consumption and low tolerance to salt 
still hinder specific applications.  
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1.1.2 Mass Analyzer 
Mass analyzer is arguably the core of MS technology. In other words, the mass 
analyzer determines the sensitivity, resolution, mass accuracy, duty cycle and data 
acquisition of MS techniques. The mass analyzer can be incorporated with ionization 
source individually or combined with others to fully take advantage of each strengths. Until 
now, there are five main categories of mass analyzers including time of flight (TOF), 
quadrupole, ion trap, Fourier transform ion cyclotron (FT-ICR) and orbitrap (Figure 1-
2).34-39 
 
Figure 1-2. Schematic representation of common mass analyzers (a) TOF; (b) quadrupole; (c) ion 
trap; (d) FT-ICR. (Figure adopted from reference12)  
 
TOF measures the time taken of an ion to travel certain distances in the device 
according to the m/z. It has been commonly used as TOF-TOF and quadrupole-TOF hybrid 
setups nowadays, and it shows advantages in rapid analyses for proteomics and structural 
characterization. Quadrupole separates different ions using a scanning/ fixed electric field 
based on their m/z. When multiple quadrupoles are aligned (e.g. triple quadrupole), it 
exhibits excellent capability in “shotgun” proteomics and quantification via multiple 
reaction monitoring (MRM). Ion trap often accumulate ions within a sector-like trap 
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device, and ejects the unstable oscillating ones for m/z measurements. It has gained 
consensus in the outstanding tandem mass spectrometry (MS/MS) and high throughput 
capabilities. FT-ICR and orbitrap can be also considered as ion trap-type mass analyzers, 
which use magnetic and electric field to regulate ions within the trap device respectively. 
These two mass analyzers share similarities in tremendous resolution, mass accuracy and 
sensitivity, whereas orbitrap does not require expensive superconducting magnet. 
1.2 Protein biomarker detection 
1.2.1 Biomarker  
Biomarker is a measurable indicator of a specific biological state which can 
represent the risk of contraction and the presence, or the stage, of a disease. Reliable 
assessment of biomarkers can lead to early detection, diagnosis and monitoring the stage 
of diseases, therefore improving effectiveness of therapy for patients, especially for ones 
with serious diseases like cancer.40-44 Well-established diagnostic hallmarks are widely 
used in clinics such as the prostate specific antigen for prostate cancer, cardiac troponin for 
myocardial infarction and glycated hemoglobin for diabetes.45-47 Biomarkers can be 
composed of various components including cells, nucleotides, proteins and small-molecule 
metabolites and can be readily collected in different biological fluids.48 For decades, major 
focus has been given to the discovery and validation of DNA-based biomarkers until people 
found out that gene expression might not accurately reveal the level of protein expression 
and protein function. Given the fact that proteins are one of the most apparent evidences 
that directly reflect the stage of disease, extensive considerations have recently been given 
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to protein-based biomarkers.13, 49 Consequently, many licensed tests based on protein 
biomarkers have been developed and have already become clinically available.50  
1.2.2 Detection method 
Detecting protein biomarkers in biofluids is often challenging. Firstly, biofluids 
(e.g. serum and plasma) are an extremely complex mixture consisting of a wide dynamic 
range of components. Even if only taking the protein portion into account, the diversity of 
proteins is also considerably huge.8, 51 Secondly, protein biomarkers are present in a very 
low abundance, usually at the pg/mL level. It is important to note that these low-abundance 
biomarkers are typically overshadowed by their naturally abundant counterparts which is 
why detecting biomarkers is usually analogized to “finding a needle in a haystack”.8, 52  
 To sensitively and reliably detect protein biomarkers, various detection methods 
have been developed. One of the most prevalent approaches is enzyme linked 
immunosorbent assay (ELISA), which uses a well-characterized antibody to bind to a 
known biomarker of disease.53 Benefits of ELISA include sensitivity and accuracy as well 
as relatively high throughput capabilities. However, it demands vigorous antibody 
development and validation which tends to be costly and time-, labor-consuming. In 
addition, it is difficult for antibodies to distinguish different antigen isoforms, which might 
eventually give rise to false positive results. 
 Alternatively, proteomics-based biomarker detection serves as an emerging 
technique that has proven to be promising in biomarker discovery and has potential to be 
routinely used in clinical diagnosis.8, 40, 49-50 Proteomics-based methods largely rely on 
advanced MS techniques to achieve biomarker identification and profiling. Since MS 
detection events are “universal”, in other words, it detects all the ionizable molecules, it is 
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most likely impossible to selectively monitor low-abundance biomarkers against an entire 
biological sample.54-55 In this sense, an effective fractioning step is frequently performed 
prior to MS analysis. Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) 
has been generally implemented for conventional proteomic studies.56-57 Nevertheless, 
some limitations hinder its utility such as low throughput, high sample volume 
requirements and inability to deal with heterogeneous biomarkers. Another category of 
fractionation is antibody-based protein microarrays, whose format is flexible and can be 
readily coupled to MS to achieve high sensitivity.58-60 Since the driving force of separation 
and enrichment is still antibody-biomarker binding, these methods share similar inherent 
limitations as ELISA. Furthermore, these enrichment materials are usually fragile because 
of the nature of the antibody’s stability. 
 1.2.3 Supramolecular assembly 
 Supramolecular assemblies are well-regulated molecular complexes with higher 
order structures usually formed by non-covalent interactions.61 In nature, one popular 
example can be protein folding, where, in general, a protein’s hydrophobic residues are 
buried in the core of an assembly, whereas hydrophilic residues are presented on the 
surface. By all means of non-covalent interactions including H-bonding, electrostatics, 
hydrophobic interaction and more, a polypeptide chain can finally fold itself to become a 
three-dimension structure. Inspired by nature, people have designed and developed various 
artificial supramolecular assemblies with different functions such as biomimetics, sensing, 
drug delivery and separation.62-65 In this dissertation, amphiphilic polymers containing both 
hydrophobic and hydrophilic moieties are used to form supramolecular assemblies to 
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simplify complex biological mixtures and enrich targeted proteins, which ultimately leads 
to an enhanced MS detection of biomarkers. 
 
Figure 1-3. (a) Self-assembly of amphiphilic homopolymers. (b) Schematic representation 
illustrates the selective enrichment of peptide biomarkers in human serum based on liquid-liquid 
extraction method using supramolecular assemblies. (Figure adopted from reference73) 
 
In the past, amphiphilic polymers have been prepared from a polystyrene 
homopolymer scaffold, which contains hydrophobic alkyl chains and hydrophilic 
functional groups. Once these polymers are subjected to polar solvent, they aggregate into 
micelle-type assemblies, while they will form reverse micelle-type assemblies in apolar 
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solvent (Figure 1-3a). These assemblies can be kinetically trapped in the solvent where 
they initially form, even after vigorous mixing with another immiscible solvent. For 
example, reverse micelle-type assemblies in toluene will not translocate across the 
interface to aqueous phase.66-67 Therefore, these assemblies can behave as supramolecular 
hosts to accommodate guest molecules from aqueous phase in a liquid-liquid extraction 
manner. Furthermore, hydrophilic functional groups in the interior of reverse micelle-type 
assemblies afford a driving force to sequester guest molecules, where the driving force 
includes, but is not limited to, electrostatic interaction, metal-ligand coordination, covalent 
binding, protein-ligand binding.68-71 Due to the tunability of the polymer structure, different 
functionalities can be readily incorporated to bind molecules of interests. In addition, these 
materials are based on a polystyrene scaffold, which are inherently cheap and stable 
compared to antibody-based materials. 
 Previously, these materials have been used to selectively enrich peptides 
biomarkers in human serum based on electrostatic interaction, where the selectivity 
depends on the isoelectric points (pI) of peptides and the pH of bulk aqueous solution.68-69, 
72 When coupled to MALDI-MS, these enriched peptides can be sensitively detected at low 
pg/mL level (Figure 1-3b).73 Despite the fact that these materials show great potentials in 
detecting biomarkers, many can be improved for this particular method. To minimize the 
synthetic efforts of the homopolymers, in Chapter II, a random co-polymer scaffold is 
designed and developed, which allows for very simple and easy structural variation. 
Chapter III reports the use of random co-polymers to fundamentally understand the 
relationship between charge density and extraction capacity, where an optimal charge 
density was found to give rise to optimal extraction capacity. In Chapter IV, random co-
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polymers containing low-pKa functional groups were developed to fundamentally 
understand how functional groups behave on micellar state as well as enhance detection of 
acidic peptides. Finally, Chapter V describes an analytical methodology using these 
extraction materials for selective depletion of abundant proteins in human breast milk and 
sensitive detection/ quantification of breast cancer biomarkers by MS. 
1.3 Protein structure characterization 
1.3.1 Protein higher order structure 
Protein higher order structure (HOS) generally refers to a protein’s tertiary and 
quaternary structure, meaning the three-dimensional folding structure of an individual 
protein and the structure of protein complexes respectively (Figure 1-4).1 A protein’s HOS 
govern its function, and so understanding the protein’s HOS is of key importance in 
comprehending its activities and investigating biological machinery.74-75 As a convincing 
example, HOS of protein therapeutics primarily accounts for drug efficacy, which requires 
intensive characterizations.76 Conventional methods such as circular dichroism (CD), 
fluorescence spectroscopy and differential scanning calorimetry (DSC) are easy to operate, 
but provides limited structural information. While high-resolution methods such as X-ray 
crystallography and nuclear magnetic resonance (NMR) usually provide structural 
information down to an atomic level.77-78 However, these methods require high quantity 
and quality of samples, as well as extensive analysis time, which severely hinders the 
throughput. As an emerging technique in structure biology, MS has been broadly 
conducted in routine protein HOS characterizations since it offers high structure resolution, 
sensitivity, throughput and sample efficiency.5-6, 10-12 
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Figure 1-4. Cartoon representation of protein (a) tertiary structure and (b) quaternary structure 
using human proliferating cell nuclear antigen (PCNA) as an example. 
 
1.3.2 Structure analysis using MS 
 MS measures the m/z of proteins, thereby obtaining protein’s HOS needs to encode 
some structural information to introduce a mass shift to the proteins.79-81 Various methods 
have been developed to study protein HOS when coupled to bottom-up MS analysis. 
Hydrogen deuterium exchange (HDX) is a well-known technique, in which deuteriums 
replace exchangeable backbone amide hydrogens. By doing so, a protein’s backbone 
structure and dynamics can be revealed.11, 23, 27, 79, 82 A drawback of this technique can be 
H/D back-exchange and scrambling which sometimes leads to ambiguous data. Chemical 
cross-linking uses bi-functionalized reagents to bridge different reactive residues within 
certain distances on the protein surface. Hence, the arrangement of exposed residues on the 
protein surface can be evaluated.26, 80, 83 Intricate data analysis, however, restricts its general 
applicability. Recently, covalent labeling (CL) becomes increasingly popular in 
characterizing protein HOS and protein-protein interactions, which emerges as a 
complementary tool to HDX and cross-linking.28-29, 84 
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1.3.3 Covalent labeling 
 CL mostly exploits amino acid specific reagents or non-specific chemical reagents 
to label solvent-accessible residues on the protein surface, so that it imparts protein surface 
topology. By comparing the modification extents of specific residues under different 
conditions, CL can pinpoint the residues that are involved in HOS changes or protein 
binding interfaces.85-86 Furthermore, CL generates stable modifications and straightforward 
data analyses, which makes it a promising method for studying protein HOS. Various bio-
orthogonal labeling reagents have been developed to modify reactive residues, for example 
N-hydroxysuccinimide (NHS) derivatives, 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide/ glycine ethyl ester (EDC/ GEE), dimethyl(2-
hydroxy-5-nitrobenzyl)sulfonium bromide (HNSB) and more.87-89 Even though they afford 
specific information of each type of residue, the combination of datasets from multiple CL 
reagents is usually necessary to fully map the whole protein, which contributes to intensive 
time and labor requirements. Non-specific regents such as hydroxyl radicals and carbenes 
are capable of reacting a significantly broader range of amino acids within a very short 
time course.90 But, these methods require specialized instrumental setups and sophisticated 
data interpretation, which are challenging to be widely comprehended.   
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Figure 1-5. Schematic representation shows covalent labeling with MS detection for the HOS 
analysis of antibody therapeutics. (Figure adopted from reference96) 
 
Lately, a CL reagent named diethylpyrocarbonate (DEPC) has arose increasing 
attention in analyzing protein HOS as it can modify various residues (Lys, His, Tyr, Ser, 
Thr) with a very simple chemical reaction that can be easily performed on benchtop.91-92 
With the help of this DEPC, protein HOS and protein-protein binding interfaces have been 
successfully discovered when coupled with bottom-up MS analyses (Figure 1-5).93-96 
Inspired by the use of DEPC, in Chapter VI, a new series of CL reagents based on α, β-
unsaturated carbonyl scaffold has been designed and developed. These new CL reagents 
can react up to 13 types of nucleophilic residues, which largely improves the mapping 
capability in assessing protein HOS. In addition, owing to the structural tunability of this 
scaffold, labeling kinetics and selectivity can be varied, and in addition, isotopes can be 
incorporated. Together, these new CL reagents serve as great probes for studying protein 
HOS. 
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CHAPTER 2 
 
SELF-ASSEMBLY OF RANDOM CO-POLYMERS FOR SELECTIVE BINDING 
AND DETECTION OF PEPTIDES 
 
Majority of this chapter is published: Zhao, B.; Serrano, M. A. C.; Gao, J.; Zhuang, J.; 
Vachet, R. W.; Thayumanavan, S. Self-assembly of random co-polymers for selective 
binding and detection of peptides. Polym. Chem. 2018, 9, 1066-1071. 
 
2.1 Abstract 
Amphiphilic random co-polymers, which form stable reverse micelle-type 
assemblies, have been designed and synthesized. We demonstrate that the reverse micelles, 
formed by these co-polymers are capable of selectively binding peptides through 
electrostatic interactions, indicating that these random polymers can self-organize into 
functionally selective materials. Moreover, these random co-polymers also enable the 
ordered co-crystallization of matrix and extracted guest molecules, giving rise to 
substantial signal enhancements during MALDI-MS detection. Together, these 
observations represent an excellent example of how random polymers can self-assemble 
into ordered, functional materials. 
2.2 Introduction 
Detecting trace amounts of a specific molecule in a complex mixture is often 
challenging.  Nowhere is this challenge more apparent than in biological samples. For 
example, peptide or protein biomarkers can be early indicators of disease, but are usually 
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present at ng/mL or lower levels in complex matrices such as serum or other biological 
fluids,1-6 and are therefore very difficult to detect.7-10 Because of the implications 
associated with detecting such molecules in complex mixtures, a variety of approaches 
have been developed over the years.11-14 
Self-assembling nanomaterials, in general, and polymer-based self-assembling 
materials, in particular, have attracted significant recent attention for detection and 
sensing,15-22 with block co-polymers being used most often.23-25 Block co-polymers rely on 
synthetic methods that allow for the continuous incorporation of hydrophilic monomers in 
a polymer, followed by continuous incorporation of hydrophobic monomers (or vice versa) 
to generate micelle or reverse micelle like structures. By comparison, amphiphilic 
homopolymers require the pre-incorporation of hydrophilic and hydrophobic moieties in 
the same monomer, enabling a greater density of the desired functional groups.26-28 Our 
group has successfully used self-assembling amphiphilic homopolymers to enrich peptides 
from a biphasic mixture for sensitive detection by matrix-assisted laser 
desorption/ionization mass spectrometry (MALDI-MS);29-31 however, the synthetic and 
structural requirements of homopolymers limit the molecular design space, thereby 
constraining the ability to systematically tune the functional groups of a homopolymer. 
Similar limitations are present for block co-polymers as well. Consequently, we and others 
have become interested in studying the self-assembly of random co-polymers and assessing 
their utility in sensing and biomarker detection applications.32-35 Random co-polymers 
provide the synthetic simplicity in that the hydrophobic and hydrophilic monomers can be 
independently chosen and their relative ratios can be tuned by simply varying the feed 
ratios of the monomers in the polymerization reaction. Because of this versatility, we 
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became interested in probing random co-polymer scaffolds for their ability to enrich 
peptides from a biphasic mixture. A question emerges, however, about the ability of 
random co-polymers to assemble appropriately to bind peptides of interest. Here, we 
describe our findings on random co-polymers forming ordered, functional assemblies that 
bind to and enhance the detection of peptides. Specifically, we are interested in using 
complementary electrostatic interactions in random co-polymers assemblies to selectively 
extract peptides and sensitively detect them.  
2.3 Results and discussion 
2.3.1 Polymer synthesis 
Random co-polymers, based on an electron-rich alkoxystyrenyl backbone, used in 
this study are shown in Figure 2-1. The hydrophobic monomer of the random co-polymers 
contains a p-alkoxy moiety, while hydrophilic monomer contains various charged and 
charge-neutral polar moieties.  While polymers P2-1 - P2-4 contain carboxylates as the 
hydrophilic moieties, P2-5 and P2-6 were synthesized as control polymers with charge-
neutral hydrophilic moieties.  All monomers were synthesized through Wittig reactions of 
the corresponding aldehydes, and the polymerizations were carried out using nitroxide-
mediated polymerization36 (Figure 2-2). The molecular weight of P2-1 was found to be 
about 10 kDa with Đ of 1.1.  For consistency, the ratio of hydrophilic and hydrophobic 
monomers was kept close to 1:1.  The control polymers required a slightly different ratio 
of the monomer to achieve the targeted reverse micelle assembly. 
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Figure 2-1. Chemical structures of amphiphilic random co-polymers P2-1 - P2-6. 
 
 
Figure 2-2. Synthesis of amphiphilic random co-polymer P2-1. 
 
2.3.2 Formation of reverse micelle from random co-polymers 
The polymer-peptide binding occurs in these systems, when the polymer based 
reverse micelle assemblies selectively extract complementarily charged peptides from an 
aqueous phase into the organic phase that has the polymeric assemblies. For this binding 
to occur with high fidelity, it is necessary that the reverse micelle assemblies are stable in 
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the organic phase, especially during the biphasic extraction process. Because these 
amphiphilic random co-polymers can form normal micelles in an aqueous phase and 
reverse micelles in an organic phase, they could potentially distribute between the two 
phases during an extraction. However, for the selective peptide extraction, the polymer-
peptide interactions should occur only in the organic phase and therefore the polymer 
should remain as a robust reverse micelle assembly in the organic phase. Consequently, we 
first tested whether the random co-polymers form reverse micelle-type assemblies in 
toluene. Solutions of polymers P2-1 - P2-6 were prepared by dissolving them in toluene 
for a final hydrophilic moiety concentration of 4.0 mM. One equivalent aqueous sodium 
hydroxide solution per hydrophilic moiety were also added to the solution to make the 
“water pool” of the reverse micelle assembly and to ensure that the carboxylic acid moieties 
are fully deprotonated. Dynamic light scattering (DLS) and transmission electron 
microscopy (TEM) measurements of P2-1 revealed assemblies of about 200 and 150 nm, 
respectively (Figure 2-3). Similar behavior was also observed with the polymers P2-2 - 
P2-6 (Figure 2-4). 
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Figure 2-3. (a) Dynamic light scattering (DLS) of reverse micelles of polymer P2-1 (1 × 10-4 M) 
in toluene. (b) Transmission electron micrograph (TEM) of reverse micelles of polymer P2-1 (1 × 
10-5 M), after drying on the TEM grid. (c) UV-Vis measurements with reverse micelles of polymer 
P2-1 (1 × 10-4 M) starting in toluene (ORG), before and after equilibration with aqueous phase 
(AQ). 
 
 
Figure 2-4. DLS of reverse micelles of polymers P2-2 - P2-6. 
 
Next, we tested the stability of the reverse micelle assemblies in a biphasic mixture. 
Accordingly, the solutions of reverse micelles in toluene were subjected to a biphasic 
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extraction procedure with water. The possible transfer of the polymer P2-1 into the aqueous 
phase was evaluated using UV-visible absorption spectroscopy. There is no discernible 
peak at ~280 nm, corresponding to the polymer, in the aqueous phase before and after 
extraction (Figure 2-3). This confirms that the polymer does not thermodynamically 
redistribute into the aqueous phase and that the polymer has an inherent preference for the 
organic phase, when it is initially assembled there. Similar behavior is observed for other 
amphiphilic random co-polymers as well (Figure 2-5). Note that toluene has an absorbance 
cut-off wavelength of 285 nm, which might interfere the assignment of the polymer peak. 
However, by blanking the baseline against the toluene solvent for the measurement of 
organic phases before and after equilibration, there is still a distinct peak at 280 nm, which 
confirms that the polymers are stably trapped in organic phase. To further confirm this 
assertion, dichloromethane (DCM) was used as the solvent with lower cut-off wavelength. 
Similar behavior of polymer assembly was indeed observed in DCM/water mixtures 
(Figure 2-6). 
 
Figure 2-5. UV-Vis measurements with reverse micelles of P2-2 - P2-4 starting in toluene (ORG), 
before and after equilibration (Eq) with aqueous phase (AQ). 
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Figure 2-6. UV-Vis measurements with reverse micelles of P2-1 starting in DCM (ORG), before 
and after equilibration (Eq) with aqueous phase (AQ). 
 
2.3.3 Selective extraction of molecules 
Given that the random co-polymers form reverse micelle like assemblies and 
remain in toluene, we next tested if they could behave as hosts that can selectively sequester 
guest molecules from an aqueous phase. To do this, we extracted an aqueous mixture of 
two hydrophilic dyes, rhodamine 6G and calcein (Figure 2-7). Because the reverse micelles 
of polymers P2-1 - P2-4 are negatively charged, we expected that the reverse micelles 
would selectively extract the positively charged dye, rhodamine 6G, while leaving the 
negatively charged calcein in the aqueous phase. After mixing the reverse micelles in 
toluene with an aqueous solution containing the two dyes, we indeed found that rhodamine 
6G is selectively extracted to the organic phase and calcein remains in the aqueous phase 
(Figure 2-7c). In a control experiment, the extraction experiment without the reverse 
micelle in toluene did not result in the extraction of either dye (Figure 2-7d).  
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Figure 2-7. (a) Example of dye extraction experiments using toluene (left) and reverse micelles of 
P2-1 (right). (b) Chemical structures of Rhodamine 6G and Calcein. (c) UV-Vis measurements of 
the dye mixture starting in water (AQ), before and after equilibration (Eq) with reverse micelles of 
P2-1 (ORG). (d) UV-Vis measurements of the dye mixture starting in water (AQ), before and after 
equilibration (Eq) with toluene (ORG). 
 
We next tested if the reverse micelles could selectively extract peptides with 
complementary charges. Five peptides (Table 2-1), with different isoelectric points (pI) 
values, were extracted from a 50 mM Tris buffer solution at pH 7.0.  At this pH, peptides 
with pI values higher than 7.0 are expected to carry a net positive charge. On the other 
hand, peptides with pI values lower than 7.0 are expected to carry a net negative charge. 
Upon extraction and subsequent phase separation and MALDI-MS detection, we found 
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that only peptides with pIs above 7.0 are effectively sequestered by the reverse micelles in 
the organic phase, whereas peptides with pIs below 7.0 remain in the aqueous phase (Figure 
2-8). Similar behaviors were found for polymer P2-2 - P2-4. (Table 2-2 and Figure 2-9)  
 
Table 2-1. Information of peptides used in extraction experiments in Figure 2-7. (a calculated using 
the program available at http://pepcalc.com.) 
Peak in 
Figures 
Peptide Sequence 
Concentration 
(μM) 
m/z pIa 
Net 
charge 
at pH 
7.0 
1 Bradykinin RPPGFSPFR 0.1 1060.57 12.5 + 
2 Angiotensin I DRVYIHPFHL 0.1 1269.68 7.7 + 
3 Malantide RTKRSGSVYEPLKI 0.1 1633.94 10.7 + 
4 β-Amyloid 1-11 DAEFRHDSGYE 0.15 1325.54 4.1 - 
5 Preproenkephalin 
SSEVAGEGDGDSM
GHEDLY 
0.15 1954.76 3.6 - 
 
 
Figure 2-8. (a) MALDI mass spectrum of the peptide mixture in the aqueous solution before 
extraction. (b) MALDI mass spectrum of the organic phase after extraction using reverse micelles 
of polymer P2-1 at pH 7.0. (c) MALDI mass spectrum of the aqueous phase after extraction using 
reverse micelles of polymer P2-1 at pH 7.0. 
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Table 2-2. Peptides used for determining the selectivity of extraction. (a calculated using the 
program available at http://pepcalc.com.) 
Peak in 
Figures 
Peptide Sequence 
Concentration 
(μM) 
m/z pIa 
Net 
charge 
at pH 
7.0 
1 Bradykinin RPPGFSPFR 0.1 1060.57 12.5 + 
2 Kinetensin IARRHPYFL 0.1 1172.67 11.1 + 
3 Angiotensin I DRVYIHPFHL 0.1 1269.68 7.7 + 
4 Malantide RTKRSGSVYEPLKI 0.1 1633.94 10.7 + 
5 β-Amyloid 1-11 DAEFRHDSGYE 0.15 1325.54 4.1 - 
6 Preproenkephalin 
SSEVAGEGDGDSM
GHEDLY 
0.15 1954.76 3.6 - 
 
 
Figure 2-9. Example of MALDI mass spectra of organic phase (ORG) and aqueous phase (AQ) 
after extraction at pH 7.0 using reverse micelles of P2-2. Identical results were seen for polymers 
P2-3 and P2-4. 
 
2.3.4 Investigation of extraction capacity 
Having shown that the random co-polymers can self-assemble into ordered 
structures and selectively extract guest molecules, we sought to test the effect of variations 
in the organization of charged moieties in the hydrophilic monomer. We first explored how 
these variations influence the extraction capacities of the reverse micelles. Capacity is 
important, as this is an indicator of how efficiently a particular type of supramolecular 
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assembly can host a set of guest molecules. Moreover, capacity also indicates the extent to 
which enrichment of the oppositely charged peptide can occur in the organic phase, which 
is significant for detection purposes. Given the importance of charge complementarity in 
the extraction process, we examined how the positioning of the charged group could 
influence capacity using bradykinin (RPPGFSPFR, pI= 12.5) as the model peptide. Note 
that small peptides, such as bradykinin, commonly exhibit random coil structure in free 
aqueous solution.  Therefore, secondary structure of the peptide does not affect binding 
capacity in these studies (Figure 2-10). When extractions are done with a homopolymer 
P2-7, which has the same amount of functionality as P2-1 and a similar molecular weight, 
we find that the capacity of the homopolymer is two times less than the random co-polymer 
(Figure 2-11). This result suggests that random co-polymer design might be advantageous 
by allowing the polymer to organize more effectively to host a greater amount of peptide 
molecules. In other words, the random arrangement of carboxylate groups present in P2-1 
improves its ability to order itself into a functional host material. The importance of charge 
complementarity in producing a functional host material is further proven by considering 
that polymers P2-5 and P2-6 have almost no capacity to host the peptide (Figure 2-11).  
 
Figure 2-10. (a) CD spectrum of bradykinin in aqueous phase before extraction. (b) 3D structure 
of bradykinin predicted by PEP-FOLD Peptide Structure Prediction Server 
(http://bioserv.rpbs.univ-paris-diderot.fr/services/PEP-FOLD/). 
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Figure 2-11. (a) Peptide binding capacities at pH 7.0 after extracting with 100 μL of 1.75 × 10-4 M 
of carboxylate or charge-neutral functional group concentrations of solution of different polymers. 
The peptide capacities for each polymer were determined in the same manner as that for Figure 2-
12. (b) Chemical structure of homopolymer P2-7. 
 
Interestingly, polymer P2-1 has a 30-fold higher capacity for the peptide than 
polymers P2-2 - P2-4. The relatively low capacities of the polymers with multiple 
carboxylate groups is somewhat surprising, as one might expect that a greater number of 
the carboxylate functionality locally would increase the number of guest peptides that can 
be hosted within the assembly. Instead, our results indicate that either an optimum number 
of carboxylates packed within the assemblies or the capability that the polymer could 
position these carboxylate groups to an appropriate extent is necessary to achieve high 
guest capacity. 
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Figure 2-12. Example of peptide extraction capacity measurement using reverse micelles of 
homopolymer P2-7 at pH 7.0, where increasing concentrations of the peptide bradykinin was 
extracted using 100 μL of each polymer and the leftover peptide in the aqueous phase was mixed 
on a 1:1 volume ratio with ACN CHCA matrix solution, then analyzed by MALDI-MS. The 
extraction capacity is taken as the concentration of peptide at which a significant increase in peptide 
signal is seen remaining in the aqueous phase, suggesting that the reverse micelles are saturated 
and can no longer accommodate more peptides in the organic phase. 
 
2.3.5 MS signal enhancement of peptides 
Finally, we tested if the random co-polymer design could organize into ordered 
structures that enhance the MALDI-MS detection of guest peptides. Previously, we 
demonstrated that amphiphilic homopolymers with electron donating alkoxy substituents 
on the aromatic ring (e.g. P2-7) cause a significant signal enhancement effect during the 
MALDI-MS analysis of peptides that are extracted into their interiors.37-38 This signal 
enhancement effect arises as a result of favorable ternary interactions between the polymer, 
peptide, and MALDI matrix that cause peptides to concentrate into “hot spots” that increase 
detection efficiency. We found that the polymer matrix interactions are mediated through 
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aromatic donor-acceptor interactions, while the polymer/peptide interactions are 
electrostatic in nature. The co-polymer design described in this work allows us to explore 
whether such ordered interactions can arise from random polymers.  
 
Figure 2-13. Structure of the TMR-Bradykinin. 
 
 
Figure 2-14. (a) MALDI ion abundance of 50 nM of TMR-BK peptide extracted using different 
polymers. Unextracted TMR-BK: 100-fold higher concentration in the unextracted sample (5 μM) 
relative to extracted sample (50 nM) to account for the 100-fold enrichment during extraction. (b) 
Fluorescence images showing the degree of clustering and co-crystallization of TMR-bradykinin 
peptide (red) and -cyano-4-hydroxy cinnamic acid (CHCA) matrix (green). Scale bar = 100 μm. 
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To test the ability of the random co-polymers to form ordered materials that 
enhance MALDI-MS detection, solutions of polymers P2-1 - P2-4 at constant carboxylate 
concentration were used to extract a 50 nM solution of fluorophore-labeled bradykinin 
(TMR-BK) (Figure 2-13). After the extractions, the organic phases were analyzed by 
MALDI-MS to determine the degree of signal enhancement and by fluorescence 
microscopy to determine the extent of hotspot formation. MALDI-MS measurements 
(Figure 2-14a) indicate that the extent of signal enhancement for extracted TMR-BK is the 
same for all the polymers P2-1 - P2-4. Consistent with this observation is the fact that an 
equal extent of hotspot formation is observed for all the polymers in the corresponding 
fluorescence images (Figure 2-14b and Figure 2-15). The degree of signal enhancement 
and hotspot formation seen with the random co-polymers is similar to that observed for a 
homopolymer P2-7. Compared to fluorescence microscopy images of unextracted TMR-
BK, polymers P2-1 - P2-4 can readily form “hot spots” that are enriched in peptides, 
indicating that the random co-polymers can organize in such a way to mediate the ternary 
interactions necessary for signal enhancement. Moreover, it appears that the organization 
of the hydrophobic and hydrophilic groups has little effect on signal enhancement as the 
random co-polymer and homopolymer behave similarly with regard to this phenomenon. 
Given the merit of signal enhancement effect, we evaluated the detection limit to be as low 
as 10 pM for P2-1 (Figure 2-16). 
 
  42 
 
Figure 2-15. Fluorescence microscopy images showing the degree of clustering and co-localization 
of TMR-BK and CHCA matrix in extracted samples (50 nM) using P2-2 - P2-4. Scale bar = 100 
m. 
  
 
Figure 2-16. (a) Signal to noise ratio (S/N) of bradykinin signal in the organic phase after extraction 
using 1.75 × 10-4 M of co-polymer P2-1. (b) Zoom-in region of (a) shows the detection limit is as 
low as 10 pM. (c) Exemplified spectrum of 10 pM of bradykinin detected in the organic phase after 
extraction. 
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2.4 Conclusions 
In summary, we have designed and developed a new amphiphilic random co-
polymer scaffold that can form supramolecular assemblies for sequestering guest 
molecules via a simple biphasic extraction method. The random co-polymers were 
synthesized by one-pot polymerization of both styrene-based hydrophobic moieties and 
hydrophilic functional groups, which are synthetically more accessible for both the 
preparations of monomers and functional group variations. With this scaffold, we have 
shown that: (i) the random co-polymers can self-assemble into reverse micelle-type 
assemblies; (ii) these reverse micellar structures are “kinetically trapped” in the organic 
phase, providing a necessary feature for biphasic extraction of guest molecules; (iii) these 
reverse micelles can selectively sequester guest molecules with complementary charge 
based on electrostatic interactions, demonstrating that random polymers can self-organize 
into functional materials; (iv) organization of the functional groups within the hydrophilic 
unit of the polymer influences the extraction capacity of reverse micelles; (v) random co-
polymers can order themselves in a way that mediates ternary interactions with the MALDI 
matrix, giving rise to signal enhancements in MS. Given the simplicity with which these 
random co-polymers can be synthesized, these materials will make it easy to investigate 
how structural variations affect guest binding and detection. These future investigations 
will improve our fundamental understanding of these materials and will allow us to design 
better materials for the selective extraction of trace level molecules in complex mixtures. 
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2.5 Experimental section 
2.5.1 Polymer synthesis and characterization 
All reagents were commercially available and used as received unless stated 
otherwise. 1H-NMR spectra were recorded on a 400 MHz NMR spectrometer using 
residual proton resonance of the solvents as internal standard. Chemical shifts are reported 
in parts per million (ppm). Mass spectra were obtained by a Bruker AmaZon quadrupole 
ion trap mass spectrometer coupled with electrospray ionization source. Gel permeation 
chromatography (GPC) was used to estimate the molecular weight of polymers using THF 
as eluent and 1μL of toluene was added as the internal reference. Polystyrene standards 
were used for calibration and data analysis. Dynamic light scattering (DLS) was measured 
by a Malvern Zetasizer. Transmission electron microscopy (TEM) images were taken from 
JEOL JEM-2000FX. Synthetic pathways were listed below and detailed information can 
be found in Appendix.  
Synthetic pathway of random co-polymer P2-1: 
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Synthetic pathway of random co-polymer P2-2: 
 
Synthetic pathway of random co-polymer P2-3: 
 
Synthetic pathway of random co-polymer P2-4: 
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Synthetic pathway of random co-polymer P2-5: 
 
Synthetic pathway of random co-polymer P2-6: 
 
2.5.2 Reagents  
The peptide bradykinin (RPPGFSPFR) was purchased from the Sigma-Aldrich. 
TMR-bradykinin (TAMRA dye conjugated at the N-terminal of the peptide) was obtained 
from Biopeptek Inc. The following peptides were purchased from the Bachem: kinetensin 
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(IARRHPYFL), malantide (RTKRSGSVYEPLKI), amyloid fragment 1-11 
(DAEFRHDSGYE), preproenkephalin (SSEVAGEGDGDSMGHEDLY). Trifluoroacetic 
acid (TFA), and cyano-4-hydroxy-cinnamic acid (CHCA) were purchased from Sigma-
Aldrich.  
2.5.3 Preparation of polymeric reverse micelles 
An appropriate amount of amphiphilic random co-polymers was dissolved in 
toluene. One equivalent of aqueous NaOH solution or H2O per functional group was added 
to the toluene solution. Sonication was conducted until the solution becomes 
homogeneously dispersed. The sizes of different polymer-based reverse micelles were 
measured by dynamic light scattering (DLS). DLS measurements were carried out in a 
quartz cuvette. The particle sizes obtained for all reverse micelles are shown below based 
on an average of 3 correlations of 10 measurements each. 
2.5.4 Matrix solutions 
CHCA in ACN solution was prepared at a concentration of 10 mg/mL in 50 μL 
ACN: 47.5 μL H2O: 2.5 μL TFA. CHCA in THF solution was prepared at a concentration 
of 30 mg/mL in 350 μL THF:150 μL H2O:6 μL TFA. 
2.5.5 Peptide extraction and sample preparation  
The general extraction procedure has been described elsewhere,38 but in short, the 
following procedure was used. Peptide solutions were prepared in 50 mM Tris buffer where 
the pH of the buffer is adjusted before-hand. 1 mL of the buffered peptide solution was 
mixed vigorously with 200 μL of the polymeric reverse micelle solution for 2 hours. After 
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mixing, the solution was centrifuged at 13,000 rpm for 60 minutes to break the emulsion. 
The aqueous phase was withdrawn and kept in a separate microtube. 10 μL of the aqueous 
phase sample was then mixed with 10 μL of ACN CHCA matrix solution. From this 
sample, 2 μL was spotted on the MALDI target plate for MALDI-MS analysis. The 
remaining organic phase was dried by blowing N2 gas. The dried residue of the mixture of 
polymer and the extracted peptides was re-dissolved in 10 μL of THF and then 20 μL of 
the THF CHCA matrix solution. From this sample, 1 μL was spotted on the MALDI target 
plate for MALDI-MS analysis or on indium tin oxide (ITO)-coated glass slides for 
fluorescence microscopy.  
2.5.6 Fluorescence microscopy  
50 nM of TAMRA-labeled Bradykinin (TMR-BK) were prepared in 1 mL 50 mM 
Tris buffer. After extraction, all the TMR-BK were extracted in organic phase. The organic 
phase was dried by blowing N2 gas. The dried residue of the mixture of polymer and the 
extracted peptides was re-dissolved in 10 L of THF, giving a final TMR-BK concentration 
of 5 μM. For the control experiment, 5 μM unextracted TMR-BK was compared to all the 
extracted results. 
Fluorescence images were obtained using an Olympus FluoView FV1000 confocal 
fluorescence microscope. 1 μL of sample spotted on ITO-coated glass slides was allowed 
to dry and was visualized under 10x magnification. The Cy3 channel (ex= 559 nm, em= 
567 nm) and the ECFP channel (ex= 405 nm and em= 476 nm) were used to image TMR-
bradykinin and CHCA matrix, respectively. Images obtained were 1024 x 1024 pixels in 
size with a scale of 0.478 m per pixel. 
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2.5.7 MALDI-MS analysis  
A Bruker Autoflex III time-of-flight mass spectrometer was used for the MALDI-
MS analysis of all samples. Acquisition of all mass spectra was done in reflectron mode 
with an accelerating voltage of 19 kV. Each spectrum is the average of 500 laser shots at 
40% laser power. 
2.5.8 Limit of detection analysis 
To better understand the sensitivity of this method, we performed extractions for a 
series of bradykinin peptide concentration (1 fM - 1μM) using 100μL of 1.75 × 10-4 M of 
co-polymer P2-1. Signal to noise (S/N) value was measured for peptide signal in the 
organic phase. We have found that we were able to detect as low as 10 pM of peptide using 
this experimental condition (Figure 2-16). Note that this detection limit is highly dependent 
on (i) the inherent sensitivity of MALDI instrument; (ii) the “hot spot” formation in the 
final sample. 
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CHAPTER 3 
 
INFLUENCE OF CHARGE DENSITY ON HOST-GUEST INTERACTIONS 
WITHIN AMPHIPHILIC POLYMER ASSEMBLIES IN APOLAR MEDIA 
 
 
Majority of this chapter is published: Zhao, B.; Zhuang, J.; Serrano, M. A. C.; Vachet, R. 
W.; Thayumanavan, S. Influence of Charge Density on Host-Guest Interactions within 
Amphiphilic Polymer Assemblies in Apolar Media. Macromolecules 2017, 50, 9734-9741. 
 
3.1 Abstract 
 The effect of charge density on supramolecular host-guest interactions between 
peptides and reverse micelles are studied using an amphiphilic random co-polymer 
scaffold. While our classical understanding of polyvalent electrostatic interactions suggests 
that the binding capacity should increase with charge density, our results indicate that this 
correlation does not necessarily hold within the nanoscale environment of reverse micelles. 
Using four series of different polymers, we show that peptide binding efficiency depends 
on the presence of an optimum charge density inside the reverse micelles. Interestingly, the 
distribution of charges does not have a significant effect on binding. Reverse micelle 
stability at high charge densities can be regained by tuning the hydrophilic-lipophilic 
balance of the polymer, yet an optimal density dependence remains. Our findings improve 
our understanding of host-guest chemistry in confined aqueous environments. 
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3.2 Introduction 
Host materials that predictably bind to guest molecules via specific interactions 
have attracted attention due to their potential applications in a variety of areas such as 
biomedical engineering, pharmaceutics and chemical synthesis.1-8 Over the past decade, 
supramolecular architectures have been widely investigated in a number of host-guest 
systems, in which the binding profile can be efficiently controlled, especially the 
selectivity, dynamics and interfacial molecular interactions.9-14 Amphiphilic assemblies 
provide an interesting and unique opportunity in that there is an inherent solvophobic 
driving force for certain molecules to bind to their interior. In addition, the functional 
groups within the interior of these assemblies can be used to introduce selectivity. For 
example, reverse micelles bearing hydrophobic moieties on the outside and hydrophilic 
groups on the inside provide a scaffold that can readily bind to hydrophilic guest molecules 
in various biphasic systems.15-16 Small molecule surfactants (e.g. sodium bis(2-ethylhexyl) 
sulfosuccinate (AOT)) or surfactant / phase transfer reagent mixtures based on reverse 
micelles have been broadly explored for the purposes of protein purification, molecular 
sensing, biomolecular separations, heterogeneous catalysis, and as nanoreactors.18-30 
Despite the widespread use of small molecule surfactant-based reverse micelles, 
their simple structures often limit their ability to achieve more sophisticated functions. 
Recently, polymeric reverse micelles have gained interest due to their advantageous 
characteristics such as tunable viscosity in solution, controlled variability in functional 
group placements, and enhanced interfacial activity.31-36 In this context, our group has 
developed polymeric reverse micelles that can be used as supramolecular hosts to 
selectively sequester peptides based on electrostatic interactions via a simple biphasic 
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extraction.37-40 Given the host-guest properties of these materials, we are interested in 
utilizing this system as a framework for understanding the fundamental structural features 
that underlie the electrostatic interactions in a dispersed aqueous phase and evaluate their 
implications in host-guest properties of the polymeric assemblies. To our knowledge, no 
studies have systematically explored how factors such as charge density or the hydrophilic-
lipophilic balance influence host-guest binding in the nanoscale spaces that are defined by 
a dispersed aqueous phase. In this work, we describe the use of a random co-polymer 
scaffold to probe the influence of charge density and hydrophilic-lipophilic balance on 
host-guest binding capacity in reverse micelles. Conventional wisdom, based on the 
strength of polyvalent interactions, would suggest that there should be a direct correlation 
between charge density and binding capacity. However, our results here show that there is 
an optimum charge density for a given polymer structure that controls guest binding 
efficiency. Interestingly, the placement of this optimal charge density is dependent on the 
hydrophobic character of the polymer and therefore is tunable. These findings should 
inform the rational design of next generation of materials for encapsulation, separation, 
and controlled release.  
3.3 Results and discussion 
3.3.1 Polymer synthesis  
The influence of charge density was initially studied using a series of styrenyl 
random co-polymers containing a mixture of hydrophobic monomers based on alkoxy 
substitution at the para-position of the phenyl ring and hydrophilic monomers containing 
an oxyacetic acid moiety at the same position (P3-1 - P3-5 in Figure 3-1). To tune the 
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charge density in this series of polymers, the percentage of the anionic monomer was 
systematically varied. The monomers were synthesized by installing the appropriate 
functional groups using the phenolic functional group in 4-hydroxybenzaldehyde, followed 
by conversion of the aldehyde moiety to the corresponding styrene using Wittig reactions. 
Co-polymerization reactions were performed using the nitroxide-mediated polymerization 
method to obtain polymers P3-1 - P3-5 (Figure 3-1). The ratio of monomers was controlled 
by simply varying the feed ratios of the constituent monomers.  
 
Figure 3-1. Synthetic scheme and chemical structures of polymers P3-1 - P3-5. 
 
3.3.2 Determination of extraction capacity  
To test the influence of charge density on host-guest binding efficiency, reverse 
micelle solutions of polymers P3-1 - P3-5 were prepared in toluene at a final polymer 
concentration of 1.0 × 10-4 M. A small volume (~ 1 µL) of aqueous NaOH was added to 
each reverse micelle solution to generate a water pool in the interior of the reverse micelles, 
which is necessary for the formation of stable assemblies. Dynamic light scattering (DLS) 
measurements were performed to confirm the formation of reverse micelle assemblies and 
to determine their sizes (Figure 3-2). Transmission electron microscopy (TEM) images 
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further validate the assemblies of spherical reverse micelle structures (Figure 3-3). Reverse 
micelle sizes are found to increase slightly for polymers P3-1 - P3-4, which is likely caused 
by increases in charge repulsion in the confined compartments inside the assemblies for 
the polymers with higher carboxylate numbers. P3-5 has a significantly larger size, which 
may indicate higher order aggregates in toluene.  
 
Figure 3-2. Size of reverse micelle solutions of P3-1 - P3-5 measured by DLS. 
 
 
Figure 3-3. Exemplified TEM images of selected reverse micelles. 
 
  60 
Host-guest binding efficiency was determined using a series of bradykinin peptide 
(RPPGFSPFR, Mw = 1060.2, pI = 12.10) standards of increasing concentrations that were 
extracted from an aqueous phase into a toluene phase containing the polymeric reverse 
micelles of interest. The binding capacity of a given polymer assembly was measured via 
matrix assisted laser desorption ionization mass spectrometry (MALDI-MS) analysis of 
both the organic and aqueous phase after extraction (Figure 3-4a and 3-2b). At low peptide 
concentrations, there are no peptide ion signals in the mass spectra of the aqueous phase, 
whereas the mass spectra of the corresponding organic phase show abundant ion signals, 
as exemplified in Figure 3-4b, indicating that the capacity of the reverse micelle has not 
been reached. At higher peptide concentrations, peptide ion signals become apparent in the 
aqueous phase (Figure 3-4b), indicating that the capacity of the reverse micelle has been 
reached. By plotting the MS signals from the aqueous and organic phases as a function of 
peptide concentration, we determine an effective capacity of the reverse micelles (Figure 
3-4c) and use this to characterize how changes in polymer structure influence binding 
efficiency.41 For the combination of the polymer P3-1 at a concentration of 1.0 x 10-4 M 
and the bradykinin peptide, the binding capacity is found to be about 0.10 µM (Figure 3-
4c).  
 
 
 
  61 
 
Figure 3-4. (a) Example mass spectra of the aqueous phase (top) and the organic phase (bottom) 
after extraction of the peptide bradykinin (0.01 µM) from an aqueous phase (1 mL) at pH 5.4 into 
a toluene phase (100 µL) containing 1.0 × 10-4 M of polymer P3-1. (b) Example mass spectra of 
the aqueous phase (top) and the organic phase (bottom) after extraction of the peptide bradykinin 
(0.35 µM) from an aqueous phase (1 mL) at pH 5.4 into a toluene phase (100 μL) containing 1.0 × 
10-4 M of polymer P3-1. (c) Example peptide extraction capacity determination for reverse micelles 
of polymer P3-1 at pH 5.4. (Vertical dashed line indicates the point that is considered as the 
capacity of reverse micelles.) 
 
3.3.3 Relationship between charge density and extraction capacity  
It is reasonable to hypothesize that reverse micelles with higher charge densities 
would have higher binding efficiencies, because they would better accommodate an 
increased number of charged peptides. To test this hypothesis, binding capacities of reverse 
micelles of P3-1 - P3-5 were examined at pH 7.6 (Figure 3-5a). Interestingly, we find that 
increasing charge density only improves binding efficiency up to a point, after which the 
binding efficiency decreases at higher charge densities. Comparisons of the capacities for 
P3-1, P3-2, and P3-3 (from 10% to 29% carboxylate) show that increasing charge density 
indeed facilitates peptide binding. Interestingly however, comparisons of P3-3, P3-4 and 
P3-5 (from 29% to 65% carboxylate) show the opposite trend. P3-5, which has the highest 
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percentage of carboxylates and thus highest charge density, has the lowest binding 
capacity. The majority (65%) of the repeat units in P3-5 are carboxylates, making it 
significantly more hydrophilic than the other co-polymers. Therefore, we speculated that 
the high hydrophilic content of this polymer might cause it to not remain stably trapped in 
the organic phase to host peptides from the aqueous phase during the biphasic extraction, 
which in turn might contribute to its lower capacity. This possibility was tested using UV-
visible absorption spectroscopy to measure the extent of possible translocation of the 
polymer from the toluene phase to the aqueous phase, after it is assembled as a reverse 
micelle in the toluene.42 The signature peak for the styrenyl polymers (around 280 nm) is 
found exclusively in the organic phase for polymers P3-1 - P3-4, before and after mixing 
toluene and water, indicating that polymers P3-1 - P3-4 are stably trapped in the organic 
phase during extraction. In contrast however, there is a discernable polymer peak detected 
in the aqueous phase for P3-5 after mixing, revealing that this polymer redistributes itself 
between the two phases, thus explaining its poor capacity. Overall, these UV-Vis 
absorption data indicate that the stability of the reverse micelle assemblies in the organic 
phase might be a prerequisite for an efficient extraction.  
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Figure 3-5. (a) Peptide capacities at pH 7.6 after extracting with 100 μL of a 1 × 10-4 M solution 
of polymers P3-1 - P3-5. The peptide capacities for each polymer were determined as shown in 
Figure 3-4c. (b) UV-Vis absorption measurements with reverse micelles of polymer P3-1 starting 
in toluene (ORG), before and after equilibration (Eq) with an aqueous Tris buffer (AQ) at pH 7.6. 
Identical results were obtained for polymer P3-2 - P3-4 (Figure 3-7). (c) UV-Vis absorption 
measurements with reverse micelles of polymer P3-5 starting in toluene (ORG), before and after 
equilibration (Eq) with an aqueous Tris buffer (AQ) at pH 7.6. (d) Peptide capacities at different 
pHs after extracting with 100 μL of a 1 × 10-4 M solution of polymers P3-3 and P3-4. (e) Peptide 
capacities at different pHs after extracting with 100 μL of 1 × 10-4 M solutions of polymers P3-1, 
P3-2 and P3-5. (f) UV-Vis absorption measurements with reverse micelles of polymer P3-5 starting 
in toluene (ORG), before and after equilibration (Eq) with an aqueous Tris buffer (AQ) at pH 5.4. 
(g) Theoretical calculations of the carboxylate concentrations in 100 μL of reverse micelle solutions 
for P3-1 - P3-5 at different pHs (assuming 5.5 as the pKa of carboxylate)43. The dashed line 
indicates the optimal charge density. Asterisks indicate the pH at which the maximum capacity is 
reached for each polymer. 
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The size of the reverse micelle assemblies could be another factor to potentially 
influence the extraction capacity. To test this hypothesis, reverse micelle solutions of P3-
4 having different assembly sizes were prepared using different water pool volumes (Figure 
3-6). We find that the initial size of the reverse micelles has no direct correlation with the 
binding capacity, indicating that the electrostatic interactions are the primary driving forces 
for the binding capacity. This is observation is attributed to the possibility that these 
assemblies eventually reach the same hydrated state after equilibration with the aqueous 
phase. Interestingly, we observed that P3-3 (29% carboxylate), which has less charge 
density than P3-4 (51% carboxylate), has a capacity that is about 1.5 times higher than P3-
4. Note that both P3-3 and P3-4 are stable in the organic phase during extractions (Figure 
3-7). Because a higher charge density clearly does not result in higher binding efficiency, 
we reasoned that the high capacity of P3-3 might be due to it having an optimal charge 
density. To test this idea, pH-dependent extractions were performed for P3-3 and P3-4. 
Since the degree of deprotonation of carboxylate moieties would vary with pH, we 
envisaged that pH changes would vary the charge density of the reverse micelles.  If charge 
density is indeed the reason for the observed binding capacity, then this variation should 
affect the binding capacity, where the capacity of polymer P3-4 is as efficient as or better 
than that of P3-3. The effective pKa of carboxylate functional groups in the reverse micelles 
is around 5.5.43 Therefore, as the pH is changed from 7.6 to pH 6.5, there will be fewer 
deprotonated carboxylates for P3-3 (29% carboxylate), which will move the charge density 
below the optimum. On the other hand, lowering the pH will reduce the number of charged 
groups in P3-4 (51% carboxylate) to an extent that is closer to optimum. Indeed, as 
expected, we observe a decrease in capacity for P3-3 and an increase in capacity for P3-4 
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at pH 6.5, which supports the idea of an optimal charge density for binding efficiency 
(Figure 3-5d). Furthermore, both polymers have lower capacities at pH 5.4, which can be 
explained by the diminished number of deprotonated carboxylate groups necessary for 
binding. At pH 8.7, both polymers bind peptides less efficiently, presumably because of an 
excess charge density.  
 
Figure 3-6. (a) Size of reverse micelle solution of P3-4 with different amount of water addition. 
(b) Capacities of reverse micelle solutions of P3-4 with different sizes at pH 7.6. 
 
 
Figure 3-7. UV-Vis measurements with reverse micelles of P3-2 - P3-4 starting in toluene (ORG), 
before and after equilibration (Eq) with aqueous phase (AQ). 
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The pH dependent capacities for other polymers in this series were also examined 
to see if pH affects the charge density and binding efficiencies in an analogous manner 
(Figure 3-5e). The capacities of the reverse micelles of P3-1 (10% carboxylate) and P3-2 
(18% carboxylate) increase as pH increases, indicating that increased deprotonation of 
these polymers helps them approach the optimum charge density to better accommodate 
guest molecules. P3-5 (65% carboxylate) behaves differently than the rest of the polymers, 
having a relatively high capacity at pH 5.4 and low capacities at higher pHs. This 
contrasting behavior at higher pH is likely due to the poor stability of polymer in organic 
phase (e.g. Figure 3-5c). Interestingly, the higher capacity at pH 5.4 is likely due to the 
ability of P3-5 to remain in the organic phase (Figure 3-5f). Therefore, the pH-dependent 
capacity suggests that the pH of bulk aqueous solution can determine the degree of 
protonation/deprotonation of polymers to further influence the charge density of the host 
assemblies, which in turn determines the guest binding capacity.   
The presence of an optimum charge density for maximal binding efficiency 
suggests there is an optimum carboxylate concentration in the reverse micelles that 
maximizes peptide binding. To determine this concentration, we assumed a pKa of 5.5 and 
calculated the number of carboxylate groups in each polymer at different pHs (Figure 3-
5g). From these calculations, we find that approximately 1.5 mM of carboxylate groups 
provides the optimum binding efficiency for these polymers, regardless of the percentage 
of carboxylic acid groups in the polymers. The percent fractional occupancy of the 
carboxylates in the reverse micelles by peptides also correlates with the extraction capacity, 
which indicates that the optimal charge density can lead to an optimal fractional occupancy 
of carboxylates and further lead to a maximum extraction capacity (Table 3-1 and Figure 
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3-8).  Moreover, this optimal charge density appears to be peptide independent as the same 
trend is observed for two other peptides with different amino acid sequences and charge 
densities (Figure 3-9). 
 
Table 3-1. Theoretical calculation of the occupied carboxylate by peptides. 
 
Amount of negatively 
charged carboxylate 
in reverse micelles 
(mol) 
Amount of extracted 
bradykinin 
(mol) 
Amount of positive 
charge provided by 
peptide (mol) 
Ratio of the occupied 
carboxylate 
(%) 
P3-1 4.6 E-8 7.0 E-10 1.41 E-9 3.0 % 
P3-2 1.2 E-8 3.9 E-9 7.76 E-9 6.6 % 
P3-3 1.4 E-7 8.8 E-9 1.76 E-8 12.4 % 
P3-4 2.0 E-7 5.7 E-9 1.15 E-8 5.7 % 
P3-5 2.9 E-7 2.9 E-10 5.86 E-10 0.2 % 
 
 
Figure 3-8. Percent occupancy of carboxylates in the reverse micelles by bradykinin peptides (net 
charge is 2 at pH 7.6) using extraction capacities in Figure 3-5a. 
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Figure 3-9. (a) Beta-amyloid 15-20 peptide capacities of P3-1 - P3-5 at pH 7.6. (b) (Lys4)-
kinetensin peptide capacities of P3-1 - P3-5 at pH 7.6. 
 
3.3.4 Comparison of “global” and “local” charge density  
While there is clearly an optimum charge density for efficient peptide binding, it is 
interesting to investigate whether restricting the positioning of the carboxylates has any 
effect on the host-guest binding capabilities of the polymeric reverse micelles. In other 
words, we sought to understand how “local” changes in charge density affect peptide 
binding. To test this, a second series of co-polymers P3-6, P3-7 and P3-8, which have 17%, 
31% and 52% of di-carboxylate functional groups respectively, was synthesized (Figure 3-
10a). The binding capacities of these polymers were then compared to mono-carboxylate 
polymers. We note that the binding capacities of P3-3 (29% carboxylate) and P3-6 (17% 
di-carboxylate) are similar. Although the overall number of carboxylate moieties are 
similar in both polymers, the former polymer contains twice as many hydrophilic 
monomers distributed over the polymer. In other words, the local charge density of P3-6 
is twice the local charge density of P3-3. The fact that the binding capacity of these 
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polymers are similar at all pHs suggests that it is the global (or the overall) carboxylate 
density that dictates capacity rather than the local charge density. However, compared to 
P3-3 (29% carboxylate), P3-7 (31% di-carboxylate) has double the amount of carboxylate 
groups, and it behaves differently from P3-3, especially at higher pHs (Figure 3-10b). It is 
reasonable to speculate that the overall charge density of P3-7 is twice the optimal charge 
density at higher pH (such as pH 8.7). Too much charge density gives rise to a poor 
extraction capacity, which is consistent with our observations above. At lower pH (such as 
pH 5.4), P3-7 has higher capacity than P3-3, since the charge density of P3-7 is closer to 
the optimum than that of P3-3 (Figure 3-11b).  
 
Figure 3-10. (a) Chemical structures of amphiphilic random co-polymers P3-6 - P3-8. (b) Peptide 
capacities at different pHs after extracting with 100 μL of 1 × 10-4 M of polymers P3-3, P3-6 and 
P3-7. (c) Peptide capacities at different pHs after extracting with 100 μL of 1 × 10-4 M of polymers 
P3-5 and P3-8. 
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Figure 3-11. (a) Peptide capacities at pH 8.7 after extracting with 100 μL of 1 × 10-4 M solution of 
polymers P3-1 - P3-8. (b) Theoretical calculations of the concentration of carboxylate in 100 μL 
solution of the reverse micelle solutions for P3-1 - P3-8 at different pHs (assuming 5.5 as the pKa 
of carboxylate)41. The dashed line indicates the optimal charge density. (c) Peptide capacities at 
different pHs after extracting with 100 μL of 1 × 10-4 M solution of polymers P3-5 and P3-7.  
 
Interestingly, P3-8 (52% di-carboxylate), which has the highest carboxylate 
number among all co-polymers, has a low binding capacity like P3-5 (65% carboxylate) 
(Figure 3-10c) but unlike P3-5, which equilibrates into the aqueous phase during the 
extraction, P3-8 does not cross the interface into the aqueous phase (Figure 3-12). The 
stability of the reverse micelle assembly of P3-8 is attributed to the higher hydrophobic 
content of the polymer, suggesting that retention of the reverse micelle of the polymer is 
largely dependent on hydrophobic content (about 50% of hydrophobic monomer repeating 
unit in the polymer). The excess charge density, however, still causes P3-8 to have a low 
binding capacity, indicating that a proper balance of hydrophobicity and charge is 
necessary for a stable assembly but not sufficient for high binding capacity. 
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Figure 3-12. UV-Vis measurements with reverse micelles of P3-8 starting in toluene (ORG), 
before and after equilibration (Eq) with aqueous phase (AQ). 
 
Upon comparing the extraction capacities of P3-1 - P3-8 at pH 8.7 (Figure 3-11a), 
we again find that there is an optimum charge density for most efficient peptide binding. 
Moreover, this optimum charge density appears to consistently correspond to a carboxylate 
concentration of 1.5 mM (Figure 3-11b). Overall, comparisons of the polymers P3-1 - P3-
8 indicate that local charge density changes have a minimal effect on the overall guest 
binding capability. A notable exception to this conclusion is evident upon comparing the 
capacities of P3-5 (65% carboxylate) and P3-7 (31% di-carboxylate), which are clearly 
different even though they possess nearly the same global charge density (Figure 3-11c). 
A possible explanation for this exception might be the fact that P3-7 has twice as much 
hydrophobic character as P3-5, which could contribute to the organization of the 
assemblies, as the increased hydrophobic character of P3-7 might lead to a better 
hydrophilic-lipophilic balance (HLB). This explanation is also consistent with the biphasic 
equilibration comparisons between P3-5 and P3-8 (52% di-carboxylate), discussed above.  
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3.3.5 Optimization of the HLB of polymers 
To explore the effect of HLB, which determines the packing of small molecule 
monomers or polymeric unimers in a micellar state,43-48 on reverse micelle binding 
efficiency, we synthesized and studied the binding abilities of a third series of polymers 
P3-9 - P3-11. Given the behavior of polymer P3-7, we predicted that an optimum HLB 
might exist for a polymer with a given charge density that would in turn influence a reverse 
micelle’s binding efficiency. The random co-polymer scaffold used in this study allows us 
to conveniently vary the HLB of a given polymer by changing the hydrophobic chain 
length without modifying the carboxylate functional group ratio and charge density.  
 
Figure 3-13. (a) Chemical structures of amphiphilic random co-polymers P3-4, P3-9 - P3-11. (b) 
Chemical structure of amphiphilic random co-polymers P3-3, P3-12 - P3-14. (c) Peptide capacities 
at pH 8.7 after extracting with 100 μL of 2.0 × 10-4 M of carboxylate functional groups of polymers 
P3-4, P3-9 - P3-11. (d) Peptide capacities at pH 8.7 after extracting with 100 μL of 1.5 × 10-4 M of 
carboxylate functional groups of polymers P3-3, P3-12 - P3-14. 
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To test the importance of the HLB, we synthesized random co-polymers P3-9 - P3-
11, all of which have carboxylate ratios (~50%) like polymer P3-4, but have different 
carbon chain lengths (Figure 3-13a).  P3-9, P3-10, and P3-11 contain hexyl, tetradecyl, 
and hexadecyl based linear alkyl chains, compared to the linear decyl chain in P3-4. We 
chose P3-4 as the control polymer for this study, because P3-4 exhibits reasonable stability 
of the assembly but does not have the optimal peptide binding capacity. Upon performing 
extractions at pH 8.7, we find that the capacity of the reverse micelle assemblies from these 
polymers indeed depend on the HLB of the polymer (Figure 3-13c).  The hexyl chain based 
P3-9 exhibit much poorer binding capacity compared to P3-4, while the tetradecyl based 
P3-10 exhibits higher binding capacity.  The increase in binding capacity levels off with a 
C14 alkyl chain, as there is no significant difference between P3-10 and P3-11.  
To further validate these findings, we synthesized a fourth series of polymers P3-
3, P3-12 - P3-14 (Figure 3-13b), where the control polymer is the best-performing polymer 
in the first series, P3-3 (30% carboxylate_C10).  Here too, the hexyl chain based polymer 
P3-12 exhibits a poorer binding capacity, compared to P3-3, while the longer chain lengths 
perform better than P3-3.  Note, however, that the increase in binding capacity upon going 
from a decyl chain to a tetradecyl chain based polymer is modest (Figure 3-13d).  We take 
this to suggest that P3-3 already contains an optimal charge density and the required HLB 
to act as a host assembly for the peptide guests. Therefore, a further change in the HLB 
does not affect the binding capacity. In the P3-4, P3-9 - P3-11 series above, however, an 
increase in the chain length provides a significant increase in binding capacity since P3-4 
(50% carboxylate_C10) does not have the optimal HLB. Overall, these results suggest that 
an appropriate HLB is critical to maximize binding efficiency, along with the optimal 
  74 
charge density in the polymer. Also, the capacity appears to be independent of polymer 
molecular weight. 
3.4 Conclusions 
 In summary, we have synthesized four different series of random co-polymers, each 
of which provides systematic variations in hydrophobic alkyl chains and the hydrophilic 
carboxylate moieties.  All these polymers form reverse micelle-type assemblies for hosting 
peptide guest molecules, which can be assessed through a simple biphasic extraction 
method. Using extraction capacity as an indicator of host-guest binding efficiency, we 
discover several structural aspects that influence peptide binding: (i) the electrostatic 
binding capacity does not increase consistently with the increase in charge density. (ii) the 
binding capacity does increase with charge density up to a certain extent, while an opposite 
trend is also observed after this optimal charge density. (iii) The optimal charge density in 
these polymers can be achieved by locally increasing the charge density within a monomer 
unit or over the entire polymer. This insensitivity to local vs. global charge density allows 
for tuning the HLB of the polymer. (iv) High charge densities in polymers compromise the 
stability of the reverse micelle assembly in the organic phase, with respect to its possible 
crossover to the aqueous phase in a biphasic mixture. (v) While the stability of the assembly 
with respect to this crossover is required, it does not seem to be a sufficient criterion for 
peptide binding capacity, as seemingly stable assemblies with high charge densities still 
exhibit low binding capacity. This suggests that the crossover experiment does not fully 
evaluate the fidelity of the as a host for complementary peptides. (vi) Hydrophobic 
reinforcement, which changes the HLB of the polymer and thus its stability as a reverse 
micelle, enhances the binding capacity of the assemblies. This observation supports the 
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previous point. Overall, these studies challenge the conventional notion that high density 
of complementary functionalities, including electrostatic interactions, will result in a 
stronger polyvalent interaction.49-51 Our studies show that in the context of studying 
electrostatics-based multivalent interactions in organic solvents, correlations between 
charge density and binding are not straightforward. Thus, this investigation will 
fundamentally influence the general design guidelines for achieving polymer assemblies 
that bind guest molecules through electrostatic interactions in confined solution 
environments. 
3.5 Experimental section 
3.5.1 Polymer synthesis and characterization 
All reagents were commercially available and used as received unless stated 
otherwise. 1H-NMR spectra were recorded on a 400 MHz NMR spectrometer using 
residual proton resonance of the solvents as internal standard. Chemical shifts are reported 
in parts per million (ppm). Mass spectra were obtained by a Bruker AmaZon quadrupole 
ion trap mass spectrometer coupled with electrospray ionization source. Gel permeation 
chromatography (GPC) was used to estimate the molecular weight of polymers using THF 
as eluent and 1μL of toluene was added as the internal reference. Polystyrene standards 
were used for calibration and data analysis. Dynamic light scattering (DLS) was measured 
by a Malvern Zetasizer. Transmission electron microscopy (TEM) images were taken from 
JEOL JEM-2000FX. Synthetic pathways were listed below and detailed information can 
be found in Appendix.  
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Synthetic pathway of random co-polymer P3-1 - P3-5: 
 
Synthetic pathway of random co-polymer P3-6 - P3-8: 
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Synthetic pathway of random co-polymer P3-9 - P3-14: 
 
3.5.2 Preparation of polymeric reverse micelles 
An appropriate amount of amphiphilic random co-polymers was dissolved in 
toluene. 2 L of 0.005 M NaOH aqueous solution and was added per 2 mL of the reverse 
micelle solution. Sonication was conducted until the polymer becomes fully dispersed. 
Dynamic light scattering (DLS) and transmission electron microscopy (TEM) 
measurements were performed to confirm the formation of reverse micelles (Figure 3-2, 3-
3 and 3-14). 
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Figure 3-14. DLS of reverse micelles of P3-6 - P3-14. 
 
3.5.3 Matrix solutions 
α-Cyano-4-hydroxycinnamic acid (CHCA) in acetonitrile (ACN) solution was 
prepared at a concentration of 10 mg/mL in 50 L ACN: 47.5 L H2O: 2.5 L 
trifluoroacetic acid (TFA). CHCA in THF solution was prepared at a concentration of 30 
mg/mL in 350 L THF:150 L H2O:6 L TFA. 
3.5.4 Peptide extraction and sample preparation 
The general extraction procedure has been described elsewhere, but in short, the 
following procedure was used. Peptide solutions were prepared in 50 mM Tris buffer where 
the pH of the buffer is adjusted beforehand. 1 mL of the buffered peptide solution was 
mixed vigorously with 200 L of the polymeric reverse micelle solution for 2 hours. After 
mixing, the solution was centrifuged at 13,000 rpm for 60 minutes to break the emulsion. 
The aqueous phase was withdrawn and kept in a separate microtube. 10 L of the aqueous 
phase sample was then mixed with 10 L of ACN CHCA matrix solution. From this 
sample, 2 L was spotted on the MALDI target plate for MALDI-MS analysis. The 
remaining organic phase was dried by blowing N2 gas. The dried residue of the mixture of 
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polymer and the extracted peptides was re-dissolved in 10 L of THF and then 20 L of 
the THF CHCA matrix solution was added. From this sample, 1 L was spotted on the 
MALDI target plate for MALDI-MS analysis. 
3.5.5 MALDI-MS analysis 
A Bruker Autoflex III time-of-flight mass spectrometer was used for the MALDI-
MS analysis of all samples. Acquisition of all mass spectra was done in reflectron mode 
with an accelerating voltage of 19 kV. Each spectrum is the average of 500 laser shots at 
40% laser power. 
3.5.6 Calculated percent occupancy of carboxylates 
 The total amount (in mol unit) of positively charged peptides were obtained from 
Figure 3-5a. Since bradykinin (RPPGFSPFR) peptide has a net charge of 2 at pH 7.6, the 
total amount of postive charge provided by bradykinin is twice of the amount of extracted 
peptide. The amount of negatively charged carboxylate is calculated from Figure 3-5g 
using the concentration of carboxylate multipled by the 100 μL volume. Assuming one 
bradykinin can bind to two carboxylates in reverse micelle, the ratio of the occupied 
carboxylate is calculated using (amount of positive charge provided by peptide)/ (amount 
of carboxylate in reverse micelles).  
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CHAPTER 4 
 
IMPROVED MASS SPECTROMETRIC DETECTION OF ACIDIC PEPTIDES 
BY VARIATIONS IN THE FUNCTIONAL GROUP PKA VALUES OF REVERSE 
MICELLE EXTRACTION AGENTS 
 
 
Majority of this chapter is published: Zhao, B.; Serrano, M. A. C.; Wang, M.; Liu, T.; 
Gordon, M. R.; Thayumanavan, S.; Vachet, R. W.; Improved mass spectrometric detection 
of acidic peptides by variations in the functional group pKa values of reverse micelle 
extraction agents. Analyst 2018, 143, 1434-1443. 
 
4.1 Abstract 
Polymeric reverse micelles can be used to selectively extract peptides from 
complex mixtures via a two-phase extraction approach. In previous work, we have shown 
that the charge polarity of the hydrophilic functional group that is in the interior of the 
reverse micelle dictates the extraction selectivity. To investigate how the extraction is 
influenced by the inherent pKa of the functional group, we designed and tested a series of 
polymeric reverse micelles with variations in the hydrophilic functional group. From this 
series of polymers, we find that the extraction capability of the reverse micelles in an apolar 
phase is directly related to the aqueous phase pKa of the interior functional group, 
suggesting that the functional groups maintain their inherent chemistry even in the confined 
environment of the reverse micelle interior. Because these functional groups maintain their 
inherent pKa in the reverse micelle interior, they provide predictable extraction selectivity 
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upon changes in aqueous phase pH. We exploit this finding to demonstrate that sulfonate-
containing polymers can be used to remove basic peptides from complex mixtures, thereby 
allowing the improved detection of acidic peptides. Using these new materials, we also 
demonstrate a new means of isoelectric point (pI) bracketing that allows the mass 
spectrometric detection of peptides with a defined and narrow range of pI values. 
4.2 Introduction 
Simplification of complex biological mixtures is of great interest, especially for a 
variety of metabolomics and proteomics measurements that rely on mass spectrometric 
detection.1-12 Due to limitations in the dynamic range of MS based detection platforms, 
effective protein/peptide sample separation strategies are usually required prior to MS 
analysis to exploit the full detection capabilities of MS.13-20 Detection of acidic peptides 
and proteins in complex mixtures is particularly challenging because the negatively 
charged nature of these molecules usually causes them to be suppressed during ionization 
or detected inefficiently by most techniques.21-24  
Over the years, various isoelectric point (pI) based fractionation methods have been 
developed to improve the detection of acidic proteins/ peptides, such as isoelectric focusing 
mass spectrometry (IEF-MS)25-27 and ion exchange chromatography MS (IEC-MS).28-31 To 
improve acidic peptide and protein identifications in mixtures, pI-based separations have 
also been coupled with techniques like activated ion negative electron-transfer dissociation 
(AI-NETD) for proteome analysis.32-33 Our group has recently demonstrated that self-
assembled amphiphilic polymers can selectively simplify peptide mixtures via a biphasic 
extraction format, thereby allowing sensitive detection of different fractions by MS.34-37 
By assembling these amphiphilic polymers as reverse micelles in an apolar phase, we have 
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demonstrated the ability of the charged interiors of these materials to selectively sequester 
peptide biomarkers from serum.38 We have also shown that materials containing positively-
charged functional groups or metal-bound functional groups can selectively extract and 
sensitively detect negatively-charged peptides and phosphorylated peptides, 
respectively.39-40 
In previous work using an amphiphilic homopolymer with carboxylate 
functionality, we discovered a pH dependency to how efficiently positively charged 
peptides could be extracted from an aqueous phase, with extraction capacities being 
minimal at pH values around 5, which is close to the typical pKa values of carboxylates. 
From this observation, we suspected that the charge state of the functional group in the 
reverse micelle might behave in a similar manner to how it behaves in free solution.35 In 
addition to being fundamentally interesting, this behavior causes carboxylate-based 
materials to have inherent limitations with respect to extraction efficiency at lower pH 
values. To better understand the relationship between the inherent pKa of functional groups 
and their effective pKa in the interior of the reverse micelles, we synthesized new 
amphiphilic polymers with phosphonate and sulfonate groups, which have much lower pKa 
values than carboxylates. In this work, we describe the extraction capabilities of these new 
materials. Our results indicate that functional groups preserve their small-molecule pKa in 
the reverse micellar state. Moreover, we show that materials having functionalities with 
lower pKa values allow us to achieve more effective separations of acidic peptides. In 
addition, we report a “pI bracketing” method that can specifically detect acidic peptides 
within a small pI range. 
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4.3 Results and discussion 
4.3.1 Extraction at acidic pH using carboxylate polymers 
Previously, we developed the random co-polymer P4-1 (Figure 4-1a) containing 
carboxylate functional groups that can selectively simplify peptide mixtures via 
electrostatic interactions.41 The extraction selectivity depends on (i) peptide pI values and 
(ii) the pH of the bulk aqueous phase, with positively-charged peptides being selectively 
extracted by the negatively-charged polymer. It is important to note that the carboxylate 
groups are charged according to their pKa, but it is interesting to see if this charging 
behavior is the same in the confined environment of reverse micelles as it is in free solution.  
To test this idea, a reverse micelle solution of polymer P4-1 was prepared in toluene at a 
final concentration of 1.0 × 10-4 M. 200 μL of this solution was then used to perform bi-
phasic extractions of peptide mixtures containing angiotensin II (DRVYIHPF, pI= 7.78), 
kinetensin (IARRHPYFL, pI= 11.01), and β-amyloid (1-11) (DAEFRHDSGYE, pI= 3.93) 
at three different pHs. Table 4-1 shows relevant properties of each these peptides. 
 
Table 4-1. Chemical and physical characteristics of peptides used in the extraction experiments 
associated with Figures 4-1 and 4-2. (a Calculated using the program available at 
http://pepcalc.com) 
 Peptide m/z Sequence pIa 
Concentration in 
aqueous phase 
(μM) 
Net 
charge at 
pH 3 
Net 
charge at 
pH 5.5 
Net 
charge at 
pH 9 
1 Angiotensin II 1046.2 DRVYIHPF 7.78 0.10 + + - 
2 Kinetensin 1172.4 IARRHPYFL 11.01 0.10 + + + 
3 β-Amyloid (1-11) 1325.3 DAEFRHDSGYE 3.93 0.15 + - - 
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Figure 4-1. (a) Chemical structure of carboxylate random co-polymer P4-1. (b) MALDI mass 
spectrum of the aqueous (AQ) and organic phases (ORG) after extraction using reverse micelles of 
polymer P4-1 at pH 9. (c) MALDI mass spectrum of the aqueous (AQ) and organic phases (ORG) 
after extraction using reverse micelles of polymer P4-1 at pH 5.5. (d) MALDI mass spectrum of 
the aqueous (AQ) and organic phases (ORG) after extraction using reverse micelles of polymer P4-
1 at pH 3.  
 
After extraction, the corresponding spectra of the organic and aqueous phases were 
obtained via MALDI-MS. We observed that, at pH 9, negatively charged P4-1 was able to 
selectively extract kinetensin, which has a positive net charge, to the organic phase while 
leaving the negatively charged peptides, angiotensin II and β-amyloid (1-11), in the 
aqueous phase (Figure 4-1b). At pH 5.5, both kinetensin and angiotensin II are positively 
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charged and are thus extracted by reverse micelles solution of P4-1, while the negatively-
charged β-amyloid (1-11) is not extracted (Figure 4-1c). However, at pH 3 where all three 
peptides are positively charged, reverse micelles of P4-1 cannot fully extract the peptides 
despite using the same polymer concentration, as indicated by peptides remaining in the 
aqueous phase after extraction (Figure 4-1d). We speculate that this behavior is due to an 
increased number of carboxylate functional groups being protonated inside the reverse 
micelles when the aqueous phase pH is 3. In other words, the carboxylate groups in the 
confined environment reverse micelle interiors are perhaps being protonated in a manner 
that reflects the inherent pKa values of these functionality in an aqueous phase. Thus, they 
have a lower number of negative charges for binding positively-charged peptides, causing 
a significant fraction of the peptides to remain in the aqueous phase. It should be stated that 
the organic phase with the amphiphilic co-polymers was prepared in an identical fashion 
for each extraction shown in Figure 4-1, suggesting that the water pool in the interior of 
the reverse micelles  “communicates” with the aqueous phase upon extraction. We also 
note that no peptides are extracted at any pH when polymers are absence from the organic 
phase, which indicates the polymers are essential for an effective extraction. 
4.3.2 pH-dependent extraction capacity 
To test the idea that the functional groups in the reverse micelle interiors have an 
effective pKa like they would have in an aqueous phse, we designed and synthesized 
random co-polymers P4-2 and P4-3 with phosphonate (pKa ≈ 2 & 7) and sulfonate (pKa ≈ 
-0.5) functional groups respectively (Figures 4-2a and 4-2c). Reverse micelles solutions of 
polymers P4-2 and P4-3 were used to extract the same peptide mixture at pH 3, the pH at 
which polymer P4-1 could not perform the extraction efficiently. Upon extraction with 
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these polymers, we observe that all the positively charged peptides are extracted to the 
organic phase and no peptides remain in the aqueous phase (Figures 4-2b and 4-2d), which 
suggest that the functional groups in P4-2 and P4-3 retain their negative charges at the low 
extraction pH likely due to the relatively lower pKa values. Upon extraction at even lower 
pHs (i.e. pHs 2.1 and lower), we find that P4-2 is can efficiently extract peptides at a pH 
as low as 2 (Figure 4-3), while P4-3 can extract peptides even at a pH as low as 1 (Figure 
4-4). Note that incomplete peptide extraction at pH 1 for polymer P4-2 is likely because 
the phosphonate pKa is about 2, meaning that many of these functional groups in the reverse 
micelle interior are protonated in a manner similar to what was observed for polymer P4-
1 (Figure 4-1d). In contrast, the very low pKa of the sulfonate group results in reverse 
micelles of P4-3 maintaining a sufficiently charged interior even at pH 1. 
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Figure 4-2. (a) Chemical structure of phosphonate random co-polymer P4-2. (b) MALDI mass 
spectrum of aqueous phase (AQ) and organic phase (ORG) after extraction using reverse micelles 
of polymer P4-2 at pH 3. (c) Chemical structure of sulfonate random co-polymer P4-3. (d) MALDI 
mass spectrum of aqueous phase (AQ) and organic phase (ORG) after extraction using reverse 
micelles of polymer P4-3 at pH 3.  
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Figure 4-3. (a) MALDI mass spectrum of aqueous phase (AQ) and organic phase (ORG) after 
extraction using reverse micelles of polymer P4-2 at pH 2.1. (b) MALDI mass spectrum of aqueous 
phase (AQ) and organic phase (ORG) after extraction using reverse micelles of polymer P4-3 at 
pH 2.1. 
 
 
Figure 4-4. (a) MALDI mass spectrum of aqueous phase (AQ) and organic phase (ORG) after 
extraction using reverse micelles of polymer P4-2 at pH 1.0. (b) MALDI mass spectrum of aqueous 
phase (AQ) and organic phase (ORG) after extraction using reverse micelles of polymer P4-3 at 
pH 1.0. 
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If the extraction efficiency of the reverse micelles is reflecting the inherent pKa of 
their functional groups, we then predicted that the polymer extraction capacities would 
follow a titration-curve like behavior as the extraction pH is varied. To test this idea, we 
measured the pH-dependent extraction capacity of polymers P4-1, P4-2, and P4-3 (Figure 
4-5) using the peptide kinetensin, which remains positively-charged up to a pH of about 
11. We find that the capacities of P4-1 and P4-2 increase from pH 1 to pH 6.5 and have 
midpoints of about 5.5 and 2.5, respectively (Figure 4-5a and 4-3b), which are close to the 
pKa values of typical carboxylates and phosphonates.  Despite the relatively high error bars, 
the capacity of P4-3 appears to be somewhat constant over the entire pH range, suggesting 
that the functional groups in these reverse micelles have an effective pKa that is like 
sulfonates in free aqueous solution. Together, these observations further suggest that the 
functional groups in the interior of the reverse micelle behave like their bulk solution 
counterparts with regard to their pKa values. 
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Figure 4-5. (a) The normalized capacity of reverse micelles of P4-1 over aqueous solution pH 1.0 
to pH 8.7. (b) The normalized capacity of reverse micelles of P4-2 over aqueous solution pH 1.0 
to pH 8.7. (c) The normalized capacity of reverse micelles of P4-3 over aqueous solution pH 1.0 to 
pH 9.8. The peptide capacities were determined as described in the materials and method and as 
illustrated in Figure 4-6. Error bars indicate the standard deviations of three experimental replicates. 
The more significant errors for some measurements, particularly for the sulfonate polymer (c), arise 
from variations in the fits used to determine the capacity values. For each polymer, capacities were 
normalized to the highest capacity over the tested pH range. 
 
 
Figure 4-6. Example of kinetensin (KIN) peptide extraction capacity measurement using reverse 
micelles of polymer P4-1 at pH 5.4. Signal-to-noise (S/N) is used as a measure of peptide signal to 
account for well-known spot-to-spot variations in the noise levels in MALDI-MS measurements. 
In addition, we used a S/N ratio of > 3 to confirm that a peptide ion was truly measured. Linear 
regression fitting was used to obtain the capacity. 
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4.3.3 Recovery of extraction capacity at high pH 
While the extraction behavior of polymers P4-1, P4-2, and P4-3 follow the pKa 
values of their functional groups at pH values below 7, there is a clear deviation at pH 
values above 7 where the capacities decrease (Figure 4-5); this is especially apparent for 
P4-1 and P4-2. There are at least two possibilities that could explain this capacity decrease. 
First, at higher pH values more functional groups are deprotonated, resulting in more 
hydrophilic random co-polymers. This increased hydrophilic character could weaken the 
stability of the assembled reverse micelle structures or cause the assemblies to translocate 
into the aqueous phase, both of which would result in a lower extraction capacity. Second, 
the net positive charge of kinetensin decreases at higher pH, thereby weakening the 
electrostatic driving force that allows peptide extraction into the reverse micelles.  
 
Figure 4-7. UV-Vis absorption measurements with reverse micelles starting in toluene (ORG), 
before and after equilibration (Eq) with an aqueous Tris buffer (AQ). (a) P4-1 at pH 8.7. (b) P4-2 
at pH 8.7. (c) P4-3 at pH 9.8. 
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Figure 4-8. (a) Chemical structure of 29% carboxylate random co-polymer P4-4 with tetradecyl 
carbon chain. (b) The normalized capacity of reverse micelles of P4-4 for kinetensin over aqueous 
solution pH 5.4 to pH 8.7. (c) Chemical structure of 11% phosphonate random co-polymer P4-5 
with tetradecyl carbon chain. (d) The normalized capacity of reverse micelles of P4-5 for kinetensin 
over aqueous solution pH 5.4 to pH 9.8. 
 
To test if the co-polymers remain stably trapped in the organic phase, UV-Vis 
absorption spectrometry measurements were conducted for all three reverse micelle 
solutions before and after equilibration with aqueous phase at the pH where the largest 
capacity decrease occurred, as seen in Figure 4-5. No measurable polymer is found in the 
aqueous phase after equilibration (Figure 4-7), which indicated that P4-1, P4-2, and P4-3 
remain in the organic phase. Even though the polymers remain in the organic phase, it is 
possible that the highly charged reverse micelles do not have the proper hydrophilic-
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lipophilic balance (HLB) and thus do not assemble in an appropriate manner to 
accommodate peptides effectively.42 Therefore, decreasing the charge density and 
increasing the hydrophobicity might recover the proper HLB at the higher pH values and 
thus recover the extraction capacity. To test this idea, extractions were performed from pH 
5.4 to 8.7 using a random co-polymer P4-4 (Figure 4-8a) with a lower carboxylate 
percentage (i.e 29% for P4-4 vs. 51% for P4-1). Upon using P4-4 for the extraction, only 
a relatively small decrease in extraction capacity, from 1.0 ± 0.2 to 0.8 ± 0.2, is observed 
for kinetensin in going from pH 7.6 to 8.7 (Figure 4-8b). This contrasts with P4-1 for which 
the capacity decreased from 1.00 ± 0.03 to 0.5 ± 0.1 over the same pH range (Figure 4-5a). 
Similarly, extractions with P4-5, which has 11% phosphonate groups (Figure 4-8c), show 
an increase in capacity at even pH values close of 9, which is unlike P4-2 that has its 
capacity decrease dramatically at pH values above 6.5 (Figure 4-5b). Overall, these 
findings suggest that an underlying reason for the decreased capacities for P4-1 and P4-2 
at higher pH values is the improper HLB for the polymer assemblies, which evidently must 
be optimized to maintain extraction capacity at higher pHs. 
4.3.4 Selective removal of high-pI peptides 
Having shown that functional group pKa affects a reverse micelles’ pH-dependent 
extraction capacity and that polymers such as P4-2 and P4-3 can efficiently extract 
positively-charged peptides at low pH, we were interested in testing the ability of these 
polymers to simplify protein digest mixtures. The idea that we decided to explore is 
whether these materials can separate out high pI peptides and leave behind low pI peptides 
in the aqueous phase that could then be more efficiently detected. Generally speaking, 
acidic peptides can be difficult to detect due to their inherently lower ionization efficiency 
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and the fact that their ionization is often suppressed by high pI peptides. Selectively 
removing high pI peptides would benefit the detection of acidic peptides. To test this idea, 
a protein digest mixture consisting of BSA, Lysozyme (Lyz) and β-2-microglobulin (β2m) 
was prepared and extracted at a pH of 4.5 using reverse micelles of P4-1, P4-2, and P4-3. 
At this pH, peptides with pI values higher than 4.5 are expected to be extracted as they 
carry a net positive charge. Upon extraction, we observe that P4-1 fails to remove 
positively charged peptides as efficiently as P4-2 and P4-3 (Figure 4-9), likely due to the 
relatively high pKa of its carboxylates and it correspondingly low capacity at pH 4.5. While 
P4-2 simplifies the peptide mixture more effectively than P4-1, 11 peptides with pI values 
> 4.5 remain in the aqueous phase. Reverse micelles of P4-3 provide the best removal of 
peptides with pI values > 4.5 (detailed peptide information can be found in Tables 4-2 - 4-
5), presumably due to the low pKa of the sulfonate functional group. A nice advantage of 
this approach over other liquid separation techniques (e.g. ion-exchange chromatography) 
is that the peptides that remain in the aqueous phase do not undergo any dilution and can 
be readily subjected to further analyses.  
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Figure 4-9. MALDI mass spectrum of (a) a protein digest mixture of BSA, Lyz and β2m before 
extraction, with each protein at 0.1 µM; (b) the remaining aqueous phase after extraction using 200 
μL of 1.0 × 10-4 M of P4-1 at pH 4.5; (c) the remaining aqueous phase after extraction using 200 
μL of 1.0 × 10-4 M of P4-2 at pH 4.5; and (d) the remaining aqueous phase after extraction using 
200 μL of 1.0 × 10-4 M of P4-3 at pH 4.5. (The number above each peak corresponds to the 
calculated peptide pI.) 
 
4.3.5 Isolation of acidic peptides using pI-bracketing 
The ability of P4-3 to effectively extract peptides at low pH values enables a pI 
bracketing scheme that can selectively purify and detect peptides with a defined range of 
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pI values, as is illustrated in Figure 4-10. The same protein digest mixture of BSA, Lyz, 
and β2m was prepared and first extracted at pH 6.0 using a reverse micelle solution of P4-
3. During the first extraction, peptides with pI values higher than 6 are extracted into the 
organic phase (Figure 4-11a and Table 4-6) while those with lower pI values remain in the 
aqueous phase (Figure 4-11b and Table 4-7). Upon lowering the pH of the remaining 
aqueous phase to 4.5, during which peptides having pIs between 4.5 and 6 become 
positively charged, an extraction with a fresh solution of P4-3 reverse micelles results in 
the successful extraction and detection of only peptides having pIs between 4.5 and 6 
(Figure 4-12a). Moreover, more acidic peptides with pIs lower than 4.5 still remain in the 
corresponding aqueous phase (Figure 4-12b). It should be noted that some peptides having 
pI values between 4.5 and 6 remain in the aqueous phase, but this might be due to the P4-
3 reverse micelles having a slightly lower capacity at pH 4.5. Interestingly, 10 low pI 
peptides (see Tables 4-6 - 4-9), which were not detectable in the original digests mixtures, 
were detected only after sequential extractions, emphasizing how signal suppression can 
be alleviated by simplifying the mixtures during this pI bracketing approach. Separating 
and selectively detecting peptides within a pI range of 1-2 units could be useful for 
improving protein identifications via database searching,43-45 especially for acidic proteins. 
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Figure 4-10. Schematic representation of the pI bracketing scheme based on sequential extractions 
with polymeric reverse micelles. 
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Figure 4-11. The MALDI spectra of (a) the organic phase after the first extraction using 400 μL of 
2.0 × 10-5 M of P4-3 at pH 6. (b) the remaining aqueous phase after the first extraction using P4-3 
at pH 6. (The number above the peaks correspond to the calculated peptide pI values.) 
 
 
Figure 4-12. The MALDI mass spectrum of (a) the organic phase after the sequential extraction 
using P4-3 at pH 4.5. (b) the remaining aqueous phase after the sequential extraction using 400 μL 
of 2.0 × 10-5 M of P4-3 at pH 4.5. (The number above the peaks correspond to the calculated peptide 
pI values.) 
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Table 4-2. Detailed information of peptides in Figure 4-9a. 
m/z Sequence Modification Protein pI 
927.89 YLYEIAR  BSA 6.0 
1026.04 WWCNDGR 1Carbamidomethyl 
2Oxidation 
Lyz 5.8 
1036.83 CELAAAMKR 1Acetyl Lyz 8.2 
1045.98 GTDVQAWIR  Lyz 5.8 
1051.83 QNCDQFEK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.4 
1089.00 GTDVQAWIR 1Acetyl Lyz 5.8 
1121.93 CCTESLVNR 1Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 6.0 
1149.92 CCTKPESER 1Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 6.1 
1164.11 LVNELTEFAK  BSA 4.5 
1246.24 IQRTPKIQVY  b2m 10.0 
1250.12 FKDLGEEHFK  BSA 5.5 
1306.24 HLVDEPQNLIK  BSA 5.3 
1360.16 TEFTPTEKDEY  b2m 4.0 
1400.25 TVMENFVAFVDK  BSA 4.4 
1416.25 TVMENFVAFVDK 1Oxidation BSA 4.4 
1420.25 SLHTLFGDELCK 1Carbamidomethyl BSA 5.3 
1429.23 FESNFNTQATNR  Lyz 6.0 
1438.22 ETYGDMADCCEK 1Carbamidomethyl 
1Oxidation 
BSA 3.9 
1440.38 RHPEYAVSVLLR  BSA 8.8 
1472.25 FESNFNTQATNR Acetyl Lyz 6.0 
1479.11 ETYGDMADCCEK 1Carbamidomethyl 
1Oxidation 
BSA 3.9 
1480.39 LGEYGFQNALIVR  BSA 6.0 
1486.26 FESNFNTQATNR Carbamidomethyl Lyz 6.0 
1503.21 EYEATLEECCAK 2Carbamidomethyl BSA 4.1 
1523.29 YTEFTPTEKDEY  b2m 4.0 
1533.37 LKECCDKPLLEK 2Carbamidomethyl BSA 6.2 
1538.40 LCVLHEKTPVSEK 1Carbamidomethyl BSA 6.8 
1555.27 DDPHACYSTVFDK 1Carbamidomethyl BSA 4.4 
1568.36 DAFLGSFLYEYSR  BSA 4.4 
1579.34 ECCHGDLLECADDR  BSA 4.1 
1629.44 YICDNQDTISSKLK  BSA 6.0 
1640.59 KVPQVSTPTLVEVSR  BSA 8.8 
1661.44 NRCKGTDVQAWIR 1Carbamidomethyl 
1Oxidation 
Lyz 9.5 
1676.45 IVSDGNGMNAWVAWR  Lyz 5.8 
1708.46 IVSDGNGMNAWVAWR 2Oxidation Lyz 5.8 
1725.50 MPCTEDYLSLILNR 1Carbamidomethyl BSA 4.4 
1731.35 ECCHGDLLECADDR 3Carbamidomethyl 
1Glu->pyro-Glu 
BSA 4.1 
1741.49 MPCTEDYLSLILNR 1Carbamidomethyl 
1Oxidation 
BSA 4.4 
1748.38 YNGVFQECCQAEDK 2Carbamidomethyl BSA 4.1 
1754.52 NTDGSTDYGILQINSR  Lyz 4.2 
1797.53 CCAADDKEACFAVEGPK 1Pyro-carbamidomethyl BSA 4.3 
1881.65 RPCFSALTPDETYVPK 1Carbamidomethyl BSA 6.1 
1902.62 NECFLSHKDDSPDLPK 1Carbamidomethyl BSA 4.7 
1908.66 LFTFHADICTLPDTEK 1Carbamidomethyl BSA 4.5 
1911.52 CCAADDKEACFAVEGPK 2Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 4.3 
2020.74 ETYGDMADCCEKQEPER / LKPDPNTLCDEFKADEK / 
VASLRETYGDMADCCEK 
1Oxidation /  
1Carbamidomethyl / 
2Carbamidomethyl 
1Oxidation 
BSA 4.1 / 4.4 / 
4.3 
2045.82 RHPYFYAPELLYYANK  BSA 8.4 
2248.79 ECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.2 
2471.01 RPCFSALTPDETYVPKAFDEK 1Carbamidomethyl BSA 4.8 
2488.04 YNGVFQECCQAEDKGACLLPK 3Carbamidomethyl BSA 4.7 
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Table 4-2 (continuation). Detailed information of peptides in Figure 4-9a. 
m/z Sequence Modification Protein pI 
2525.10 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.6 
2542.13 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl BSA 4.6 
2613.15 VHKECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.9 
3039.38 EYEATLEECCAKDDPHACYSTVFDK 3Carbamidomethyl BSA 4.2 
 
Table 4-3. Detailed information of peptides in Figure 4-9b. 
m/z Sequence Modification Protein pI 
927.89 YLYEIAR  BSA 6.0 
993.81 WWCNDGR 1Carbamidomethyl Lyz 5.8 
1246.24 IQRTPKIQVY  b2m 10.0 
1365.18 ETYGDMADCCEK  BSA 3.9 
1429.23 FESNFNTQATNR  Lyz 6.0 
1472.25 FESNFNTQATNR Acetyl Lyz 6.0 
1479.11 ETYGDMADCCEK 1Carbamidomethyl 
1Oxidation 
BSA 3.9 
1503.21 EYEATLEECCAK 2Carbamidomethyl BSA 4.1 
1523.29 YTEFTPTEKDEY  b2m 4.0 
1533.37 LKECCDKPLLEK 2Carbamidomethyl BSA 6.2 
1629.44 YICDNQDTISSKLK  BSA 6.0 
1640.59 KVPQVSTPTLVEVSR  BSA 8.8 
1657.39 QEPERNECFLSHK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 5.5 
1676.45 IVSDGNGMNAWVAWR  Lyz 5.8 
1731.35 ECCHGDLLECADDR 3Carbamidomethyl 
1Glu->pyro-Glu 
BSA 4.1 
1748.38 YNGVFQECCQAEDK 2Carbamidomethyl BSA 4.1 
1751.63 LSQKFPKAEFVEVTK  BSA 8.5 
1754.52 NTDGSTDYGILQINSR  Lyz 4.2 
1797.53 CCAADDKEACFAVEGPK 1Pyro-carbamidomethyl BSA 4.3 
1881.65 RPCFSALTPDETYVPK 1Carbamidomethyl BSA 6.1 
1902.62 NECFLSHKDDSPDLPK 1Carbamidomethyl BSA 4.7 
1911.52 CCAADDKEACFAVEGPK 2Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 4.3 
1928.54 CCAADDKEACFAVEGPK 3Carbamidomethyl BSA 4.3 
2020.74 ETYGDMADCCEKQEPER / LKPDPNTLCDEFKADEK / 
VASLRETYGDMADCCEK 
1Oxidation /  
1Carbamidomethyl / 
2Carbamidomethyl 
1Oxidation 
BSA 4.1 / 4.4 / 
4.3 
2045.82 RHPYFYAPELLYYANK  BSA 8.4 
2114.70 VHKECCHGDLLECADDR 3Carbamidomethyl BSA 4.8 
2118.66 ETYGDMADCCEKQEPER 2Carbamidomethyl BSA 4.1 
2248.79 ECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.2 
2525.10 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.6 
2542.13 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl BSA 4.6 
2613.15 VHKECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.9 
 
 
 
 
 
 
  108 
Table 4-4. Detailed information of peptides in Figure 4-9c. 
m/z Sequence Modification Protein pI 
927.89 YLYEIAR  BSA 6.0 
993.81 WWCNDGR 1Carbamidomethyl Lyz 5.8 
1026.04 WWCNDGR 1Carbamidomethyl 
2Oxidation 
Lyz 5.8 
1036.83 CELAAAMKR 1Acetyl Lyz 8.2 
1045.98 GTDVQAWIR  Lyz 5.8 
1051.83 QNCDQFEK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.4 
1246.24 IQRTPKIQVY  b2m 10.0 
1429.23 FESNFNTQATNR  Lyz 6.0 
1472.25 FESNFNTQATNR Acetyl Lyz 6.0 
1479.11 ETYGDMADCCEK 1Carbamidomethyl 
1Oxidation 
BSA 3.9 
1503.21 EYEATLEECCAK 2Carbamidomethyl BSA 4.1 
1523.29 YTEFTPTEKDEY  b2m 4.0 
1555.27 DDPHACYSTVFDK 1Carbamidomethyl BSA 4.4 
1640.59 KVPQVSTPTLVEVSR  BSA 8.8 
1657.39 QEPERNECFLSHK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 5.5 
1731.35 ECCHGDLLECADDR 3Carbamidomethyl 
1Glu->pyro-Glu 
BSA 4.1 
1748.38 YNGVFQECCQAEDK 2Carbamidomethyl BSA 4.1 
1754.52 NTDGSTDYGILQINSR  Lyz 4.2 
1797.53 CCAADDKEACFAVEGPK 1Pyro-carbamidomethyl BSA 4.3 
1881.65 RPCFSALTPDETYVPK 1Carbamidomethyl BSA 6.1 
1911.52 CCAADDKEACFAVEGPK 2Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 4.3 
1928.54 CCAADDKEACFAVEGPK 3Carbamidomethyl BSA 4.3 
2020.74 
  
 
  
ETYGDMADCCEKQEPER / LKPDPNTLCDEFKADEK 
/ VASLRETYGDMADCCEK 
1Oxidation /  
1Carbamidomethyl / 
2Carbamidomethyl 
1Oxidation 
BSA 4.1 / 4.4 / 
4.3 
2118.66 ETYGDMADCCEKQEPER 2Carbamidomethyl BSA 4.1 
2248.79 ECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.2 
2525.10 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.6 
2542.13 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl BSA 4.6 
 
Table 4-5. Detailed information of peptides in Figure 4-9d. 
m/z Sequence Modification Protein pI 
927.89 YLYEIAR  BSA 6.0 
993.81 WWCNDGR 1Carbamidomethyl Lyz 5.8 
1365.18 ETYGDMADCCEK  BSA 3.9 
1429.23 FESNFNTQATNR  Lyz 6.0 
1479.11 ETYGDMADCCEK 2Carbamidomethyl BSA 3.9 
1503.21 EYEATLEECCAK 2Carbamidomethyl BSA 4.1 
1555.27 DDPHACYSTVFDK 1Carbamidomethyl BSA 4.4 
1731.35 ECCHGDLLECADDR 3Carbamidomethyl 
1Glu->pyro-Glu 
BSA 4.1 
1748.38 YNGVFQECCQAEDK 2Carbamidomethyl BSA 4.1 
1750.38 ECCHGDLLECADDR 3Carbamidomethyl BSA 4.1 
1754.52 NTDGSTDYGILQINSR  Lyz 4.2 
1911.52 CCAADDKEACFAVEGPK 2Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 4.3 
1928.54 CCAADDKEACFAVEGPK 3Carbamidomethyl BSA 4.3 
2117.78 ETYGDMADCCEKQEPER 2Carbamidomethyl BSA 4.1 
2248.79 ECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.2 
2525.10 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.6 
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Table 4-6. Detailed information of peptides in Figure 4-12a. 
m/z Sequence Modification Protein pI 
1026.04 WWCNDGR 1Carbamidomethyl 
2Oxidation 
Lyz 5.8 
1246.24 IQRTPKIQVY  b2m 10.0 
1344.19 SRHPAENGKSNF  b2m 8.5 
1440.38 RHPEYAVSVLLR  BSA 8.8 
1480.39 LGEYGFQNALIVR  BSA 6.0 
1568.36 DAFLGSFLYEYSR  BSA 4.4 
1640.59 KVPQVSTPTLVEVSR  BSA 8.8 
1881.65 RPCFSALTPDETYVPK 1Carbamidomethyl BSA 6.1 
2045.82 RHPYFYAPELLYYANK  BSA 8.4 
 
Table 4-7. Detailed information of peptides in Figure 4-12b. Peptides with asterisks are peptides 
that were not detected in the original digests mixtures. 
m/z Sequence Modification Protein pI 
927.89 YLYEIAR  BSA 6.0 
1036.83 CELAAAMKR 1Acetyl Lyz 8.2 
1045.98 GTDVQAWIR  Lyz 5.8 
1051.83 QNCDQFEK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.4 
1089.00 GTDVQAWIR 1Acetyl Lyz 5.8 
1121.93 CCTESLVNR 1Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 6.0 
1149.92 CCTKPESER 1Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 6.1 
1164.11 LVNELTEFAK  BSA 4.5 
1250.12 FKDLGEEHFK  BSA 5.5 
1306.24 HLVDEPQNLIK  BSA 5.3 
1360.16 TEFTPTEKDEY  b2m 4.0 
1400.25 TVMENFVAFVDK  BSA 4.4 
1416.25 TVMENFVAFVDK 1Oxidation BSA 4.4 
1429.23 FESNFNTQATNR  Lyz 6.0 
1438.22 ETYGDMADCCEK 1Carbamidomethyl 
1Oxidation 
BSA 3.9 
1440.38 RHPEYAVSVLLR  BSA 8.8 
*1444.22 YICDNQDTISSK 1Carbamidomethyl BSA 4.2 
*1464.18 TCVADESHAGCEK 2Carbamidomethyl BSA 4.7 
1472.25 FESNFNTQATNR Acetyl Lyz 6.0 
1479.11 ETYGDMADCCEK 1Carbamidomethyl 
1Oxidation 
BSA 3.9 
1480.39 LGEYGFQNALIVR  BSA 6.0 
1486.26 FESNFNTQATNR Carbamidomethyl Lyz 6.0 
1503.21 EYEATLEECCAK 2Carbamidomethyl BSA 4.1 
1523.29 YTEFTPTEKDEY  b2m 4.0 
1533.37 LKECCDKPLLEK 2Carbamidomethyl BSA 6.2 
1538.40 LCVLHEKTPVSEK 1Carbamidomethyl BSA 6.8 
1555.27 DDPHACYSTVFDK 1Carbamidomethyl BSA 4.4 
1568.36 DAFLGSFLYEYSR  BSA 4.4 
*1577.40 LKPDPNTLCDEFK 1Carbamidomethyl BSA 4.6 
*1674.45 ECCHGDLLECADDR  2Carbamidomethyl 
1Glu->pyro-Glu 
BSA 4.1 
*1739.58 DDPHACYSTVFDKLK  BSA 5.3 
1748.38 YNGVFQECCQAEDK 2Carbamidomethyl BSA 4.1 
1754.52 NTDGSTDYGILQINSR  Lyz 4.2 
1797.53 CCAADDKEACFAVEGPK 1Pyro-carbamidomethyl BSA 4.3 
1902.62 NECFLSHKDDSPDLPK 1Carbamidomethyl BSA 4.7 
1911.52 CCAADDKEACFAVEGPK 2Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 4.3 
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Table 4-7 (continuation). Detailed information of peptides in Figure 4-12b. Peptides with 
asterisks are peptides that were not detected in the original digests mixtures. 
m/z Sequence Modification Protein pI 
*1928.53 CCAADDKEACFAVEGPK 3Carbamidomethyl BSA 4.3 
2020.74 ETYGDMADCCEKQEPER / LKPDPNTLCDEFKADEK / 
VASLRETYGDMADCCEK 
1Oxidation /  
1Carbamidomethyl / 
2Carbamidomethyl 
1Oxidation 
BSA 4.1 / 4.4 / 
4.3 
*2114.72 VHKECCHGDLLECADDR 3Carbamidomethyl BSA 4.8 
2248.79 ECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.2 
2471.01 RPCFSALTPDETYVPKAFDEK 1Carbamidomethyl BSA 4.8 
2488.04 YNGVFQECCQAEDKGACLLPK 3Carbamidomethyl BSA 4.7 
2525.10 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.6 
2542.13 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl BSA 4.6 
2613.15 VHKECCHGDLLECADDRADLAK 3Carbamidomethyl BSA 4.9 
3039.38 EYEATLEECCAKDDPHACYSTVFDK 3Carbamidomethyl BSA 4.2 
 
Table 4-8. Detailed information of peptides in Figure 4-12a. Peptides with asterisks are peptides 
that were not detected in the original digests mixtures. 
m/z Sequence Modification Protein pI 
1045.98 GTDVQAWIR  Lyz 5.8 
*1077.98 GTDVQAWIR 2Oxidation Lyz 5.8 
1164.11 LVNELTEFAK  BSA 4.5 
*1202.08 KNGERIEKVE  b2m 6.2 
1250.12 FKDLGEEHFK  BSA 5.5 
1306.24 HLVDEPQNLIK  BSA 5.3 
*1344.19 SRHPAENGKSNF  b2m  
1429.23 FESNFNTQATNR  Lyz 6.0 
1472.25 FESNFNTQATNR Acetyl Lyz 6.0 
1480.39 LGEYGFQNALIVR  BSA 6.0 
1538.40 LCVLHEKTPVSEK 1Carbamidomethyl BSA 6.8 
1568.36 DAFLGSFLYEYSR  BSA 4.4 
1754.52 NTDGSTDYGILQINSR  Lyz 4.2 
*1824.59 RPCFSALTPDETYVPK  BSA 6.1 
2525.10 QEPERNECFLSHKDDSPDLPK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.6 
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Table 4-9. Detailed information of peptides in Figure 4-12b. Peptides with asterisks are peptides 
that were not detected in the original digests mixtures. 
m/z Sequence Modification Protein pI 
927.89 YLYEIAR  BSA 6.0 
1036.83 CELAAAMKR 1Acetyl Lyz 8.2 
1045.98 GTDVQAWIR  Lyz 5.8 
1051.83 QNCDQFEK 1Carbamidomethyl 
1Gln->pyro-Glu 
BSA 4.4 
1089.00 GTDVQAWIR 1Acetyl Lyz 5.8 
1121.93 CCTESLVNR 1Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 6.0 
1149.92 CCTKPESER 1Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 6.1 
1164.11 LVNELTEFAK  BSA 4.5 
1306.24 HLVDEPQNLIK  BSA 5.3 
1360.16 TEFTPTEKDEY  b2m 4.0 
*1421.08 ETYGDMADCCEK 1Carbamidomethyl BSA 3.9 
1429.23 FESNFNTQATNR  Lyz 6.0 
*1444.22 YICDNQDTISSK 1Carbamidomethyl BSA 4.2 
*1464.18 TCVADESHAGCEK 2Carbamidomethyl BSA 4.7 
1472.25 FESNFNTQATNR Acetyl Lyz 6.0 
1479.11 ETYGDMADCCEK 1Carbamidomethyl 
1Oxidation 
BSA 3.9 
1486.26 FESNFNTQATNR Carbamidomethyl Lyz 6.0 
1503.21 EYEATLEECCAK 2Carbamidomethyl BSA 4.1 
1523.29 YTEFTPTEKDEY  b2m 4.0 
*1541.18 LCVLHEKTPVSEK 1Carbamidomethyl BSA 6.8 
1555.27 DDPHACYSTVFDK 1Carbamidomethyl BSA 4.4 
1731.35 ECCHGDLLECADDR 3Carbamidomethyl 
1Glu->pyro-Glu 
BSA 4.1 
1748.38 YNGVFQECCQAEDK 2Carbamidomethyl BSA 4.1 
1754.52 NTDGSTDYGILQINSR  Lyz 4.2 
*1786.37 NTDGSTDYGILQINSR 2Oxidation Lyz 4.2 
1797.53 CCAADDKEACFAVEGPK 1Pyro-carbamidomethyl BSA 4.3 
1911.52 CCAADDKEACFAVEGPK 2Carbamidomethyl 
1Pyro-carbamidomethyl 
BSA 4.3 
*1928.53 CCAADDKEACFAVEGPK 3Carbamidomethyl BSA 4.3 
*1949.49 VASLRETYGDMADCCEK 1Carbamidomethyl BSA 4.3 
 
4.4 Conclusions 
In summary, we have synthesized random co-polymers with carboxylate, 
phosphonate, sulfonate functional groups that can form reverse micelle type assemblies 
and simplify peptide mixtures through a biphasic extraction method. Using pH dependent 
extraction capacities of standard peptides as indicators, we show that functional group pKa 
values in the confined reverse micelle state are consistent with the expected values in free 
aqueous solution. In addition to the pKa-dependence, a decrease in capacity was also 
observed at high pHs, which is attributed to the change in the HLB of the polymer. By 
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optimizing the HLB through variations in the polymer structure, the decreased capacity can 
be recovered. Using polymers having functional groups with low pKa values, we have 
shown that complex peptide mixtures can be efficiently simplified at acidic pH. 
Furthermore, extraction and bracketing of peptides within a narrow pI range enables 
selective and sensitive detection of acidic peptides. Overall, our study here explores 
variations in functional group pKa values in the context of their interactions with peptides 
inside the confined environment of supramolecular assemblies. The fundamental 
understanding developed here could have broad implications in a variety of applications 
involving separation of peptides. Taking the advantage of low pKa polymers to realize 
specific isolation and detection of acidic peptides could potentially benefit studies in 
proteomics and detection of disease biomarkers in complex mixtures. Compared to other 
techniques used for acidic peptide detection, such as isoelectric focusing (IEF)-MS and 
ion-exchange chromatography (IEC)-MS, our method provides predictable separations 
with a variable and definable pI range and is readily compatible with detection by MS 
without a need for significant sample pre-treatment before analysis by MS. 
4.5 Experimental method 
4.5.1 Polymer synthesis and characterization 
All reagents were commercially available and used as received unless stated 
otherwise. 1H-NMR spectra were recorded on a 400 MHz NMR spectrometer using 
residual proton resonance of the solvents as internal standard. Chemical shifts are reported 
in parts per million (ppm). Mass spectra were obtained by a Bruker AmaZon quadrupole 
ion trap mass spectrometer coupled with electrospray ionization source. Gel permeation 
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chromatography (GPC) was used to estimate the molecular weight of polymers using THF 
as eluent and 1μL of toluene was added as the internal reference. Polystyrene standards 
were used for calibration and data analysis. Synthetic pathways were listed below and 
detailed information can be found in Appendix.  
Synthetic pathway of random co-polymer P4-1: 
Synthesis of co-polymer P4-1 was mentioned elsewhere.41 
Synthetic pathway of random co-polymer P4-2: 
 
Synthetic pathway of random co-polymer P4-3: 
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4.5.2 Reagents 
The following peptides were purchased from the Bachem (Torrance, CA): 
kinetensin (IARRHPYFL), Angiotensin II (DRVYIHPF), -amyloid fragment 1-11 
(DAEFRHDSGYE). The peptide bradykinin (RPPGFSPFR) and the proteins bovine serum 
albumin (BSA) and lysozyme were obtained from Sigma-Aldrich (St. Louis, MO). The 
protein β2-microglobulin, purified from human urine, was purchased from Lee 
Biosolutions (Maryland Heights, MO). Immobilized trypsin, immobilized chymotrypsin 
and triethylamine acetate (pH 8.0, 1 M) were obtained from Princeton Separations 
(Adelphia, NJ). Trifluoroacetic acid (TFA), and cyano-4-hydroxy-cinnamic acid (CHCA) 
were purchased from Sigma-Aldrich (St. Louis, MO). Acetonitrile, tetrahydrofuran, 
toluene, sodium hydroxide, ammonium acetate and HPLC grade water were all purchased 
from Fisher Scientific (Fair Lawn, NJ).  
4.5.3 Proteolytic digestion 
The protein sample was dissolved by adding 100 mM triethylamine acetate (pH 
8.0). To reduce the disulfide bonds, TCEP in water was added at a protein:TCEP molar 
ratio of 1:80, and the sample was incubated at 37 °C for 10 min. To alkylate the reduced 
cysteines, an iodoacetamide stock solution (made in 100 mM triethylamine acetate, pH 8.0) 
was added at a protein:iodoacetamide molar ratio of 1:80, and the sample was incubated in 
the dark at room temperature for 30 min. Next, the sample was incubated with 10% (v/v) 
acetonitrile at 50 °C for 45 min to denature the protein. The protein sample was then applied 
to the selected enzyme at an enzyme: substrate ratio of 1:10. Digestion of β2m was 
performed with immobilized chymotrypsin. Digestion of BSA and lysozyme were 
performed with immobilized trypsin. After 2 h of digestion at 37 °C, the enzyme was 
  115 
separated from the mixture by centrifugation, and the supernatant was collected. After the 
digests of each protein were collected individually, they were mixed for subsequent 
extraction.  
4.5.4 Preparation of polymeric reverse micelles  
Amphiphilic random co-polymers were dispersed in toluene at a final concentration 
of 1.0 × 10-4 M. 1 μL of 0.01 M NaOH aqueous solution and was added per 1 mL of the 
reverse micelle solution. Sonication was conducted until the solution became optically 
clear.  
4.5.5 Matrix solutions 
CHCA was prepared at a concentration of 10 mg/mL in a mixture of 50 μL 
acetonitrile, 47.5 μL H2O, and 2.5 μL TFA. CHCA in THF was prepared at a concentration 
of 30 mg/mL in a mixture of 350 μL THF, 150 μL H2O, and 6 μL TFA. 
4.5.6 Peptide Extraction and Sample Preparation 
The general extraction procedure is described elsewhere,37 but in short, the 
following procedure was used. Peptide solutions were prepared in 50 mM Tris buffer where 
the pH of the buffer was adjusted beforehand. One mL of the buffered peptide solution was 
mixed vigorously with 200 μL of the polymeric reverse micelle solution in toluene for 2 
hours. After mixing, the solution was centrifuged at 13,000 rpm for 60 minutes to break 
the emulsion. The aqueous phase was withdrawn and kept in a separate microtube. 10 μL 
of the aqueous phase sample was then mixed with 10 μL of the CHCA matrix solution in 
acetonitrile. From this sample, 2 μL was spotted on the MALDI target plate for MALDI-
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MS analysis. The remaining organic phase was dried by blowing N2 gas. The dried residue 
of the mixture of polymer and the extracted peptides were re-dissolved in 10 μL of THF 
and then 20 μL of the THF-containing CHCA matrix solution. From this sample, 1 μL was 
spotted on the MALDI target plate for MALDI-MS analysis.  
4.5.7 MALDI-MS analysis 
A Bruker Autoflex III time-of-flight mass spectrometer was used to acquire mass 
spectra in reflectron mode with an accelerating voltage of 19 kV. Each spectrum was the 
average of 500 laser shots at 40% laser power. For the MALDI-MS analysis of pI 
bracketing of peptide mixtures and protein digests, a Bruker UltrafleXtreme MALDI-
TOF/TOF mass spectrometer was used. Acquisition of all mass spectra was done in 
reflectron mode with an accelerating voltage of 20 kV. Each spectrum was the average of 
2000 laser shots at 50% laser power.  
4.5.8 Extraction capacity determination 
Increasing concentrations of the peptide kinetensin (IARRHPYFL, pI 11.01) were 
extracted using 100 μL of 1.0 × 10-4 M of each polymer in toluene, and the left-over peptide 
in the aqueous phase was mixed on a 1:1 volume ratio with the acetonitrile containing 
CHCA matrix solution before analysis by MALDI-MS. The extraction capacity is taken as 
the concentration of peptide at which a measurable amount of peptide remains in the 
aqueous phase, suggesting that the reverse micelles are saturated and can no longer 
accommodate more peptides in the organic phase. The capacity is determined by 
performing a linear regression on a plot of the peptide signal in the aqueous phase after 
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extraction as a function of peptide concentration (e.g. Figure 4-6). The capacity 
concentration is chosen by extrapolating the line to zero peptide signal. 
4.6 References 
(1) Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature 2003, 422, 
198-207. 
(2) Cravatt, B. F.; Simon, G. M.; Yates III, J. R.; The biological impact of mass-
spectrometry-based proteomics. Nature 2007, 450, 991-1000. 
(3) Link, A. J.; Eng, J.; Schieltz, D. M.; Carmack, E.; Mize, G. J.; Morris, D. R.; 
Garvik, B. M.; Yates III, J. R. Direct analysis of protein complexes using mass 
spectrometry. Nat. Biotechnol. 1999, 17, 676-682. 
(4) Harkewicz, R.; Dennis, E. A. Applications of Mass Spectrometry to Lipids and 
Membranes. Annu. Rev. Biochem. 2011, 80, 301-325. 
(5) Dunn, W. B.; Broadhurst, D.; Begley, P.; Zelena, E.; Francis-McIntyre, S.; 
Anderson, N.; Brown, M.; Knowles, J. D.; Halsall, A.; Haselden, J. N.; Nicholls, A. W.; 
Wilson, I. D.; Kell, D. B.; Goodacre, R.; The Human Serum Metabolome (HUSERMET) 
Consortium, Procedures for large-scale metabolic profiling of serum and plasma using gas 
chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 
2011, 6, 1060-1083. 
(6) Strege, M. A. Hydrophilic Interaction Chromatography-Electrospray Mass 
Spectrometry Analysis of Polar Compounds for Natural Product Drug Discovery. Anal. 
Chem. 1998, 70, 2439-2445. 
(7) Gingras, A.; Gstaiger, M.; Raught, B.; Aebersold, R. Analysis of protein complexes 
using mass spectrometry. Nat. Rev. Mol. Cell Biol. 2007, 8, 645-654. 
  118 
(8) Premstaller, A.; Oberacher, H.; Huber, C. G. High-Performance Liquid 
Chromatography-Electrospray Ionization Mass Spectrometry of Single- and Double-
Stranded Nucleic Acids Using Monolithic Capillary Columns. Anal. Chem. 2000, 72, 
4386-4393. 
(9) Bantscheff, M.; Schirle, M.; Sweetman, G.; Rick, J.; Kuster, B. Quantitative mass 
spectrometry in proteomics: a critical review. Anal. Bioanal. Chem. 2007, 389, 1017-1031. 
(10) Toby, T. K.; Fornelli, L.; Kelleher, N. L.; Progress in Top-Down Proteomics and 
the Analysis of Proteoforms. Annu. Rev. Anal. Chem. 2016, 9, 499-519. 
(11) Gillet, L. C.; Leitner, A.; Aebersold, R.; Mass Spectrometry Applied to Bottom-Up 
Proteomics: Entering the High-Throughput Era for Hypothesis Testing. Annu. Rev. Anal. 
Chem. 2016, 9, 449-472. 
(12) Lesur, A.; Domon, B. Advances in high-resolution accurate mass spectrometry 
application to targeted proteomics. Proteomics 2015, 15, 880-890. 
(13) Kailemia, M. J.; Ruhaak, L. R.; Lebrilla, C. B.; Amster, I. J. Oligosaccharide 
Analysis by Mass Spectrometry: A Review of Recent Developments. Anal. Chem. 2014, 
86, 196-212. 
(14) Ritorto, M. S.; Cook, K.; Tyagi, K.; Pedrioli, P. G. A.; Trost, M. Hydrophilic Strong 
Anion Exchange (hSAX) Chromatography for Highly Orthogonal Peptide Separation of 
Complex Proteomes. J. Proteome Res. 2013, 12, 2449-2457. 
(15) Chen, B.; Peng, Y.; Valeja, S. G.; Xiu, L.; Alpert, A. J.; Ge, Y. Online Hydrophobic 
Interaction Chromatography-Mass Spectrometry for Top-Down Proteomics. Anal. Chem. 
2016, 88, 1885-1891. 
  119 
(16) Zhou, H.; Ye, M.; Dong, J.; Corradini, E.; Cristobal, A.; Heck, A. J. R.; Zou, H.; 
Mohammed, S. Robust phosphoproteome enrichment using monodisperse microsphere-
based immobilized titanium (IV) ion affinity chromatography. Nat. Protoc. 2013, 8, 461-
480. 
(17) Simpson, D. C.; Smith, R. D. Combining capillary electrophoresis with mass 
spectrometry for applications in proteomics. Electrophoresis 2005, 26, 1291-1305. 
(18) Zhang, Y.; Zhang, C.; Jiang, H.; Yang, P.; Lu, H. Fishing the PTM proteome with 
chemical approaches using functional solid phases. Chem. Soc. Rev. 2015, 44, 8260-8287.  
(19) Smith, J.; Mittermayr, S.; Váradia, C.; Bones, J. Quantitative glycomics using 
liquid phase separations coupled to mass spectrometry. Analyst 2017, 142, 700-720. 
(20) Bergman, N.; Bergquist, J. Recent developments in proteomic methods and disease 
biomarkers. Analyst 2014, 139, 3836-3851. 
(21) Annesley, T. M. Ion Suppression in Mass Spectrometry. Clin. Chem. 2003, 49, 
1041-1044. 
(22) King, R.; Bonfiglio, R.; Fernandez-Metzler, C.; Miller-Stein, C.; Olah, T. 
Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. 
Mass. Spectrom. 2000, 11, 942-950.  
(23) Furey, A.; Moriarty, M.; Bane, V.; Kinsella, B.; Lehane, M. Ion suppression; A 
critical review on causes, evaluation, prevention and applications. Talanta 2013, 115, 104-
122. 
(24) Lou, X.; de Waal, B. F. M.; Milroy, L.; van Dongen, J. L. J. A sample preparation 
method for recovering suppressed analyte ions in MALDI TOF MS. J. Mass Spectrom. 
2015, 50, 766-770. 
  120 
(25) Zhu, G.; Sun, L.; Keithley, R. B.; Dovichi, N. J. Capillary Isoelectric Focusing-
Tandem Mass Spectrometry and Reversed-Phase Liquid Chromatography-Tandem Mass 
Spectrometry for Quantitative Proteomic Analysis of Differentiating PC12 Cells By Eight-
Plex Isobaric Tags for Relative and Absolute Quantification. Anal. Chem. 2013, 85, 7221-
7229. 
(26) Wang, S.; Chen, S.; Wang, J.; Xu, P.; Luo, Y.; Nie, Z.; Du, W. Interface solution 
isoelectric focusing with in situ MALDI-TOF mass spectrometry. Electrophoresis 2014, 
35, 2528-2533. 
(27) Przybylski, C.; Mokaddem, M.; Prull-Janssen, M.; Saesen, E.; Lortat-Jacob, H.; 
Gonnet, F.; Varenne, A.; Daniel, R. On-line capillary isoelectric focusing hyphenated to 
native electrospray ionization mass spectrometry for the characterization of interferon-γ 
and variants. Analyst 2015, 140, 543-550. 
(28) Barron, L.; Gilchrist, E. Ion chromatography-mass spectrometry: A review of 
recent technologies and applications in forensic and environmental explosives analysis. 
Anal. Chim. Acta 2014, 806, 27-54. 
(29) Alpert, A. J.; Hudecz, O.; Mechtler, K. Anion-Exchange Chromatography of 
Phosphopeptides: Weak Anion Exchange versus Strong Anion Exchange and Anion-
Exchange Chromatography versus Electrostatic Repulsion-Hydrophilic Interaction 
Chromatography. Anal. Chem. 2015, 87, 4704-4711. 
(30) Wang, S.; Shi, X.; Xu, G. Online Three Dimensional Liquid Chromatography/Mass 
Spectrometry Method for the Separation of Complex Samples. Anal. Chem. 2017, 89, 
1433-1438. 
  121 
(31) Fekete, S.; Beck, A.; Fekete, J.; Guillarme, D. Method development for the 
separation of monoclonal antibody charge variants in cation exchange chromatography, 
Part II: pH gradient approach. J. Pharm. Biomed. Anal. 2015, 102, 282-289. 
(32) McAlister, G. C.; Russell, J. D.; Rumachik, N. G.; Hebert, A. S.; Syka, J. E. P.; 
Geer, L. Y.; Westphall, M. S.; Pagliarini, D. J.; Coon, J. J. Analysis of the Acidic Proteome 
with Negative Electron-Transfer Dissociation Mass Spectrometry. Anal. Chem. 2012, 84, 
2875-2882. 
(33) Riley, N. M.; Rush, M. J. P.; Rose, C. M.; Richards, A. L.; Kwiecien, N. W.; Bailey, 
D. J.; Hebert, A. S.; Westphall, M. S.; Coon, J. J. The Negative Mode Proteome with 
Activated Ion Negative Electron Transfer Dissociation (AI-NETD). Mol. Cell. Proteomics 
2015, 14, 2644-2660. 
(34) Combariza, Y.; Savariar, E. N.; Vutukuri, D. R.; Thayumanavan, S.; Vachet, R. W. 
Polymeric Inverse Micelles as Selective Peptide Extraction Agents for MALDI-MS 
Analysis. Anal. Chem. 2007, 79, 7124-7130. 
(35) Rodthongkum, N.; Washington, J. D.; Savariar, E. N.; Thayumanavan, S.; Vachet, 
R. W. Generating Peptide Titration-Type Curves Using Polymeric Reverse Micelles As 
Selective Extraction Agents along with Matrix-Assisted Laser Desorption Ionization-Mass 
Spectrometry Detection. Anal. Chem. 2009, 81, 5046-5053. 
(36) Wang, F.; Gomez-Escudero, A.; Ramireddy, R. R.; Murage, G.; Thayumanavan, 
S.; Vachet, R. W. Electrostatic Control of Peptide Side-Chain Reactivity Using 
Amphiphilic Homopolymer-Based Supramolecular Assemblies. J. Am. Chem. Soc. 2013, 
135, 14179-14188. 
  122 
(37) Serrano, M. A. C.; He, H.; Zhao, B.; Ramireddy, R. R.; Vachet, R. W.; 
Thayumanavan, S. Polymer-mediated ternary supramolecular interactions for sensitive 
detection of peptides. Analyst 2017, 142, 118-122. 
(38) Rodthongkum, N.; Ramireddy, R.; Thayumanavan, S.; Vachet, R. W. Selective 
enrichment and sensitive detection of peptide and protein biomarkers in human serum 
using polymeric reverse micelles and MALDI-MS. Analyst 2012, 137, 1024-1030. 
(39) Rodthongkum, N.; Chen, Y.; Thayumanavan, S.; Vachet, R. W. Selective 
Enrichment and Analysis of Acidic Peptides and Proteins Using Polymeric Reverse 
Micelles and MALDI-MS. Anal. Chem. 2010, 82, 8686-8691. 
(40) Wang, M.; Zhao, B.; Gao, J.; He, H.; Castellanos, L. J.; Thayumanavan, S.; Vachet, 
R. W. Altering the Peptide Binding Selectivity of Polymeric Reverse Micelle Assemblies 
via Metal Ion Loading. Langmuir 2017, 33, 14004-14010. 
(41) Zhao, B.; Serrano, M. A. C.; Gao, J.; Zhuang, J.; Vachet, R. W.; Thayumanavan, 
S. Self-assembly of random co-polymers for selective binding and detection of peptides. 
Polym. Chem. 2018, 9, 1066-1071. 
(42) Zhao, B.; Zhuang, J.; Serrano, M. A. C.; Vachet, R. W.; Thayumanavan, S. 
Influence of Charge Density on Host-Guest Interactions within Amphiphilic Polymer 
Assemblies in Apolar Media. Macromolecules 2017, 50, 9734-9741.  
(43) Cargile, B. J.; Stephenson, J. L. An Alternative to Tandem Mass Spectrometry:  
Isoelectric Point and Accurate Mass for the Identification of Peptides. Anal. Chem. 2004, 
76, 267-275. 
  123 
(44) Essader, A. S.; Cargile, B. J.; Bundy, J. L.; Stephenson, J. L. A comparison of 
immobilized pH gradient isoelectric focusing and strong-cation-exchange chromatography 
as a first dimension in shotgun proteomics. Proteomics 2005, 5, 24-34. 
(45) Cargile, B. J.; Bundy, J. L.; Stephenson, J. L. Potential for False Positive 
Identifications from Large Databases through Tandem Mass Spectrometry. J. Proteome 
Res. 2004, 3, 1082-1085. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  124 
CHAPTER 5 
 
POLYMERIC SUPRAMOLECULAR ASSEMBLIES FOR ENHANCED MASS 
SPECTROMETRIC DETECTION OF BREAST CANCER BIOMARKER IN 
HUMAN BREAST MILK  
 
5.1 Abstract 
Human breast milk is an understudied biological fluid that may be useful for early 
detection of breast cancer. Methods for enriching and detecting biomarkers in human breast 
milk, however, are not as well-developed as compared to other biological fluids. In this 
work, we demonstrate a new enrichment method based on polymeric nanoassemblies that 
is capable of enhancing the mass spectrometry-based detection of peptides and proteins in 
human breast milk. In this method positively-charged nanoassemblies are used to 
selectively deplete abundant proteins in human breast milk based on electrostatic 
interactions, which simplifies the mixture and enhances detection of positively-charged 
peptides and proteins. Negatively-charged nanoassemblies are used in a subsequent 
enrichment step to further enhance the detection and quantification of trace-level peptides 
and proteins. Together the depletion and enrichment steps allow model biomarkers to be 
detected at low nM levels, which are close to instrumental limits of detection. This new 
method not only demonstrates the ability to detect proteins in human breast milk but also 
provides an alternative approach for targeted biomarker detection in complex biological 
matrices. 
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5.2 Introduction 
Breast cancer remains a major health concern for women worldwide,1-2 but early 
detection and effective treatments at an early stage of the disease can significantly extend 
the overall survival rates in patients.3 Despite progress in conventional tools such as 
mammograms and breast biopsies, a diagnostic challenge still remains due to the lack of 
sensitivity and specificity of these strategies at the very earliest stages of the disease. 
Biomarkers, as measurable hallmarks of specific disease states, have been extensively 
investigated and validated for cancer detection and monitoring since they can (i) cover a 
broad range of biological species; (ii) provide risk assessment at the earliest stage, even at 
the premalignant stage; (iii) deal with the high heterogeneity of cancer subtypes; (iv) guide 
targeted therapies; and (v) help evaluate therapeutic responses.4-6 Proteins are often 
excellent biomarkers because their levels of expression or activity directly impact cellular 
activities.7-9  
  Various biological fluids, such as serum, nipple aspirate and breast milk, can be 
used as sources of breast cancer biomarkers.5, 10-12 Among these, collection of breast milk 
is the least invasive means because it is collected in a totally non-invasive manner, and it 
provides valuable information about breast tissue, especially in young women and for 
pregnancy-associated breast cancers.13-15 Previous biomarker discovery work has shown 
that both specific DNA methylation and differential expression of cancer-associated 
proteins can be identified in human breast milk (HBM).16-19 Driven by these observations, 
we have begun to investigate effective methods to measure biomarkers in HBM as a means 
of detecting breast cancer detection before the disease is clinically apparent. 
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To reliably detect and quantify protein biomarkers, various methods have been 
developed including enzyme linked immunosorbent assay (ELISA), two-dimensional 
polyacrylamide gel electrophoresis (2D-PAGE) and proteomics based techniques using 
mass spectrometry (MS).3, 20-24 MS is one of the most promising methods due to its high 
specificity, high throughput and multiplexed detection capability. However, detecting and 
quantifying protein biomarkers using MS is a significant challenge due to the inherently 
low biomarker abundances (usually pg/mL) as well as the complex biological backgrounds, 
and therefore often requires simplification and enrichment prior to MS measurements. 
Biomarker enrichment methods in HBM are understudied as compared to other 
biological fluids such as serum or urine. Most methods are based on affinity binding, where 
antibody- or affinity probe-based particles can specifically capture and concentrate 
biomarkers of interest.25-27 Vigorous antibody development tends to be costly, time- and 
labor-consuming, and limits the scope of these methods. As an alternative to these previous 
methods, we have been investigating supramolecular nanomaterials as enrichment methods 
to combine with MS detection. Recently, our group has developed an approach that uses 
polymeric supramolecular nanoassemblies to selectively enrich peptides or proteins via a 
biphasic extraction format, where electrostatic interactions are used for selective and 
predictable enrichment.28-29 Our amphiphilic polymers self-assemble into reverse micelle-
type architectures in apolar solvents and sequester targeted peptides or proteins based on 
their isoelectric points (pI).30-32 High enrichment selectivity and capacity can be easily 
achieved by tuning the functional groups on the polymers and varying the extraction 
conditions.33-35 Moreover, these materials are easy to synthesize, low-cost and highly stable 
as compared to current antibody-based enrichment reagents. Hence, we envision that these 
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materials are capable of selectively enriching biomarkers in the complex matrix of HBM, 
thereby enhancing their detection using MS. In this work, we describe an analytical method 
based on these supramolecular nanoassemblies that can (i) selectively deplete abundant 
proteins in HBM; (ii) effectively enrich the biomarker-related peptides; and (iii) allow the 
sensitive quantitation of the biomarkers of interest using MS. 
5.3 Results and discussion 
5.3.1 Detection workflow  
To design a rational analytical method for quantification of protein biomarkers, we 
first investigated the total protein concentration and the protein composition of the given 
HBM sample because HBM composition can vary depending on the lactation stage.38-43 
Bradford assays were performed to determine the total protein concentration of each 
sample (e.g. Figure 5-1), and this information was used to choose the amount of the 
nanoassemblies for depletion of the abundant proteins. The HBM sample was also analyzed 
using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to 
visualize the most abundant protein species in the sample before (Figure 5-2) and after 
depletion.  Three of the four most abundant proteins, including serum albumin, caseins, 
and lactalbumin have low pI values, so they are negatively charged at physiological pH. 
Therefore, we used nanoassemblies with positively-charged interiors to selectively remove 
these abundant proteins based on electrostatic interactions, allowing the complex mixture 
to be simplified for improved detection sensitivity of the target molecules.  
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Figure 5-1. Determination of the total protein concentration in HBM using Bradford assay. A 
concentration of 10.5 mg/mL was obtained. 
 
 
Figure 5-2. SDS-PAGE analysis of HBM (right lane). Abundant proteins were identified and the 
pIs of these proteins are indicated. 
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Figure 5-3. Schematic representation of the workflow for quantifying targeted peptides/proteins in 
HBM based on sequential extractions using polymeric supramolecular assemblies. Peptides of 
interest are shown in purple. 
 
A multi-step procedure that included this depletion step was explored as a means 
of enriching target biomarkers for detection and quantification by mass spectrometry 
(Figure 5-3). After removing the lipids and cells from the HBM sample and adjusting the 
pH to 6, as described in the experimental section, proteins having pI values < 6 were 
depleted by nanoassemblies of polymer P5-1, whereas positively charged proteins, 
including the target proteins, remained in the aqueous phase. The proteins remaining in the 
aqueous phase were digested at pH 8, and then nanoassemblies of the negatively charged 
polymer P5-2 were used to selectively enrich positively charged peptides into the organic 
phase. The enriched peptides were released from the organic phase into fresh aqueous 
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phase using THF and acid as described previously. Finally, the enriched and back-extracted 
peptides were quantified by LC-MS based MRM measurements on a triple quadrupole 
mass spectrometer. 
5.3.2 Selective depletion of abundant proteins   
To identify an efficient protocol for depletion of the abundant negatively-charged 
proteins, we tested different extents of dilution, numbers of depletion steps, and 
concentrations and volumes of the nanoassemblies. We found that two sequential 
depletions of five-fold diluted HBM (i.e. ~ 2 mg/mL total protein) at pH 6.0 using 400 μL 
of 2 mg/mL of polymer P5-1 provide reliable conditions that are capable of efficiently 
removing abundant low-pI proteins. As an example, a five-fold dilution of HBM leads to 
more effective removal of human serum albumin (pI 4.7), caseins (pI 4.7) and lactalbumin 
(pI 4.5) after three depletion steps (Figure 5-4, lanes 6 - 9) than a two-fold dilution (Figure 
5-4, lanes 2 - 5). Different from other abundant proteins, Lactroferrin (pI 8.7), as a high-pI 
protein with a positive charge, does not decrease under the same conditions, confirming 
that the depletion step is selective for low pI proteins. Moreover, this observation suggests 
that the positively charged nanoassemblies of polymer P5-1 are not likely to remove other 
positively charged proteins including target proteins. 
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Figure 5-4. SDS-PAGE analysis of HBM before and after depletions using positively charged 
polymer P5-1. (Lane 1: Molecular weight marker; Lane 2: HBM after a two-fold dilution; Lanes 
3-5: Two-fold diluted HBM after 1, 2, and 3 depletion steps, respectively; Lane 6: HBM after a 
five-fold dilution; Lanes 7-9: Five-fold diluted HBM after 1, 2, and 3 depletion steps, respectively. 
The red dashed rectangle indicates the results from the optimal depletion conditions.) 
 
To test this idea further, we digested the proteins in the HBM sample before and 
after depletion and used spectral counts (SC) from LC-MS measurements as a label-free 
quantification method to assess the relative abundance of each protein in the diluted HBM 
aliquots before and after depletion. A selected set of measured proteins having multiple 
peptides with total SC values above 100 in multiple experiments is included in Figure 5-5. 
After depletion with nanoassemblies of P5-1, we observe a decrease in SC for almost all 
the negatively charged proteins (pI < 6), indicating that these proteins are effectively 
depleted (Figure 5-5a). In contrast, almost all of the positively charged proteins (pI > 6) 
show enhanced SC (Figure 5-5b) likely because of the reduction of interfering signals from 
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the more abundant proteins that initially suppressed the signal of low-abundance proteins. 
One protein that is now detectable that was not before depletion is cytochrome c, which 
was spiked into the HBM at a concentration of 1 μM.  
 
Figure 5-5. Comparison of the relative abundance of proteins in HBM before and after depletions 
using the optimal depletion conditions identified in Figure 5-4. The relative abundance of (a) 
negatively charged proteins (pI < 6) and (b) positively charged proteins (pI > 6) was assessed by 
spectral counts as described in the experimental section. The identities of the proteins in both (a) 
and (b) are indicated in Table 5-1. 
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Table 5-1. Detected proteins in proteomic study in Figure 5-5. 
Abbreviation Name pI Abbreviation Name pI 
CASB Beta-casein 4.7 TRFL Lactotransferrin 8.7 
LALBA Alpha-lactalbumin 4.5 CASK Kappa casein 8.9 
CEL Bile salt-activated lipase 5.3 B2MG beta-2-microglobulin 6.5 
CASA1 Alpha-S1-casein 5.4 LYSC Lysozyme C 9.2 
APOA2 Apolipoprotein A-II 4.9 TRY1 Trypsin-1 6.1 
A1AT Alpha-1-antitrypsin 5.6 *CYC *Cytochrome C 9.6 
OSTP Osteopontin 4.6 CYTC Cystatin-C 9.0 
PIGR 
Polymeric 
immunoglobulin receptor 
5.7 TIMP1 
Metalloproteinase 
inhibitor 1 
8.5 
HPT Haptoglobin 5.6 ZA2G 
Zinc-alpha-2-
glycoprotein 
6.1 
CD14 
Monocyte differentiation 
antigen CD14 
4.6 NPC2 
Epididymal secretory 
protein E1 
7.6 
BT1A1 
Butyrophilin subfamily 1 
member A1 
5.5 PPIA 
Peptidyl-prolyl cis-trans 
isomerase A 
7.7 
MUC1 Mucin-1 2.9 MFGM Lactadherin 8.2 
CLUS Clusterin 5.2 CAH6 Carbonic anhydrase 6 6.5 
ALBU Serum albumin 4.7 XDH 
Xanthine 
dehydrogenase/oxidase 
7.7 
APOA1 Apolipoprotein A-I 5.6 SOSD1 
Sclerostin domain-
containing protein 1 
9.8 
   TRFE Serotransferrin 6.8 
   IBP2 
Insulin-like growth 
factor-binding protein 2 
7.5 
   KLK6 Kallikrein-6 7.2 
   PERL Lactoperoxidase 8.9 
 
5.3.3 Enrichment of target peptides 
While depleting the abundant HBM proteins can improve the detectability of low 
abundance proteins, further improving the detectability of trace-level biomarkers can be 
achieved via a subsequent enrichment step. For the purposes of this study, we focused on 
the enrichment of positively-charged biomarkers using nanoassemblies of polymer P5-2. 
Surrogate peptides from the target protein can be extracted into the organic phase based on 
electrostatic interactions that simplify the mixture, which also concentrates them because 
of the smaller volume of the organic solvent.  Then, an efficient back-extraction step can 
be used to release the enriched peptides for quantitation by MRM in an LC -MS experiment. 
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Figure 5-6. Exemplified MRM chromatograms of (a) RPPGFSPFR and (b) TGPNLHGLFGR in 
HBM samples without any depletion and extraction/ back-extraction. 
 
Figure 5-7. Exemplified MRM chromatograms of (a) RPPGFSPFR and (b) TGPNLHGLFGR in 
HBM samples after depletions and extraction/ back-extraction. 
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Figure 5-8. MRM quantification of target peptides in HBM after depletion and extraction/ back-
extraction. Results were obtained from three experimental replicates. 
 
To test the effectiveness of this approach, we spiked two potential biomarkers, 
bradykinin and cytochrome c, into HBM, using the surrogate peptide TGPNLHGLFGR for 
detection of cytochrome c. For the model biomarkers in aqueous solutions, the limit of 
detection (LOD) for both peptides is approximately 6 nM, whereas neither is detectable 
when spiked into HBM at µM concentrations due to the complexity of the sample (Figure 
5-6). If the abundant HBM proteins are depleted with nanoassemblies of polymer P5-1, 
and the subsequently digested samples are enriched by nanoassemblies of polymer P5-2, 
bradykinin and cytochrome c can be detected in HBM at concentrations of 10 nM and 7 
nM, respectively, which is close to the instrument LOD for these biomolecules (Figure 5-
7 and 5-8). To investigate the contribution of each sample preparation step to the detection 
sensitivity, LODs with and without depletion and enrichment steps were determined (Table 
5-2).  The data in Table 5-2 indicate that the depletion step lowers the LOD more 
extensively than the enrichment step, but evidently the depletion and enrichment steps 
work synergistically to lower the LOD close to the instrument LOD.  We predict that the 
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methods developed in this work could achieve even lower LODs when coupled with more 
sensitive instrumentation. 
 
Table 5-2. MRM LOD of peptides RPPGFSPFR and TGPNLHGLFGR (from cytochrome c) in 
HBM using different sample preparation conditions. (Note that the first entry represents the LODs 
of pure peptides.) 
Sample preparation Limit of detection (nM) 
Breast milk Depletion 
Extraction/ 
Back-extraction 
RPPGFSPFR 
(pI 12.0) 
TGPNLHGLFGR 
(pI 9.4) 
- - - 6 ± 4 6 ± 6 
+ - - > 1000 > 800 
+ - + > 1000 200 ± 70 
+ + - 50 ± 20 30 ± 3 
+ + + 10 ± 3 7 ± 2 
 
5.4 Conclusions 
In summary, we have developed an analytical method using supramolecular 
nanoassemblies to enrich and quantify trace-level biomolecules in HBM, opening up the 
possibility of biomarker detection in this understudied biological fluid. Abundant proteins 
in HBM can be efficiently depleted using positively charged nanoassemblies to remove 
low pI proteins, thereby simplifying HBM samples and enhancing detection of low-
abundance positively charged proteins. Selective extraction/ back-extraction enables 
further enrichment and sensitive detection of peptides and surrogate peptides from target 
proteins. Overall, this method allows for over 3 orders of magnitude improvement in 
detection sensitivity for target proteins in HBM. When combined with MRM in LC-MS 
experiments, the described method provides advantageous quantification capability, 
providing an alternative approach to antibody-based methods for assessment of protein 
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biomarkers in HBM. The polymeric nanoassemblies used in this work also offer other 
features such as tunable structures, low-cost and high stability, allowing them to have great 
potential biomarker and biomolecule detection in complex mixtures.  
5.5 Experimental section 
5.5.1 Materials 
HBM was collected with Institutional Review Board approval at the University of 
Massachusetts-Amherst. The peptide bradykinin (RPPGFSPFR) was purchased from 
Bachem (Torrance, CA). Bovine serum albumin (BSA) and cytochrome c, 3-
morpholinopropanesulfonic acid (MOPS), urea, dithiothreitol (DTT), and iodoacetamide 
(IAM) were obtained from Sigma-Aldrich (St. Louis, MO). 
Tris(hydroxymethyl)aminomethane (Tris), acetic acid, toluene and tetrahydrofuran (THF) 
were obtained from Fisher Scientific (Fair Lawn, NJ). Deionized water was prepared from 
a Millipore (Burlington, MA) Simplicity 185 water purification system. Trypsin and Lys-
C were purchased from Promega (Madison, WI). 
5.5.2 Polymer synthesis and characterization 
 
Syntheses of polymers were mentioned elsewhere.30, 32 In general, hydrophobic 
monomers containing p-alkoxy moiety and hydrophilic monomers containing charged 
functionality were polymerized using nitroxide-mediated polymerization to yield the 
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polystyrene-based random co-polymers. Ratios between hydrophobic and hydrophilic 
units were calculated based on monomers’ characteristic peaks in 1H-NMR. Molecular 
weights were obtained using gel permeation chromatography (GPC). 
5.5.3 Collection of breast milk proteins  
We focused on secreted proteins in HBM. HBM sample was first centrifuged at 453 
x g for 5 min at room temperature. The lipid layer was then removed from the top of 
mixture, while the cells were pelleted at the bottom of the centrifuge tube. The supernatant 
layer containing secreted proteins was collected. The centrifugation process was repeated 
several times until no further lipid layer or cell pellets were formed. Finally, the whey 
proteins were aliquoted for further experiments. 
5.5.4 Bradford assay 
The Bradford assay was used to evaluate the total protein concentration of HBM. 
The Coomassie reagent and albumin standards were prepared for calibration curve. Next, 
the absorbance of each solution at 595 nm was measured on a spectrophotometer. Finally, 
the absorbance of HBM samples at 50-fold dilutions were measured. The original protein 
concentration in HBM was back calculated based on the calibration curve. 
5.5.5 SDS-PAGE analysis 
HBM aliquots for SDS-PAGE were mixed 1:1 (v/v) with a 2× loading dye 
containing 3% DTT and then heated at 95 ℃ for 10 min. 10 μL of the sample was loaded 
into each well of the gel (4% polyacrylamide stacking gel, 12% polyacrylamide resolving 
gel). Electrophoretic runs were done at 150 V for 40-50 min in a Tris/glycine/SDS running 
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buffer. Staining was done using a Coomassie Brilliant Blue R-250 solution from Bio-Rad. 
The gel images were obtained using a photo scanner and analyzed by ImageJ. 
5.5.6 Preparation of polymeric reverse micelles 
Amphiphilic random co-polymers were dispersed in toluene at a final concentration 
of 2 mg/mL. 1 μL of H2O was added per 1 mL of the reverse micelle solution to allow for 
the formation of a water pool inside the reverse micelles. Sonication was performed until 
the solution became optically clear. 
5.5.7 Depletion/Extraction procedure 
The general depletion/extraction and back-extraction workflows have been 
described elsewhere30, 36, but in short, the following procedure was used. For the protein 
depletion step, HBM protein aliquots were diluted 5 times with 100 mM MOPS buffer at 
a specific pH. The buffered HBM protein sample (1 mL) was vigorously mixed with 400 
μL of a polymeric reverse micelle solution in toluene for 1 h. After equilibration, the 
mixture was centrifuged at 12500 rpm for 30 min. Then, the aqueous phase was collected 
for sequential depletions or proteolytic digestions. For the back-extraction step, 200 μL of 
THF was mixed with the organic phase from the previous extraction step to disassemble 
the polymeric reverse micelles, followed by the addition of 200 μL of a 10% acetic acid 
aqueous solution to release the extracted molecules back into an aqueous phase. The entire 
mixture was vortexed for 30 min, and then centrifuged at 10000 rpm for 1 h to separate the 
aqueous layer containing the molecules of interest.  
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5.5.8 Proteolytic digestion 
500 μL of a HBM protein sample (before or after depletion) were incubated with 2 
M urea to denature the proteins. To reduce the disulfide bonds, the sample was incubated 
with 10 mM DTT for 30 min at room temperature. To alkylate the reduced cysteines, IAM 
was added at a DTT: IAM molar ratio of 1:4, and the sample was incubated in the dark for 
30 min at room temperature. After alkylation, the sample was diluted with 200 mM Tris 
buffer to reduce the urea concentration to 1 M as well as adjust the pH of solution to 8.0. 
Protein samples were then digested with 10 μg of trypsin and 0.5 μg of Lys-C. After 24 h 
of digestion at 37 °C, the enzyme was separated from the mixture by centrifugation using 
a 10K NMWL Microcon filter (Millipore, Burlington, MA). The filtrate was then directly 
analyzed by LC-MS/MS or extracted by polymeric reverse micelle solutions for targeted 
peptide enrichment. 
5.5.9 LC-MS analysis 
Protein digests were separated on a Thermo Scientific EASY-nLC 1000 liquid 
chromatography system (Thermo Scientific, Tewksbury, MA) with an Acclaim PepMap 
RSLC C18 reverse phase column (75 μm × 15 cm, 2 μm particle size) from Thermo 
Scientific (Tewksbury, MA). To achieve efficient separation of the proteolytic peptides, a 
shallow gradient was used where % B (0.1% formic acid in acetonitrile) was increased 
from 0% to 50% over 90 min. The column was then flushed by increasing to 95% B over 
5 min. The column was then cleaned at 95% B for another 20 min. A flow rate of 300 
nL/min was used throughout the run. The LC system was coupled with a Thermo Orbitrap 
Fusion Tribrid (Tewksbury, MA) mass spectrometer. The electrospray ionization source 
was typically operated at a needle voltage of 2100 V, and the ion transfer tube temperature 
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was set to 300 °C. Tandem mass spectra were collected using CID with a normalized 
collision energy of 35%. Due to the large number of detectable peaks, an exclusion limit 
of 60 s was applied after 3 spectra had been collected for any given peak within 15 s. The 
resolution of the Orbitrap was set to 60000. 
5.5.10 Protein identification and quantification 
Raw mass spectral data files were analyzed by Thermo Proteome Discoverer 2.2 
software. Spectra were searched against the human proteome database using Sequest HT 
as the search engine. Variable modifications such as oxidation of methionine and 
carboxyamidomethylation of cysteine were used in the searches. Trypsin enzyme cleavage 
was selected, and a precursor mass tolerance of 10 ppm was used. Peptides were identified 
at high confidence levels based on MS/MS data. To perform the label free quantification 
of specific proteins before and after depletion, spectral counts were used as an indicator. 
Four different search engines (X! Tandem, MS-GF+, OMSSA, and MyriMatch) were used 
to identify the HBM proteins and their corresponding peptides. PeptideShaker37 
(CompOmics) was used to integrate the results from different search engines and export 
the spectral counts value for label-free quantification of each identified protein. 
5.5.11 Multiple reaction monitoring 
Targeted peptides were detected and quantified by multiple reaction monitoring 
(MRM) on a Waters TQD triple quadrupole mass spectrometer coupled with Waters 
ACQUITY UPLC system with a Sigma-Aldrich Supelco Discovery C18 reverse phase 
column (150 mm × 2.1 mm, 5 μm particle size). A gradient was used where % B (0.1% 
formic acid in acetonitrile) was increased from 5% to 31.5% over 35 min. The column was 
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then flushed by increasing to 95% B over 5 min. The column was then cleaned at 95% B 
for another 10 min. Finally, the gradient was adjusted back to 5% B over 5 min. A flow 
rate of 0.2 mL/min was used throughout the run. The optimized MRM parameters are listed 
in the supporting information (Table 5-3). The MRM data were analyzed by MassLynx 
software. Peak heights of the target peptides, as measured in MRM, were used to estimate 
the limit of detection (LOD) based on signal-to-noise (S/N) ratio of response. The LOD is 
taken as the analyte concentration corresponding to a S/N ratio that is 3 times the blank 
S/N ratio (Figure 5-9).  
 
Table 5-3. Optimized MRM parameters for target peptide detection. 
Peptides 
Cone 
voltage 
Collision energy 
Dwell 
time 
  
b2 
m/z = 
254.2 
b4 
m/z = 
408.2 
y2 
m/z = 
322.2 
y3 
m/z = 
419.2 
y3
2+ 
m/z = 
210.1 
y4 
m/z = 
506.3 
 
RPPGFSPFR 
m/z = 354.2 (+3) 
15 V 8 V 14 V 8 V 8 V 8 V 12 V 20 ms 
  
b2 
m/z = 
158.9 
y5 
m/z = 
549.2 
y6
2+ 
m/z = 
343.9 
y9
2+ 
m/z = 
506.0 
y9
3+ 
m/z = 
337.5 
y10
2+ 
m/z = 
535.2 
 
TGPNLHGLFGR 
m/z = 390.4 (+3) 
25 V 12 V 16 V 18 V 12 V 12 V 12 V 20 ms 
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Figure 5-9. External calibration curves for target peptides from aqueous samples were measured 
using MRM in an LC- MS experiment. The peptide bradykinin (RPPGFSPFR) and surrogate 
peptide TGPNLHGLFGR from a cytochrome c digest were prepared in water. Standard curves of 
both peptides show ~ 10 nM limit of detections which is comparable to instrumental sensitivity. 
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CHAPTER 6 
 
COVALENT LABELING WITH AN Α, Β UNSATURATED CARBONYL 
SCAFFOLD FOR STUDYING PROTEIN STRUCTURE AND INTERACTIONS 
BY MASS SPECTROMETRY  
 
6.1 Abstract 
A new covalent labeling (CL) reagent based on an α, β-unsaturated carbonyl 
scaffold has been developed for studying protein structure and protein-protein interactions 
when coupled with mass spectrometry. We show that this new reagent scaffold can react 
with up to 13 different types of residues on protein surfaces, thereby providing excellent 
structural resolution. This reagent’s reactivity with surface residues can be used to reveal 
residues involved in protein-protein interfaces, as demonstrated for the Zn(II)-induced 
dimer of β-2-microglobulin. The modular design of the α, β-unsaturated carbonyl scaffold 
allows facile variation of the functional groups, thereby enabling labeling kinetics and 
selectivity to be tuned. Moreover, by introducing isotopically enriched functional groups 
into the reagent structure, labeling sites can be more easily identified by MS and MS/MS. 
Overall, this reagent scaffold should be a valuable CL reagent for protein structure 
characterization by MS. 
6.2 Introduction 
 Reliable and versatile methods that can analyze protein higher order structure 
(HOS) are essential for understanding protein activities and investigating biological 
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machinery. Nuclear magnetic resonance (NMR) spectroscopy, X-ray crystallography (X-
ray) and cryo-electron microscopy (cryo-EM) are the primary tools used for protein HOS 
analysis due to the high-resolution information they provide,1-3 but they have limitations 
with regard to relatively high sample amounts and purities that are needed, as well as 
extensive analysis times that limit their throughput. In comparison to these techniques, 
mass spectrometry (MS) is emerging as a valuable tool for protein HOS analysis because 
it requires less sample and has fewer purity constraints, while at the same time providing 
higher throughput.4-14  
Because MS measures the mass to charge ratio (m/z) of an ion, obtaining structural 
information about a protein in solution requires encoding the desired structural information 
into the mass of the protein by some reagent. Hydrogen deuterium exchange (HDX) is a 
popular means of obtaining structural information by MS. In HDX, exchangeable backbone 
amide hydrogens are replaced with deuterium at rates that depend on protein backbone 
structure and dynamics.12-13, 15-18 Back exchange and scrambling, however, can sometimes 
limit structural information or lead to ambiguous data. Another common method is 
chemical cross-linking, which uses bi-functionalized chemical reagents to bridge different 
residues with certain distance constraints, thereby providing insight into the structural 
arrangement of residues that are distant in primary sequence.10-11, 19-21 Cross-linking usually 
produces complicated datasets that can be difficult to analyze by MS, and the best cross-
linking reagents tend to react with a limited set of residues. Covalent labeling (CL) methods 
that utilize non-specific labeling reagents or amino acid-specific reagents to modify amino 
acid side chains are beginning to emerge as complementary methods to HDX and cross-
linking approaches.22-27 These CL methods use reagents that react with solvent-accessible 
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side chains and are typically most useful for identifying changes in the surface topology of 
a protein as caused by protein binding or protein HOS changes. CL together with MS can 
pinpoint specific amino acids that are involved in interaction sites by comparing labeling 
extents of the same residue under different conditions (e.g. bound version vs. unbound 
version). The irreversible side chain modifications and straightforward data analyses make 
CL/MS an excellent method for probing interfaces in protein complexes.  
Numerous CL reagents that are capable of reacting with specific amino acids have 
been developed and used with MS to analyze protein structure, including N-
hydroxysuccinimide (NHS) derivatives, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/ 
glycine ethyl ester (EDC/ GEE), dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium bromide 
(HNSB) and many more.28-31 Even so, due to the specificities of these reagents, multiple 
reagents are typically necessary to more fully map protein structure, making such an 
approach more time and labor intensive. More non-specific labeling reagents, such as 
hydroxyl radicals and carbenes, overcome the problems with specific reagents as they are 
capable of modifying numerous residues simultaneously.25-27, 32-34 Production of hydroxyl 
radicals or carbenes, however, requires specialized equipment, such as synchrotron sources 
or lasers, which cause these approaches to be less broadly accessible. Furthermore, due to 
the high reactivity of radicals, these methods usually generate many different modification 
products, making data interpretation challenging. Our group has been interested in 
developing and applying reagents that retain the simplicity of amino-acid specific reagents 
(e.g. NHS derivatives) while at the same time reacting with a broader set of residues. To 
this end, we have explored diethylpyrocarbonate (DEPC) as a CL reagent because it labels 
various nucleophilic residues such as Lys, His, Tyr, Ser and Thr simultaneously, enabling 
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a typical structural resolution of 8-12 Å.35-36 Using this reagent, we have successfully 
studied protein HOS and protein complexes.37-40 Despite the successful use of DEPC, its 
amino acid coverage and chemical tunability could still be improved upon, so new CL 
reagents that retain its ease of use are of interest. 
 To expand the number of residues that can be labeled and to introduce tunability 
and other attributes, we have designed and studied a new class of CL reagents having an α, 
β-unsaturated carbonyl scaffold. In this work, we describe these new reagents that can 
modify a broad set of nucleophilic residues on the protein surface, rendering them excellent 
probes for studying protein structure and interactions. When coupled with MS, we have 
successfully used these new reagents to investigate protein-protein interactions and 
demonstrate the ability to incorporate isotopic tags for improved CL performance. 
Moreover, by varying the functional groups on the reagent, labeling kinetics and selectivity 
can be tuned.  
6.3 Results and discussion 
6.3.1 Protein modification by CL reagents 
The α, β-unsaturated carbonyl scaffold that was investigated as a CL reagent was 
designed and synthesized as a Michael acceptor to react with nucleophilic residues on a 
protein’s surface (Figure 6-1). Nucleophilic functional groups in residue side chains are 
particularly reactive with the CL reagent when a good leaving group such as -NEt3
+ is 
present as R2.  When R1 is a methyl group, the resulting mass shift is 98 Da as confirmed 
via LC-MS measurements of intact proteins (Figure 6-2). 
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Figure 6-1. Nucleophilic residues (i.e. -Nu:) on the proteins surface can react with the CL reagent 
to generate a covalent adduct that can then be identified by MS. 
 
 
Figure 6-2. (a) Example mass spectrum of Myo after reaction with the indicated CL reagent. (b) 
Expanded region of the mass spectrum from m/z 870 to 1040, showing labeling of the protein. 
 
 To identify the types of nucleophilic residues that are reactive, four different model 
proteins, including bovine carbonic anhydrase (bCA), β-2-microglobulin (β2m), 
myoglobin (Myo) and β-lactoglobulin b (βLGb) were reacted for 30 min at a molar excess 
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of 20 with the reagent bearing -CH3 as R1 and -NEt3
+ as R2. After proteolytic digestion and 
LC-MS/MS analyses of the labeled proteins, as expected we detect labeling on relatively 
strong nucleophilic residues such as Cys, His, and Lys. For instance, solvent exposed 
Lys42 in Myo is readily labeled as indicated by collision induced dissociation (CID) of the 
peptide TGHPETLEKFDKF (Figure 6-3a). Other example tandem mass spectra of labeled 
Cys and His peptides are found in Figure 6-3b and A-6-2c. Surprisingly, weak nucleophilic 
residues such as Ser, Thr, Tyr, Asp, Glu, Arg, Trp, Asn, Gln and Met are also found to be 
modified by this reagent, as exemplified by MS/MS of the HPGDFGADAQGAMTK 
peptide from Myo that shows labeling at Asp123 (Figure 6-3d). Additional examples can 
be found in the SI (Figure 6-3e - 6-3j). We speculate that good reactivity with such a wide 
range of residues is due to both the good alkyamine leaving group on this reagent and the 
stability of the resulting product that is not prone to hydrolysis after labeling. This 
resistance to hydrolysis is in contrast to DEPC labeling, whose Ser, Thr, and Tyr products 
have been shown to be subject to hydrolysis after labeling.43 Overall, the 13 different types 
of amino acid residues that can be labeled by this new reagent account for about 55% of 
the sequence of the average protein, indicating that it should provide excellent structural 
resolution. Moreover, among these labeled residues, Tyr, Arg and Trp are frequent “hot 
spots” at protein-protein interfaces,44 so that this new reagent should be an excellent probe 
of protein-protein interfaces.  
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(a) K42 from Myo 
 
 
(b) C160 from βLGb 
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(c) H113 from Myo 
 
 
(d) D123 from Myo 
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(e) T86 from β2m 
 
 
(f) Y146 from Myo 
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 (g) W7 from Myo 
 
  
(h) R45 from β2m 
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(i) Q89 from β2m 
 
 
(j) M132 from Myo 
 
Figure 6-3. Tandem mass spectra of select peptides illustrating the breadth of different residues 
that are modified by the α, β-unsaturated carbonyl reagent. 
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Figure 6-4. Space-filling models for (a) bovine carbonic anhydrase (bCA), (b) β-2-microglobulin 
(β2m) and (c) Myoglobin (Myo). The residues labeled on each protein are indicated in orange. (d) 
Bar graph showing that most residues that are labeled by the reagent have high solvent accessible 
surface areas (SASA). 
 
Because probing protein-protein interactions via CL relies on monitoring the 
solvent accessibilities of the protein residues that are involved at the interfaces, we 
evaluated whether those residues labeled by this reagent are primarily solvent accessible 
ones. Based on previous CL work,23, 35 proteins are likely to maintain their HOS when the 
total labeling extent is below 1.4 labels/protein. We decided to carry out labeling reactions 
that led to a labeling level of 1.1-1.2 labels/protein for the following experiments to 
minimize protein structural perturbations. Upon reaction of bCA, β2m, and Myo with the 
reagent having -CH3 as R1 and -NEt3
+ as R2, we find that the vast majority of the labeled 
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residues are on the surface of the protein (Figure 6-4). Space-filling models show that the 
residues labeled in bCA, β2m and Myo cover much of the surface of the protein (Figure 6-
4a - 6-4c). In addition, greater than 90% of the labeled residues have SASA values above 
20%, which typically qualifies them as solvent accessible, and almost 60% of the labeled 
residues are highly exposed with SASA values of greater than 50% (Figure 6-4d).  Of the 
10 residues having SASA values < 20%, most of them are either Lys or His residues that 
have high reactivities or residing in specific micro-environments. 
6.3.2 Investigation of protein-protein binding interface using CL reagents 
With a good evidence that this reagent reacts with solvent exposed residues, we 
examined its ability to identify the residues present at the interface of a protein dimer. We 
chose the Zn(II)-induced dimer of the protein β2m as a testbed for this reagent. β2m forms 
amyloid fibrils in the presence of Cu(II), and the structure of the pre-amyloid dimer formed 
upon Cu(II) binding is known.37 In contrast, Zn(II) enables the formation of a very stable 
dimer, but it does not induce amyloid fibril formation.41-42 A comparison of the 
modification levels for the apo β2m monomer and SEC-purified Zn(II)-induced dimer 
(Figure 6-5) after reaction with the reagent described above can be found in Figure 6-6a. 
Ten residues are found to undergo statistically significant differences in modification 
extents, with four of them undergoing increases in reactivity and six of them undergoing 
decreases in reactivity. The sites of these changes can be mapped onto the structure of the 
β2m monomer (Figure 6-6b) with decreases shown in blue and increases shown in red. A 
cluster of residues near the C-terminal end of β2m and at His51 are found to undergo 
decreases in the extent of modification. His51 has previously been identified as the Zn(II) 
binding site in the protein, explaining this residue’s decreased modification extent.42, 45 The 
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other residues, including S11/R12, H13, K19, K41, and K75, are clustered near the C-
terminus or “tail” of the protein, suggesting that the Zn(II)-induced dimer is formed via a 
“tail-to-tail” interaction of two monomers. This interface contrasts sharply with the Cu(II)-
induced β2m dimer, which forms a side-to-side interaction (Figure 6-7).37 This distinct 
interface in the Zn(II)-induced dimer perhaps explains why Zn(II) does not allow β2m 
amyloid formation to occur, whereas Cu(II) does. 
 
Figure 6-5. SEC chromatography of the Zn(II)-induced β2m dimer and monomer. Dimer fraction 
within two dashed blue lines was collected for further experiments.  
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Figure 6-6. (a) Residue modification levels after reactions of the reagent with the β2m monomer 
(green) and Zn(II)-induced β2m dimer (orange). The bar with an arrow indicates a statistically 
significant change at a 95% confidence interval. (b) Sites of modification level changes mapped 
onto the monomeric structure of β2m. The labeling decreases (in blue) are clustered around the C-
terminal “tail” of β2m, with the exception of His51, which is the known binding site of Zn(II). The 
increases in labeling (in red) are also indicated. 
 
 
Figure 6-7. Cartoon representation of Cu(II)-induced β2m dimer structure and interactions based 
on previous studies4. The Cu(II)-induced dimer forms an anti-parallel interface involving ABED β 
strands, which is different from Zn(II)-induced β2m dimer interface that is found with the new 
labeling reagent. 
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6.3.3 Labeling kinetics and selectivity 
 Another feature of the reagent indicated in Figure 6-1 is that the R1 group and R2 
group can be varied to introduce new reactivity or new capability for the CL reagent. For 
instance, the CL reaction kinetics can be tuned by varying the functional groups at R1 and 
R2 (Figure 6-8a). With a more electron withdrawing group as R1 and a better leaving group 
as R2, the reaction can be accelerated, whereas the reaction is slowed when R1 is an electron 
donating group and R2 is a poor leaving group. As an example, Reagent 6-2, which was 
used in all the experiments described above, reacts to yield 1.2 labels per protein during a 
4 min reaction, whereas Reagent 6-6, which has a relatively weak leaving group in the R2 
position, requires a 32 h reaction to achieve the same labeling extent (Figure 6-8b). 
Reagent 6-6, which has both a good leaving group at R2 and a good electron withdrawing 
group at R1, achieves a labeling extent of 1.2 labels/protein after only a 5 sec reaction 
(Figure 6-8c). 
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Figure 6-8. (a) Chemical structures of different CL reagents with functional group variations. (b) 
Covalent labeling reaction kinetics of 100 μM Myoglobin with 2 mM different CL reagents 
respectively in 50 mM pH 8.0 phosphate buffer. (c) Zoom-in of the 0-0.5 h region of plot (b).  
 
Tuning the reaction kinetics can allow for the tuning of the labeling selectivity to 
some extent. Upon comparison of the Myo labeling results from reactions with Reagent 6-
2 and Reagent 6-6, we find differences in the reactivity at certain residues. As a particularly 
compelling example, we observed that His113 reacts quite distinctly with these two 
reagents. The ISDAIIHVL peptide that contains His113 gives rise to two isomeric products 
due to reactions on the δN and εN of His113, which can be separated by LC and confirmed 
by tandem MS (Figure 6-9). Interestingly, Reagent 6-2 reacts about equally with both 
nitrogens on the side chain, whereas the Reagent 6-6 reacts three times more extensively 
with only one of the nitrogens on this residue (Figure 6-10a). An analysis of the micro-
environment surrounding His113 in Myo reveals that one of the nitrogens is more solvent 
exposed than the other due to an adjacent Arg side chain (Figure 6-10b). Such reaction 
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selectivity might arise from the interplay between the dynamics of the protein around 
His113 and the relatively slow reactivity of Reagent 6-6. Perhaps Reagent 6’s low 
reactivity causes it to primarily label the protein conformational state that has the exposed 
nitrogen on His113, whereas Reagent 6-2 reacts rapidly enough to label both states, 
leading to almost equivalent reactivity at both nitrogens on His113. Analogous atom-
specific reactivity on the side chains of Phe residues was recently observed in hydroxyl 
radical labeling of wide-type and ΔN6 β2m.46 
 
Figure 6-9. (a) Proposed mechanism of the reactions between histidine and CL reagent. (b) Tandem 
mass spectra of ISDAIIHVL from Myo. Top: retention time at 33.6 min; Bottom: retention time at 
34.6 min (Figure 6-10a). Identical dissociation patterns were found for the peptides with the 
different retention times, suggesting that CL reagent reacts with His to form isomers. 
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Figure 6-10. (a) Extracted ion chromatograms (XIC) of both unmodified and modified 
ISDAIIHVL peptide containing His113 in myoglobin. Labeling reaction with Reagent 6-2 for 4 
min (top two columns). Labeling reaction with Reagent 6-6 for 32 h (bottom two columns). Peak 
area (PA) from XIC was used to calculate the ratio between the two modified peptides in the digests 
mixture. (b) Cartoon representation of the micro-environment of His113 in myoglobin, where 
His113 are stabilized by the adjacent Arg31 and a free H2O in bulk solvent. 
 
6.3.4 Isotopic Labeling of protein 
The R1 group in the reagent can also be isotopically enriched with deuterium instead 
of hydrogen on the ethyl group (Figure 6-11a), and if both the normal and deuterated form 
are simultaneously reacted with proteins under identical conditions, the labeled peptides 
after digestion can be readily identified by the characteristic multiplet of peaks (Δm/z = 
1.67 for a +3 ion; Δm/z = 2.5 for a +2 ion; or Δm/z = 5.0 for a +1 ion) with equal ion 
abundances (Figure 6-11b). Moreover, simultaneous tandem MS of both covalently labeled 
peptides (i.e. the normal and deuterium enriched peptide) can generate tandem mass spectra 
that make it easier to identify the covalently labeled residue in the peptide.47 For example, 
  168 
upon MS/MS of the labeled peptide IARRHPYFL, all the b ions appear as doublets, and 
all the y ions appear as singlets, indicating that the labeling site is on the N-terminus (Figure 
6-12). Given the fact that both the normal and deuterated reagents are chemically identical, 
we envisage using these set of reagents to perform relative labeling quantification, which 
would facilitate CL analyses of proteins under 2 or more conditions. 
 
Figure 6-11. (a) Chemical structures of normal and deuterated form of the CL reagent. (b) Mass 
spectra of labeled IARRHPYFL peptide when it is simultaneously reacted with both reagents from 
(a). A characteristic 5 mass unit difference (Δm/z = 1.67 for a +3 ion or Δm/z = 2.50 for a +2 ion) 
allows the labeled peptide to be readily identified. 
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Figure 6-12. Simultaneous tandem mass spectrometry of the normal and deuterated form of 
covalently labeled IARRHPYFL peptide, where the N-terminal modification is easily identified 
due to all the doublet b ions and singlet y ions. 
 
6.4 Conclusions 
In summary, we have developed and used a new CL reagent based on an α, β 
unsaturated carbonyl scaffold that can react with 13 different types of residues on protein 
surfaces. These residues range from very nucleophilic residues, such as Cys, His, and Lys, 
to much less nucleophilic residues such as Asp, Glu, Asn, and Gln. This broad reactivity 
with surface exposed residues enables probing of protein-protein interactions as 
demonstrated for the Zn(II)-induced β2m dimer. The new reagent can also be easily 
functionalized due to its outstanding structural tunability. Labeling kinetics and selectivity 
can be controlled in a predictable way by varying functional groups on the reagent. In 
addition, by incorporating isotopes into the reagent structure, labeling sites during MS and 
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MS/MS analyses can be identified in straightforward way. Overall, we feel that this new 
CL reagent will be a potentially powerful tool for studying protein HOS and protein 
interactions because (i) it reacts with a wide range of residues, thereby providing high 
structural resolution; (ii) its reactivity can be tuned by simple synthetic changes; and (iii) 
it can be isotopically enriched to facilitate MS analysis.  
6.5 Experimental section 
6.5.1 CL reagent synthesis and characterization 
All reagents were commercially available and used as received unless stated 
otherwise. To confirm the structures of synthetic small molecules, 1H-NMR spectra were 
recorded on a 400 MHz Bruker NMR spectrometer using residual proton resonance of the 
solvents as internal standards. Chemical shifts are reported in parts per million (ppm). To 
further validate reagent structures, mass spectra were obtained using a Bruker AmaZon 
quadrupole ion trap mass spectrometer coupled with electrospray ionization source. The 
electrospray needle voltage was kept at ∼4 kV, and the capillary temperature was set at 
220 °C. Synthetic pathways were listed below and detailed information can be found in 
Appendix. 
Synthetic pathway of Reagent 6-1: 
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Synthetic pathway of Compound 6-2b: 
 
Synthetic pathway of Reagent 6-2: 
 
Synthetic pathway of Reagent 6-3: 
 
Synthetic pathway of Reagent 6-4: 
 
Synthetic pathway of Reagent 6-5: 
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Synthetic pathway of Reagent 6-6: 
 
Synthetic pathway of Reagent 6-7: 
 
Synthetic pathway of Reagent 6-8: 
 
Synthetic pathway of Reagent 6-9: 
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6.5.2 Materials 
Human β-2-microglobulin (β2m) that was purified from human urine was 
purchased from Lee Biosolutions (St. Louis, MO). Myoglobin (Myo), bovine carbonic 
anhydrase (bCA), 3-morpholinopropanesulfonic acid (MOPS), triethylammonium acetate, 
potassium acetate, urea, zinc sulfate, tris(2-carboxyethyl)-phosphine (TCEP), and 
Iodoacetamide (IAM) were obtained from Sigma-Aldrich (St. Louis, MO). Sodium 
phosphate dibasic anhydrous, sodium phosphate monobasic anhydrous, ammonium 
acetate, acetonitrile, and formic acid were obtained from Fisher Scientific (Fair Lawn, NJ). 
Deionized water was prepared from a Millipore (Burlington, MA) Simplicity 185 water 
purification system. Trypsin and chymotrypsin were purchased from Promega (Madison, 
WI). 
6.5.3 Protein covalent labeling 
Stock solutions of CL reagents were prepared in water. Covalent labeling reactions 
were typically performed for 10 min at room temperature with 100 μM protein and various 
molar excesses of CL reagents in 50 mM pH 8.0 phosphate buffer. For kinetic experiments, 
20 equivalents of various CL reagents were used to react with Myo for different time 
periods. After labeling, the reaction mixtures were injected immediately into an HPLC to 
remove excess CL reagents and phosphate salts and then later analyzed by ESI-MS.  
6.5.4 β2m dimer preparation 
β2m was dissolved in 25 mM MOPS, 150 mM potassium acetate and 500 mM urea 
at pH 7.4, and then zinc sulfate was added to the protein solution at a ratio of 4:1 
Zn(II):protein. The final zinc(II) and protein concentrations were 800 and 200 µM, 
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respectively. Incubation was kept at 37 °C for 1 hour. Based on previous studies,41-42 β2m 
is known to form a stable dimer under these conditions.   
6.5.5 Proteolytic digestion 
The labeled protein samples were first buffer-exchanged using 10K NMWL 
Amicon Ultra centrifugal filters (Millipore, Burlington, MA) with 100 mM triethylamine 
acetate (pH 8.0). For β2m and Myo, the samples were incubated with 10% (v/v) acetonitrile 
at 50 °C for 45 min to denature the protein. For bCA, the samples were incubated with 8 
M urea to denature the protein, and this urea concentration was reduced to 1 M before 
enzymatic digestion. To reduce the disulfide bonds in β2m, TCEP in water was added at a 
protein:TCEP molar ratio of 1:20, and the sample was incubated at room temperature for 
10 min. To alkylate the reduced cysteines, iodoacetamide in water was added at a 
protein:iodoacetamide molar ratio of 1:80, and the sample was incubated in the dark at 
room temperature for 30 min. The denatured, reduced, and alkylated protein samples were 
then digested with trypsin or chymotrypsin at an enzyme: substrate ratio of 1:10. After 4 h 
of digestion at 37 °C, the enzyme was separated from the mixture by centrifugation using 
a 10K NMWL Microcon filter (Millipore, Burlington, MA). The filtrate was then analyzed 
by LC-MS and LC-MS/MS. 
6.5.6 HPLC separation 
To quench the CL reaction and to remove excess CL reagents and buffer salts, a 
Thermo Scientific Ultimate 3000 HPLC system (Thermo Scientific, Tewksbury, MA) with 
an OPTI-TRAP C4 reverse phase column (1 × 8 mm) was used. The protein was eluted 
using an acetonitrile gradient that increases from 1 to 99% over 12 min at a flow rate of 0.2 
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mL/min. The labeled protein was collected for proteolytic digestion or intact protein MS 
characterization.  
 Size-exclusion chromatography (SEC) of the β2m dimer was separated using a 
TSK-gel SuperSW2000 column (Tosoh Bioscience, Prussia, PA) installed on an HP1100 
series high-performance liquid chromatography system (Agilent, Santa Clara, CA). A 
mobile phase containing 150 mM ammonium acetate at pH 8.0 was used at a 0.35 mL/min 
flow rate, and a variable wavelength detector set to 214 nm was used for detection. 100 μL 
of the metal-β2m samples were injected. A solution containing 5 μM bovine serum albumin 
(MW = 66000), 5 μM ovalbumin (MW = 45000), 5 μM carbonic anhydrase (MW = 29040), 
and 5 μM β2m (MW = 11731) was used for molecular weight calibration. The β2m dimer 
fraction was collected for subsequent protein labeling experiments.   
 To analyze the digests from the CL experiments, a Thermo Scientific EASY-nLC 
1000 liquid chromatography system (Thermo Scientific, Tewksbury, MA) with an Acclaim 
PepMap RSLC C18 reverse phase column (75 μM × 15 cm, 2 μm particle size) from 
Thermo Scientific (Tewksbury, MA) was used. To achieve efficient separation of the 
proteolytic peptides, a shallow gradient was used where %B (0.1% formic acid in 
acetonitrile) was increased from 0% to 40% over 45 min. The column was then flushed by 
increasing to 95% B over 15 min. The column was then cleaned at 95% B for another 20 
min. A flow rate of 300 nL/min was used throughout the run.  
6.5.7 Mass spectrometry 
Mass spectral analyses of the HPLC separated intact protein samples from the 
covalent labeling experiments were acquired on a Bruker AmaZon (Billerica, MA) 
quadrupole ion trap mass spectrometer equipped with an electrospray ionization source. 
  176 
The electrospray needle voltage was kept at 4 kV, and the capillary temperature was set to 
250 °C. 
LC-MS and LC-MS/MS analyses of protein proteolytic fragments were conducted 
on a Thermo Orbitrap Fusion Tribrid (Tewksbury, MA) mass spectrometer. The 
electrospray ionization source was typically operated at a needle voltage of 2100 V, and 
the ion transfer tube temperature was set to 300 °C. Tandem mass spectra were collected 
using CID with a normalized collision energy of 35%. Due to the large number of 
detectable peaks, an exclusion limit of 60 s was applied after five spectra had been collected 
for any given peak. The resolution of the Orbitrap was set to 60000. 
6.5.8 Peptide Identification and quantification 
Raw mass spectral data files were analyzed by Thermo Proteome Discoverer 2.2 
software. Spectra were searched against the corresponding protein sequence. Variable 
modification by certain covalent labeling reagents of the residues and the protein N-
terminus was added as a dynamic modification. Other dynamic modifications such as 
oxidation of methionine and carboxyamidomethylation of cysteine were also used in the 
searches. Either trypsin or chymotrypsin enzyme cleavage was selected, and a precursor 
mass tolerance of 10 ppm was used. Identifications of peptides and modifications at high 
confidence levels were used and were manually checked in all cases. Quantifications of 
peptides and modifications from the mass spectra were performed using the Thermo 
Xcalibur software. Chromatograms were extracted, and peak areas of peptide species were 
used for quantification. 
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6.5.9 Solvent accessibility calculation 
The online software GetArea was used to calculate the solvent accessible surface 
area (SASA) of residues on β2m (pdb: 1JNJ), Myo (pdb: 1DWR), and bCA (pdb: 1V9E). 
A probe radius of 1.4 Å was used. Residues having SASA above 20% were considered as 
solvent accessible.  
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CHAPTER 7 
 
CONCLUSIONS AND FUTURE DIRECTIONS  
This dissertation demonstrates the use of synthetic polymers and small molecules 
to enhance protein detection in complex mixtures as well as analyze protein structures and 
protein-protein interactions in combination with different MS techniques. In Chapter II, a 
new amphiphilic random co-polymer scaffold was designed and developed to be able to 
form functional nanoassemblies for selective enrichment and sensitive detection of 
peptides. Comparing to previously used homopolymer scaffold, this random co-polymer 
scaffold has hydrophobic and hydrophilic moieties in different repeating units. 
Hydrophobic moieties and different functional groups can be readily incorporated to the 
styrene structure, which offers minimized synthetic efforts for monomer preparation. In 
addition, the combination and the ratio of each repeating unit can be easily varied for 
optimization and to realize different applications. Within the random co-polymer based 
nanoassemblies, the spatial arrangement and the packing density of functional groups can 
be tuned, which is not easily accomplished for homopolymer-based nanoassemblies that 
may have rigid functional groups on the polymer backbone. Similar to homopolymer, 
random co-polymers can also regulate themselves to form an ordered structure, which 
offers selective binding as well as signal enhancement in MALDI detection. In contrast to 
homopolymers, whose properties are highly defined by the monomer structure, the 
properties of random co-polymer, in general, are relatively difficult to predict. However, 
this issue can be addressed by screening the optimal structure that is synthetically 
straightforward. 
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These features of the random co-polymers are especially beneficial for the 
fundamental investigations of structure property relationship, such as the investigation of 
how charge density influences the extraction capacity in Chapter III and how functional 
groups with different pKa values behave on the micellar state in Chapter IV. In addition, 
this scaffold is so robust and versatile that various functional groups can be incorporated 
into the structure, which paves the road for other applications such as enrichment of post 
translational modified peptides, enrichments of intact proteins and possibilities of 
generating an enzyme-based nanoreactor in organic solvent.  
 In Chapter III, four different series of random co-polymers were synthesized, where 
the charge density was systematically varied using the aforementioned random co-polymer 
scaffold. An optimal charge density was observed to achieve the highest extraction 
capacity, which helps in understanding the electrostatic host-guest interactions within the 
confined micellar compartment in apolar media. By fine-tuning the HLB of the polymer, 
the stability of nanoassemblies can be improved to obtain an optimized extraction capacity. 
These findings suggest that in the context of studying host-guest system in confined 
micellar compartments in apolar environments, correlations between multivalent 
electrostatic interaction and binding capability are not straightforward, meaning that a large 
number of multivalent interactions does not necessarily lead to high binding capacity as 
other factors may also influence the integrity of the nanoassemblies. Overall, these 
mechanistic investigations guide the design of next-generation self-assembling materials 
when electrostatics is used in the host-guest system. And, the understandings gained from 
this study would potentially impact many areas such as separation of biomolecules from 
complex mixtures, building enzyme-based nanoreactors and efficient drug encapsulation 
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in drug delivery vehicles, where both high loading capacity and stability are required in the 
apolar media.  
 In Chapter IV, random co-polymers containing low pKa functional groups were 
developed, where these functional groups within the assemblies maintain their aqueous 
phase pKa and allow selective extraction of peptides according to their pI. Taking the 
fundamental understandings of pKa dependency, efficient isolation and pI-bracketing of 
peptides from complex mixtures at acidic pH has been achieved, which ultimately leads to 
a selective and sensitive platform for the detection of acidic peptides. Together, specific 
isolation and detection of acidic peptides using low-pKa co-polymers provides more 
predictable separations and decent compatibility to MS comparing to other techniques such 
as isoelectric focusing (IEF)-MS and ion exchange chromatography (IEC)-MS. As another 
advantageous attribute, pI-bracketing allows for improved detection of peptides whose 
ionization is suppressed by their more abundant counterparts. Simplifying mixtures in a 
predictable way could improve the sequence coverage of low-abundance or acidic proteins 
that are often difficult to detect in proteomics-type studies. Overall, this method can be 
considered to serve as a complementary tool for applications such as proteomics or disease 
biomarker detection.   
In Chapter V, an analytical methodology using polymeric extraction materials has 
been developed to selectively deplete abundant proteins in human breast milk and 
efficiently enrich breast cancer biomarkers. This method provides an alternative approach 
to evaluate the profile of disease biomarker in biofluids, which is specifically beneficial in 
the detection of high-pI protein biomarkers. Comparing to current techniques such as 
ELISA, multiplex detection of different biomarkers as well as differentiation of biomarker 
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isoforms can be achieved using this method, which is capable of improving the detection 
fidelity. On the other hand, the polystyrene-based extraction materials are inherently cheap 
and stable, which outcompetes the antibody-based enrichment probes. Since this method 
is promising in assessing basic species, another application can include the quantification 
of low-abundance variance of protein therapeutics caused by specific sequence 
modification. To further extend the scope of this method, different biological-relevant 
samples can be tested such as serum, saliva, urine, cell lysates and exosomes. In parallel, 
low-pI biomarker can be also detected using a similar strategy, where it can be enriched by 
a known small-molecule ligand (binds to targeted protein) and followed by a quantitative 
release of this enriched biomarker back to the aqueous phase for quantification. 
Alternatively, they can be isolated within a narrow pI range using sequential extractions, 
where high-pI proteins can be initially removed and the targeted biomarkers can be 
enriched by nanoassemblies subsequently accordingly to their pIs. Overall, the works 
presented from Chapter II to Chapter V focus on enhancing MS-based protein detection 
using polymeric supramolecular assemblies, which holds great potentials for a great deal 
of applications in biomedical researches. 
 Finally, Chapter VI highlights another interdisciplinary research where a series of 
synthetic small-molecule CL reagents are developed to study protein HOS when coupled 
with MS. These new CL reagents are based on an α, β-unsaturated carbonyl scaffold and 
are capable of reacting with a broad range of nucleophilic residues on a protein’s surface, 
which in turn probes a protein’s HOS as well as protein-protein interaction interfaces with 
high structural resolution. Due to the excellent structural tunability, the functional groups 
within the reagent can be easily varied to achieve desired labeling kinetics and selectivity. 
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In the scenario of histidine labeling, CL reagents with different reactivities can reveal the 
specific microenvironments of different nitrogens based upon relative labeling extents. 
Therefore, this feature also offers an opportunity to investigate the microenvironments of 
specific residues, which other reagents rarely afford. In addition, isotopes can be 
incorporated into the reagent, which will generate isotopically labelled products. These 
products can be further utilized in software searching for facilitated labeling identification 
and quantification, which improves both the confidence and the speed of data 
interpretation.  
 Furthermore, many other investigations and applications can originate from these 
new reagents in the near future. In protein HOS characterization by MS, (i) more in-depth 
validations need to be performed to test the stability of the labeled products under different 
conditions (e.g. protein digestion condition and LC-MS condition); (ii) CL experimental 
results provided by these reagents need to be compared with other techniques such as HDX 
to validate the consistency of structural information. (iii) Reagents with a series of isotopes 
can be synthesized, which will be helpful for labeling quantification. (iv) isotopic labeling 
of protein complexes can be conducted to facilitate the discovery of protein-protein binding 
interfaces. (v) taking advantages of controlled reactivity and selectivity of different 
reagents, protein dynamics and residue specific micro-environments can be studied. (vi) 
new reagents containing functional groups with specific capabilities of easy ionization or 
easy fragmentation can be designed and tested to improve MS analysis. In other 
applications, (i) protein conjugation can be carried out using this scaffold to offer protein 
external properties (e.g. fluorescence labeling and protein pegylation, real-time 
monitoring). (ii) various drugs can be introduced to protein therapeutics through these 
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reagents to produce antibody drug conjugates (ADCs). (iii) Driven by the idea of selective 
labeling, specific protein enrichment can be accomplished with a proper design of reagent 
structure. (iv) these reagents could be incorporated into drug delivery vehicles for targeted 
conjugation and release of drug. Take everything into account, these new reagents are so 
gifted that they should be valuable probes for protein HOS analysis by MS as well as 
promise various applications in many different areas.  
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APPENDIX 
 
SYNTHESES AND CHARACTERIZATIONS 
 
Synthesis of poly(dialkoxystyrene) (PDAS) amphiphilic homopolymer  
The PDAS carboxylate homopolymer P2-7 was synthesized as previously 
described elsewhere.1 
Synthesis of random co-polymer P2-1 
Synthesis of compound 2-1a: 
To a solution of acetone mixed with K2CO3 (11.84 g, 85.65 mmol) and 18-crown-6 (1.13 
g, 4.28 mmol), 4-Hydroxybenzaldehyde (5.23 g, 42.83 mmol) was added and stirred for 5 
min. To this mixture, 1-Bromodecane (14.21 g, 64.24 mmol) was added and stirred with 
reflux for 20 h. The reaction mixture was then cooled to room temperature and filtered to 
afford the crude product in acetone solution. The solvent was evaporated to dryness and 
purified by silica gel column chromatography (8-10% ethyl acetate in hexanes) to obtain 
10.5 g (95% yield) of 2-1a. 1H NMR (400MHz, CDCl3) δ 9.86 (s, 1H), δ 7.80-7.82 (d, 2H), 
δ 6.96-6.99 (d, 2H), δ 4.00-4.04 (t, 2H), δ 1.76-1.83 (quint, 2H), δ 1.47-1.26 (m, 14H), δ 
0.85-0.89 (t, 3H).  
 
Synthesis of compound 2-1b: 
Methyltriphenylphosphonium bromide (6.58 g, 25.11 mmol) and Potassium tert-butoxide 
(3.94 g, 35.15 mmol) were mixed in a round bottom flask, and dry THF (20 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 2-1a (6.58 g, 25.11 mmol) was slowly added to the 
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mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (3-5% ethyl acetate in hexanes) to afford 5.5 g (85% 
yield) of 2-1b. 1H NMR (400MHz, CDCl3) δ 7.31-7.33 (d, 2H), δ 6.83-6.85 (d, 2H), δ 6.61-
6.68 (q, 1H), δ 5.57-5.61 (d, 1H), δ 5.09-5.12 (d, 1H), δ 3.93-3.96 (t, 3H), δ 1.73-1.80 
(quint, 2H), δ 1.27-1.46 (m, 14H), δ 0.86-0.89 (t, 3H). 
 
Synthesis of compound 2-1c: 
To a solution of acetone mixed with K2CO3 (6.79 g, 49.13 mmol), NaI (7.36 g, 49.13 mmol) 
and 18-crown-6 (0.65 g, 2.46 mmol), 4-Hydroxybenzaldehyde (3.00 g, 24.57 mmol) was 
added and stirred for 5 min. To this mixture, tert-Butyl bromoacetate (9.58 g, 49.13 mmol) 
was added and stirred with reflux for 20 h. The reaction mixture was then cooled to room 
temperature and filtered to afford the crude product in acetone solution. The solvent was 
evaporated to dryness and purified by silica gel column chromatography (10-13% ethyl 
acetate in hexanes) to obtain 5.5 g (95% yield) of 2-1c. 1H NMR (400MHz, CDCl3) δ 9.88 
(s, 1H), δ 7.82-7.84 (d, 2H), δ 6.97-6.99 (d, 2H), δ 4.59 (s, 2H), δ 1.47 (s, 9H); ESI-MS 
(expected: [m+H]+= 237.1, obtained: [m+Na]+= 259.1) 
 
Synthesis of compound 2-1d: 
Methyltriphenylphosphonium bromide (7.94 g, 22.24 mmol) and Potassium tert-butoxide 
(2.50 g, 22.24 mmol) were mixed in a round bottom flask, and dry THF (15 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
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to yield the bright yellow solution. 2-1c (3.5 g, 14.83 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (3-5% ethyl acetate in hexanes) to afford 3.1 g (90% 
yield) of 2-1d. 1H NMR (400MHz, CDCl3) δ 7.33-7.35 (d, 2H), δ 6.84-6.87 (d, 2H), δ 6.63-
6.68 (q, 1H), δ 5.60-5.64 (q, 1H), δ 5.13-5.15 (q, 1H), δ 4.51 (s, 2H), δ 1.49 (s, 9H); ESI-
MS (expected: [m+H]+= 235.1, obtained: [m+Na]+= 257.1) 
 
Synthesis of random co-polymer 2-1e: 
A mixture of the compound 2-1b (300 mg, 1.15 mmol), 2-1d (269 mg, 1.15mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 15 mg, 0.046 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 12 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
precipitated 3 times in the MeOH. The precipitate was collected and dried under vacuum 
to yield 430 mg (75% yield) of 2-1e. GPC (PMMA/THF): Mn= 10K Da, Đ=1.1;  
  193 
 
 
Synthesis of random co-polymer P2-1: 
DCM (2 mL) was added to dissolve the dried random co-polymer 2-1e (420 mg). 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum to obtain the final product P2-1.  
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Synthesis of random co-polymer P2-2 
Synthesis of compound 2-2a: 
To a solution of Thionyl chloride (5.0 g, 3 mL, 42.03 mmol), 4-Formylbenzoic acid (1.0 g, 
6.66 mmol) was added to afford a cloudy solution. This mixture was stirred with reflux for 
18 h. The reaction mixture was then cooled to room temperature and filtered to afford the 
brown clear solution. The reaction mixture was evaporated and dried under vacuum for 3 
h. Then the crude product was dissolved in DCM, and mixed with Triethylamine (2.02 g, 
19.98 mmol) for 30 min in an ice bath. To the reaction mixture, commercial available 
compound L-Aspartic acid di-tert-butyl ester hydrochloride (2.06 g, 7.33 mmol) was added 
and stirred for 12 h. The mixture was evaporated and purified by silica gel column 
chromatography (10-15% ethyl acetate in hexanes) to obtain 1.1 g (overall 45% yield) of 
2-2a. 1H NMR (400MHz, CDCl3) δ 10.07 (s, 1H), δ 7.95 (s, 4H), δ 7.30-7.32 (d, 1H), δ 
4.84-4.88 (quint, 1H), δ 2.83-3.02 (m, 2H), δ 1.44-1.48 (d, 18H); ESI-MS (expected: 
[m+H]+= 378.2, obtained: [m+Na]+=  400.2)  
 
Synthesis of compound 2-2b: 
Methyltriphenylphosphonium bromide (1.56 g, 4.37 mmol) and Potassium tert-butoxide 
(0.49 g, 4.37 mmol) were mixed in a round bottom flask, and dry THF (15 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 2-2a (1.1 g, 2.92 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
  195 
silica gel column chromatography (5-8% ethyl acetate in hexanes) to afford 0.77 g (70% 
yield) of 2-2b. 1H NMR (400MHz, CDCl3) δ 7.61-7.78 (q, 2H), δ 7.45-7.47 (d, 2H), δ 7.19-
7.20 (d, 1H), δ 6.70-6.77 (q, 1H), δ 5.81-5.85 (d, 1H), δ 5.33-5.36 (d, 1H), δ 4.85-4.89 
(quint, 1H), δ 2.82-3.00 (m, 2H), δ 1.44-1.48 (d, 18H); ESI-MS (expected: [m+H]+= 376.2, 
: obtained: [m+Na]+= 398.2) 
 
Synthesis of random co-polymer 2-2c: 
A mixture of the compound 2-1b (150 mg, 0.58 mmol), 2-2b (216 mg, 0.58mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 7.5 mg, 0.023 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 12 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in DCM, and dialyzed against 
DCM/MeOH (v/v= 6/1) for 2 days. The solution was collected and dried under vacuum to 
yield 260 mg (70% yield) of 2-2c. GPC (PMMA/THF): Mn= 12K Da, Đ=1.2;  
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Synthesis of random co-polymer P2-2: 
DCM (2 mL) was added to dissolve the dried random co-polymer 2-2c (250 mg). 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum to obtain the final product P2-2.  
 
 
Synthesis of random co-polymer P2-3 
Synthesis of compound 2-3a: 
To a solution of acetone mixed with K2CO3 (6.00 g, 43.44 mmol), NaI (3.91 g, 26.06 mmol) 
and 18-crown-6 (0.57 g, 2.17 mmol), 3,4-Dihydroxybenzaldehyde (1.50 g, 10.86 mmol) 
was added and stirred for 5 min. To this mixture, tert-Butyl bromoacetate (5.08 g, 26.06 
mmol) was added and stirred with reflux for 20 h. The reaction mixture was then cooled to 
room temperature and filtered to afford the crude product in acetone solution. The solvent 
was evaporated to dryness and purified by silica gel column chromatography (10-13% 
ethyl acetate in hexanes) to obtain 3.4 g (85% yield) of 2-3a. 1H NMR (400MHz, CDCl3) 
δ 9.83 (s, 1H), δ 7.45-7.47 (q, 1H), δ 7.35-7.36 (d, 1H), δ 6.88-6.91 (d, 1H), δ 4.66-4.69 
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(d, 4H), δ 1.47-1.48 (d, 18H); ESI-MS (expected: [m+H]+= 367.2, obtained: [m+Na]+= 
389.2) 
 
Synthesis of compound 2-3b: 
Methyltriphenylphosphonium bromide (4.24 g, 11.88 mmol) and Potassium tert-butoxide 
(1.33 g, 11.88 mmol) were mixed in a round bottom flask, and dry THF (20 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 2-3a (2.9 g, 7.92 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (3-5% ethyl acetate in hexanes) to afford 2.3 g (80% 
yield) of 2-3b. 1H NMR (400MHz, CDCl3) δ 6.94-6.96 (t, 2H), δ 6.78-6.80 (d, 1H), δ 6.57-
6.64 (q, 1H), δ 5.55-5.60 (q, 1H), δ 5.13-5.16 (q, 1H), δ 4.59-4.61 (d, 4H), δ 1.47-1.48 (d, 
18H); ESI-MS (expected: [m+H]+= 365.2, obtained: [m+Na]+= 387.2) 
 
Synthesis of random co-polymer 2-3c: 
A mixture of the compound 2-1b (200 mg, 0.77 mmol), 2-3b (280 mg, 0.77mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 10 mg, 0.031 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 12 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
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precipitated 3 times in the MeOH. The precipitate was collected and dried under vacuum 
to yield 340 mg (70% yield) of 2-3c. GPC (PMMA/THF): Mn= 14K Da, Đ=1.1;  
 
 
Synthesis of random co-polymer P2-3: 
DCM (2 mL) was added to dissolve the dried random co-polymer 2-3c (330 mg). 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum to obtain the final product P2-3.  
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Synthesis of random co-polymer P2-4 
Synthesis of compound 2-4a: 
To a solution of acetone mixed with K2CO3 (3.85 g, 27.88 mmol), NaI (2.50 g, 16.73 mmol) 
and 18-crown-6 (0.37 g, 1.39 mmol), 3,4,5-Trihydroxybenzaldehyde (0.8 g, 4.65 mmol) 
was added and stirred for 5 min. To this mixture, tert-Butyl bromoacetate (3.26 g, 16.73 
mmol) was added and stirred with reflux for 20 h. The reaction mixture was then cooled to 
room temperature and filtered to afford the crude product in acetone solution. The solvent 
was evaporated to dryness and purified by silica gel column chromatography (10-13% 
ethyl acetate in hexanes) to obtain 1.9 g (85% yield) of 2-4a. 1H NMR (400MHz, CDCl3) 
δ 9.78 (s, 1H), δ 7.06 (s, 2H), δ 4.82 (s, 2H), δ 4.64 (s, 4H), δ 2.17 (s, 9H), δ 1.47-1.48 (d, 
27H); ESI-MS (expected: [m+H]+= 497.2, obtained: [m+Na]+= 519.2) 
 
Synthesis of compound 2-4b: 
Methyltriphenylphosphonium bromide (2.05 g, 5.74 mmol) and Potassium tert-butoxide 
(0.64 g, 5.74 mmol) were mixed in a round bottom flask, and dry THF (20 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 2-4a (1.9 g, 3.93 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (3-5% ethyl acetate in hexanes) to afford 1.3 g (70% 
yield) of 2-4b. 1H NMR (400MHz, CDCl3) δ 6.50-6.58 (quint, 3H), δ 5.55-5.59 (q, 1H), δ 
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5.16-5.19 (d, 1H), δ 4.59-4.63 (d, 6H), δ 1.46-1.48 (d, 27H); ESI-MS (expected: [m+H]+= 
495.3, obtained: [m+Na]+= 517.3) 
 
Synthesis of random co-polymer 2-4c: 
A mixture of the compound 2-1b (100 mg, 0.38 mmol), 2-4b (190 mg, 0.38 mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 5 mg, 0.015 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 12 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
precipitated 3 times in the MeOH. The precipitate was collected and dried under vacuum 
to yield 170 mg (60% yield) of 2-4c. GPC (PMMA/THF): Mn= 15K Da, Đ=1.2;  
 
 
Synthesis of random co-polymer P2-4: 
DCM (2 mL) was added to dissolve the dried random co-polymer 2-4c (160 mg). 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum to obtain the final product P2-4.  
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Synthesis of random co-polymer P2-5 
Synthesis of compound 2-5a: 
To a solution of acetone mixed with K2CO3 (1.17 g, 8.45 mmol), and 18-crown-6 (0.56 g, 
2.11 mmol), 4-Hydroxybenzaldehyde (0.52 g, 4.23 mmol) was added and stirred for 5 min. 
To this mixture, tosylate of pentaethylene glycol monomethyl ether (2.06 g, 5.07 mmol) 
was added and stirred with reflux for 20 h. The reaction mixture was then cooled to room 
temperature and filtered to afford the crude product in acetone solution. The solvent was 
evaporated to dryness and purified by silica gel column chromatography (3-5% MeOH in 
DCM) to obtain 1.0 g (65% yield) of 2-5a. 1H NMR (400MHz, CDCl3) δ 9.88 (s, 1H), δ 
7.82-7.84 (t, 2H), δ 7.01-7.03 (d, 2H), δ 4.20-4.22 (t, 2H), δ 3.88-3.90 (t, 2H), δ 3.53-3.73 
(m, 16H), δ 3.37 (s, 3H); ESI-MS (expected: [m+H]+= 357.2, obtained: [m+Na]+= 379.2) 
 
Synthesis of compound 2-5b: 
Methyltriphenylphosphonium bromide (1.35 g, 3.79 mmol) and Potassium tert-butoxide 
(0.42 g, 3.74 mmol) were mixed in a round bottom flask, and dry THF (15 mL) was added 
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to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 2-5a (0.9 g, 2.53 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (30-40% ethyl acetate in hexanes) to afford 0.54 g (60% 
yield) of 2-5b. 1H NMR (400MHz, CDCl3) δ 7.31-7.32 (d, 2H), δ 6.85-6.86 (d, 2H), δ 6.61-
6.67 (q, 1H), δ 5.57-5.61 (q, 1H), δ 5.09-5.12 (q, 1H), δ 4.10-4.12 (t, 2H), δ 3.83-3.85 (t, 
2H), δ 3.53-3.72 (m, 16H), δ 3.37 (s, 3H); ESI-MS (expected: [m+H]+= 355.2, obtained: 
[m+Na]+= 377.2) 
 
Synthesis of random co-polymer P2-5: 
A mixture of the compound 2-1b (200 mg, 0.77 mmol), 2-5b (272 mg, 0.77 mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 10 mg, 0.030 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 12 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
precipitated 3 times in the MeOH. The precipitate was collected and dried under vacuum 
to yield 240 mg (50% yield) of P2-5. GPC (PMMA/THF): Mn= 10K Da, Đ=1.3;  
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Synthesis of random co-polymer P2-6 
Synthesis of compound 2-6a: 
To a solution of 2-(Methylamino)ethanol (5.37 g, 71.45 mmol) in dry THF, Triethylamine 
(10.89 g, 107.6 mmol) was added and stirred for 15 min at room temperature. To the 
reaction mixture, tert-Butyl bromoacetate (15.40 g, 78.97 mmol) was added and stirred for 
12 h. After the reaction, NaCl saline and ethyl acetate were added for extraction. The 
combined organic layer was separated and washed with saline 3 times. The combined 
organic phase was evaporated to dryness to obtain 11.9 g (90% yield) of 2-6a. 1H NMR 
(400MHz, CDCl3) δ 3.55-3.57 (t, 2H), δ 3.19 (s, 2H), δ 2.66-2.68 (t, 2H), δ 2.40 (s, 3H), δ 
1.45 (s, 9H); ESI-MS (expected: [m+H]+= 190.1, obtained: [m+Na]+=212.1) 
 
Synthesis of compound 2-6b: 
Methyltriphenylphosphonium bromide (17.55 g, 49.13 mmol) and Potassium tert-butoxide 
(5.54 g, 49.37 mmol) were mixed in a round bottom flask, and dry THF (40 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
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to yield the bright yellow solution. 4-Hydroxybenzaldehyde (3.0 g, 24.57 mmol) solution 
(in dry THF) was slowly added to the mixture. The reaction mixture was further stirred for 
5 h. After the reaction, NaCl saline and ethyl acetate were added for extraction. The 
combined organic layer was separated and washed with saline 3 times. The organic layer 
was evaporated to dryness and purified by silica gel column chromatography (8-9% ethyl 
acetate in hexanes) to afford 1.3 g (45% yield) of 2-6b. 1H NMR (400MHz, CDCl3) δ 7.29-
7.32 (q, 2H), δ 6.78-6.80 (q, 2H), δ 6.61-6.69 (q, 1H), δ 5.58-5.62 (d, 1H), δ 5.11-5.14 (d, 
1H), δ 4.71 (s, 1H); ESI-MS (expected: [m+H]+= 121.1, obtained: [m+Na]+= 143.1) 
 
Synthesis of compound 2-6c: 
2-6a (0.62 g, 3.30 mmol) and 2-6b (0.33 g, 2.75 mmol) and Triphenylphosphine (0.86 g, 
3.29 mmol) were mixed in a round bottom flask, and dry THF (10 mL) was added to the 
mixture. The mixture was stirred under argon atmosphere in an ice bath for 10 min. 
Diisopropyl azodicarboxylate (0.70 g, 3.47 mmol) was added dropwise to the mixture. The 
reaction mixture was further stirred for 12 h. Then the solvent was evaporated. 3 mL of 
Ethyl acetate was added to dissolve the mixture, and 30 mL of Hexanes was added, while 
white solids precipitated from the solution. The mixture was filtered, evaporated to dryness 
and purified by silica gel column chromatography (14-17% ethyl acetate in hexanes) to 
afford 0.4 g (50% yield) of 2-6c. 1H NMR (400MHz, CDCl3) δ 7.31-7.33 (q, 2H), δ 6.84-
6.87 (q, 2H), δ 6.61-6.68 (q, 1H), δ 5.57-5.61 (q, 1H), δ 5.09-5.12 (q, 1H), δ 4.07-4.10 (t, 
2H), δ 3.30 (s, 2H), δ 2.97-3.00 (t, 2H), δ 2.49 (s, 3H), δ 1.46 (s, 9H); ESI-MS (expected: 
[m+H]+= 292.2, obtained: [m+Na]+= 314.2) 
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Synthesis of compound 2-6d: 
To a solution of acetone mixed with K2CO3 (4.97 g, 35.96 mmol) and 18-crown-6 (0.79 g, 
2.99 mmol), 4-Hydroxybenzaldehyde (3.66 g, 29.97 mmol) was added and stirred for 5 
min. To this mixture, 1-Bromohexadecane (10.98 g, 35.96 mmol) was added and stirred 
with reflux for 20 h. The reaction mixture was then cooled to room temperature and filtered 
to afford the crude product in acetone solution. The solvent was evaporated to dryness and 
purified by silica gel column chromatography (8-10% ethyl acetate in hexanes) to obtain 
9.0 g (90% yield) of 2-6d. 1H NMR (400MHz, CDCl3) δ 9.88 (s, 1H), δ 7.81-7.84 (q, 2H), 
δ 6.98-7.00 (q, 2H), δ 4.02-4.05 (t, 2H), δ 1.79-1.83 (quint, 2H), δ 1.26-1.55 (m, 26H), δ 
0.88-0.90 (t, 3H). 
 
Synthesis of compound 2-6e: 
Methyltriphenylphosphonium bromide (7.69 g, 21.53 mmol) and Potassium tert-butoxide 
(2.48 g, 22.10 mmol) were mixed in a round bottom flask, and dry THF (20 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 2-6d (4.78 g, 14.37 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (1-3% ethyl acetate in hexanes) to afford 3.8 g (80% 
yield) of 2-6e. 1H NMR (400MHz, CDCl3) δ 7.32-7.34 (q, 2H), δ 6.84-6.86 (q, 2H), δ 6.62-
6.69 (q, 1H), δ 5.58-5.62 (q, 1H), δ 5.10-5.13 (q, 1H), δ 3.94-3.97 (t, 2H), δ 1.76-1.79 
(quint, 2H), δ 1.26-1.54 (m, 26H), δ 0.87-0.90 (t, 3H). 
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Synthesis of random co-polymer 2-6f: 
A mixture of the compound 2-6e (150 mg, 0.45 mmol), 2-6c (132 mg, 0.45 mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 5.9 mg, 0.018 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 24 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
precipitated 3 times in the MeOH. The precipitate was collected and dried under vacuum 
to yield 140 mg (50% yield) of 2-6f. GPC (PMMA/THF): Mn= 20K Da, Đ=1.4;  
 
 
Synthesis of random co-polymer P2-6: 
DCM (2 mL) was added to dissolve the dried random co-polymer 2-6f (130 mg). 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum. THF (2 mL) was then added to dissolve 
the solid polymers. Methyl iodide (0.2 mL) was added in the ice bath, and the reaction 
mixture was further stirred for 12 h. The solvent was evaporated, and the brown solids were 
dried under vacuum to afford the random co-polymer P2-6. 
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Synthesis of random co-polymer P3-1 - P3-5 
Synthesis of compound 3-1a: 
To a solution of acetone mixed with K2CO3 (11.84 g, 85.65 mmol) and 18-crown-6 (1.13 
g, 4.28 mmol), 4-Hydroxybenzaldehyde (5.23 g, 42.83 mmol) was added and stirred for 5 
min. To this mixture, 1-Bromodecane (14.21 g, 64.24 mmol) was added and stirred while 
refluxing for 20 h. The reaction mixture was then cooled to room temperature and filtered 
to afford the crude product in acetone solution. The solvent was evaporated to dryness and 
purified by silica gel column chromatography (8-10% ethyl acetate in hexanes) to obtain 
10.5 g (95% yield) of 3-1a. 1H NMR (400MHz, CDCl3) δ 9.86 (s, 1H), δ 7.80-7.82 (d, 2H), 
δ 6.96-6.99 (d, 2H), δ 4.00-4.04 (t, 2H), δ 1.76-1.83 (quint, 2H), δ 1.47-1.26 (m, 14H), δ 
0.85-0.89 (t, 3H); 13C NMR (400MHz, CDCl3) δ 190.84, δ 164.36, δ 132.05, δ 129.83, δ 
114.82, δ 68.50, δ 31.98, δ 29.64, δ 29.63, δ 29.43, δ 29.40, δ 29.14, δ 26.05, δ 22.76, δ 
14.19. 
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Synthesis of compound 3-1b: 
Methyltriphenylphosphonium bromide (6.58 g, 25.11 mmol) and Potassium tert-butoxide 
(3.94 g, 35.15 mmol) were mixed in a round bottom flask, and dry THF (20 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 3-1a (6.58 g, 25.11 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (3-5% ethyl acetate in hexanes) to afford 5.5 g (85% 
yield) of 3-1b. 1H NMR (400MHz, CDCl3) δ 7.31-7.33 (d, 2H), δ 6.83-6.85 (d, 2H), δ 6.61-
6.68 (q, 1H), δ 5.57-5.61 (d, 1H), δ 5.09-5.12 (d, 1H), δ 3.93-3.96 (t, 3H), δ 1.73-1.80 
(quint, 2H), δ 1.27-1.46 (m, 14H), δ 0.86-0.89 (t, 3H); 13C NMR (500MHz, CDCl3) δ 
159.11, δ 136.43, δ 130.35, δ 127.48, δ 114.62, δ 111.51, δ 68.18, δ 32.05, δ 29.73, δ 29.71, 
δ 29.55, δ 29.47, δ 29.42, δ 26.19, δ 22.83, δ 14.26. 
 
Synthesis of compound 3-1c: 
To a solution of acetone mixed with K2CO3 (6.79 g, 49.13 mmol), NaI (7.36 g, 49.13 mmol) 
and 18-crown-6 (0.65 g, 2.46 mmol), 4-Hydroxybenzaldehyde (3.00 g, 24.57 mmol) was 
added and stirred for 5 min. To this mixture, tert-Butyl bromoacetate (9.58 g, 49.13 mmol) 
was added and stirred while refluxing for 20 h. The reaction mixture was then cooled to 
room temperature and filtered to afford the crude product in acetone solution. The solvent 
was evaporated to dryness and purified by silica gel column chromatography (10-13% 
ethyl acetate in hexanes) to obtain 5.5 g (95% yield) of 3-1c. 1H NMR (400MHz, CDCl3) 
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δ 9.88 (s, 1H), δ 7.82-7.84 (d, 2H), δ 6.97-6.99 (d, 2H), δ 4.59 (s, 2H), δ 1.47 (s, 9H); 13C 
NMR (400MHz, CDCl3) δ 190.80, δ 167.23, δ 162.88, δ 132.02, δ 130.69, δ 114.95, δ 
83.00, δ 65.63, δ 28.10; ESI-MS (expected: [m+H]+= 237.1, obtained: [m+Na]+= 259.1) 
 
Synthesis of compound 3-1d: 
Methyltriphenylphosphonium bromide (7.94 g, 22.24 mmol) and Potassium tert-butoxide 
(2.50 g, 22.24 mmol) were mixed in a round bottom flask, and dry THF (15 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 3-1c (3.5 g, 14.83 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (3-5% ethyl acetate in hexanes) to afford 3.1 g (90% 
yield) of 3-1d. 1H NMR (400MHz, CDCl3) δ 7.33-7.35 (d, 2H), δ 6.84-6.87 (d, 2H), δ 6.63-
6.68 (q, 1H), δ 5.60-5.64 (q, 1H), δ 5.13-5.15 (q, 1H), δ 4.51 (s, 2H), δ 1.49 (s, 9H); 13C 
NMR (400MHz, CDCl3) δ 168.04, δ 157.75, δ 136.17, δ 131.33, δ 127.48, δ 114.69, δ 
112.09, δ 82.45, δ 65.81, δ 28.11; ESI-MS (expected: [m+H]+= 235.1, obtained: [m+Na]+= 
257.1) 
 
Synthesis of random co-polymer 3-1e - 3-5e: 
A mixture of the compound 3-1b (108 mg, 0.41 mmol), 3-1d (11 mg, 0.046 mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 3 mg, 0.009 mmol) were degassed by three freeze/thaw cycles, sealed under 
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argon, and heated at 125 oC under argon for 12 h. After the reaction cooled down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
precipitated 3 times in MeOH. The precipitate was collected and dried under vacuum to 
yield 90 mg (75% yield) of 3-1e. GPC (PMMA/THF): Mn= 12K Da, Đ= 1.14; Same 
method was used for 3-2e - 3-5e except for feeding ratios.  
3-1b (160 mg, 0.61 mmol), 3-1d (36 mg, 0.15 mmol) and NMP (5 mg, 0.015 mmol) were 
polymerized to get 3-2e (GPC (PMMA/THF): Mn= 15K Da, Đ= 1.08). 
3-1b (84 mg, 0.32 mmol), 3-1d (32 mg, 0.14 mmol) and NMP (3 mg, 0.009 mmol) were 
polymerized to get 3-3e (GPC (PMMA/THF): Mn= 12K Da, Đ= 1.12). 
3-1b (300 mg, 1.15 mmol), 3-1d (269 mg, 1.15 mmol) and NMP (15 mg, 0.046 mmol) 
were polymerized to get 3-4e (GPC (PMMA/THF): Mn= 10K Da, Đ= 1.08).  
3-1b (36 mg, 0.14 mmol), 3-1d (76 mg, 0.32 mmol) and NMP (3 mg, 0.009 mmol) were 
polymerized to get 3-5e (GPC (PMMA/THF): Mn= 11K Da, Đ= 1.16).  
1H NMR (400MHz, CDCl3) are shown below.  
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Synthesis of random co-polymer P3-1 - P3-5: 
DCM (2 mL) was added to dissolve the dried random co-polymer 3-1e - 3-5e. 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum to obtain the final product P3-1 - P3-5. 
1H NMR (400MHz, CDCl3) are shown below. 
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Synthesis of random co-polymer P3-6 - P3-8 
Synthesis of compound 3-6a: 
To a solution of acetone mixed with K2CO3 (6.00 g, 43.44 mmol), NaI (3.91 g, 26.06 mmol) 
and 18-crown-6 (0.57 g, 2.17 mmol), 3,4-Dihydroxybenzaldehyde (1.50 g, 10.86 mmol) 
was added and stirred for 5 min. To this mixture, tert-Butyl bromoacetate (5.08 g, 26.06 
mmol) was added and stirred while refluxing for 20 h. The reaction mixture was then 
cooled to room temperature and filtered to afford the crude product in acetone solution. 
The solvent was evaporated to dryness and purified by silica gel column chromatography 
(10-13% ethyl acetate in hexanes) to obtain 3.4 g (85% yield) of 3-6a. 1H NMR (400MHz, 
CDCl3) δ 9.83 (s, 1H), δ 7.45-7.47 (q, 1H), δ 7.35-7.36 (d, 1H), δ 6.88-6.91 (d, 1H), δ 4.66-
4.69 (d, 4H), δ 1.47-1.48 (d, 18H); 13C NMR (400MHz, CDCl3) δ 190.66, δ 167.44, δ 
167.19, δ 153.22, δ 148.39, δ 130.88, δ 126.81, δ 113.21, δ 112.52, δ 82.93, δ 82.77, δ 
66.46, δ 28.17, δ 28.16; ESI-MS (expected: [m+H]+= 367.2, obtained: [m+Na]+= 389.2) 
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Synthesis of compound 3-6b: 
Methyltriphenylphosphonium bromide (4.24 g, 11.88 mmol) and Potassium tert-butoxide 
(1.33 g, 11.88 mmol) were mixed in a round bottom flask, and dry THF (20 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 3-6a (2.9 g, 7.92 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (3-5% ethyl acetate in hexanes) to afford 2.3 g (80% 
yield) of 3-6b. 1H NMR (400MHz, CDCl3) δ 6.94-6.96 (t, 2H), δ 6.78-6.80 (d, 1H), δ 6.57-
6.64 (q, 1H), δ 5.55-5.60 (q, 1H), δ 5.13-5.16 (q, 1H), δ 4.59-4.61 (d, 4H), δ 1.47-1.48 (d, 
18H); 13C NMR (400MHz, CDCl3) δ 168.20, δ 168.13, δ 148.14, δ 148.02, δ 136.27, δ 
132.14, δ 120.73, δ 114.89, δ 112.66, δ 112.63, δ 82.37, δ 82.35, δ 67.17, δ 67.05, δ 28.20; 
ESI-MS (expected: [m+H]+= 365.2, obtained: [m+Na]+= 387.2) 
 
Synthesis of random co-polymer 6c-8c: 
A mixture of the compound 3-1b (200 mg, 0.77 mmol), 3-6b (49 mg, 0.14 mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 6 mg, 0.018 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 12 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
precipitated 3 times in the MeOH. The precipitate was collected and dried under vacuum 
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to yield 175 mg (70% yield) of 3-6c. GPC (PMMA/THF): Mn= 13K Da, Đ= 1.11; Same 
method was used for 3-7c - 3-8c except for feeding ratios.  
3-1b (280 mg, 1.08 mmol), 3-6b (168 mg, 0.46 mmol) and NMP (10 mg, 0.031 mmol) 
were polymerized to get 3-7c (GPC (PMMA/THF): Mn= 18K Da, Đ= 1.17).  
3-1b (200 mg, 0.77 mmol), 3-6b (280 mg, 0.77 mmol) and NMP (10 mg, 0.031 mmol) 
were polymerized to get 3-8c (GPC (PMMA/THF): Mn= 14K Da, Đ= 1.07).  
1H NMR (400MHz, CDCl3) are shown below. 
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Synthesis of random co-polymer P3-6 - P3-8: 
DCM (2 mL) was added to dissolve the dried random co-polymer 3-6c - 3-8c. 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum to obtain the final product P3-6 - P3-8. 
1H NMR (400MHz, CDCl3) are shown below. 
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Synthesis of random co-polymer P3-9 - P3-14 
Synthesis of compound 3-9a - 3-14a: 
The method of synthesizing 3-9a - 3-14a is as same as 3-1a above, except that the reagents 
were 1-Bromohexane (for 3-9a and 3-12a), 1-Bromotetradecane (for 3-10a and 3-13a) and 
1-Bromohexadecane (for 3-11a and 3-14a). 1H NMR (400MHz, CDCl3) of 3-9a, δ 9.87 (s, 
1H), δ 7.81-7.83 (d, 2H), δ 6.97-6.99 (d, 2H), δ 4.01-4.05 (t, 2H), δ 1.77-1.82 (quint, 2H), 
δ 1.34-1.46 (m, 6H), δ 0.90 (s, 3H); 13C NMR (400MHz, CDCl3) of 3-9a, δ 190.85, δ 
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164.35, δ 132.04, δ 129.81, δ 114.81, δ 68.49, δ 31.58, δ 29.08, δ 25.70, δ 22.64, δ 14.07; 
1H NMR (400MHz, CDCl3) of 3-10a, δ 9.88 (s, 1H), δ 7.81-7.83 (d, 2H), δ 6.98-7.00 (d, 
2H), δ 4.02-4.05 (t, 2H), δ 1.77-1.84 (quint, 2H), δ 1.27-1.50 (m, 24H), δ 0.87-0.90 (t, 3H); 
13C NMR (400MHz, CDCl3) of 3-10a, δ 190.97, δ 164.43, δ 132.14, δ 129.89, δ 114.90, δ 
68.59, δ 32.07, δ 29.83, δ 29.82, δ 29.80, δ 29.73, δ 29.69, δ 29.50, δ 29.48, δ 29.20, δ 
26.10, δ 22.84, δ 14.27; 1H NMR (400MHz, CDCl3) of 3-11a, δ 9.88 (s, 1H), δ 7.81-7.84 
(q, 2H), δ 6.98-7.00 (q, 2H), δ 4.02-4.05 (t, 2H), δ 1.79-1.83 (quint, 2H), δ 1.26-1.55 (m, 
26H), δ 0.88-0.90 (t, 3H); 13C NMR (400MHz, CDCl3) of 3-11a, δ 190.96, δ 164.42, δ 
132.13, δ 129.89, δ 114.89, δ 68.58, δ 32.07, δ 29.83, δ 29.80, δ 29.80, δ 29.72, δ 29.69, δ 
29.51, δ 29.48, δ 29.20, δ 26.10, δ 22.84, δ 14.26. 
 
Synthesis of compound 3-9b - 3-14b: 
The method of synthesizing 3-9b - 3-14b is as same as 3-1b above. 1H NMR (400MHz, 
CDCl3) of 3-9b, δ 7.33-7.35 (d, 2H), δ 6.84-6.86 (d, 2H), δ 6.63-6.70 (q, 1H), δ 5.58-5.63 
(d, 1H), δ 5.10-5.13 (d, 1H), δ 3.94-3.98 (t, 2H), δ 1.43-1.50 (quint, 2H), δ 1.32-1.36 (m, 
4H), δ 0.92-0.94 (t, 3H); 13C NMR (400MHz, CDCl3) of 3-9b, δ 159.10, δ 136.43, δ 130.34, 
δ 127.47, δ 114.61, δ 111.47, δ 68.15, δ 31.74, δ 29.38, δ 25.86, δ 22.75, δ 14.17; 1H NMR 
(400MHz, CDCl3) of 3-10b, δ 7.32-7.34 (d, 2H), δ 6.84-6.86 (d, 2H), δ 6.62-6.69 (q, 1H), 
δ 5.58-5.62 (d, 1H), δ 5.10-5.13 (d, 1H), δ 3.94-3.97 (t, 2H), δ 1.74-1.81 (quint, 2H), δ 
1.27-1.49 (m, 22H), δ 0.87-0.90 (t, 3H); 13C NMR (400MHz, CDCl3) of 3-10b, δ 159.10, 
δ 136.43, δ 130.36, δ 127.48, δ 114.63, δ 111.52, δ 68.20, δ 32.08, δ 29.85, δ 29.83, δ 
29.81, δ 29.75, δ 29.73, δ 29.55, δ 29.52, δ 29.42, δ 26.19, δ 22.85, δ 14.28; 1H NMR 
(400MHz, CDCl3) of 3-11b, δ 7.32-7.34 (q, 2H), δ 6.84-6.86 (q, 2H), δ 6.62-6.69 (q, 1H), 
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δ 5.58-5.62 (q, 1H), δ 5.10-5.13 (q, 1H), δ 3.94-3.97 (t, 2H), δ 1.76-1.79 (quint, 2H), δ 
1.26-1.54 (m, 26H), δ 0.87-0.90 (t, 3H); 13C NMR (400MHz, CDCl3) of 3-11b, δ 159.11, 
δ 136.44, δ 130.36, δ 127.48, δ 114.63, δ 111.50, δ 68.18, δ 32.09, δ 29.86, δ 29.84, δ 
29.82, δ 29.76, δ 29.74, δ 29.56, δ 29.53, δ 29.42, δ 26.19, δ 22.85, δ 14.27. 
Synthesis of random co-polymer 3-9c - 3-14c: 
The method of synthesizing 3-9c - 3-14c is as same as 3-1e above with corresponding 
monomer 3-9b - 3-14b and 3-1d. 3-9b (157 mg, 0.77 mmol), 3-1d (180 mg, 0.77 mmol) 
and NMP (10 mg, 0.031 mmol) were polymerized to get 3-9c (GPC (PMMA/THF): Mn= 
8K Da, Đ= 1.20).  
3-10b (243 mg, 0.77 mmol), 3-1d (180 mg, 0.77 mmol) and NMP (10 mg, 0.031 mmol) 
were polymerized to get 3-10c (GPC (PMMA/THF): Mn= 12K Da, Đ= 1.11).  
3-11b (133 mg, 0.39 mmol), 3-1d (90 mg, 0.39 mmol) and NMP (5 mg, 0.015 mmol) were 
polymerized to get 3-11c (GPC (PMMA/THF): Mn= 17K Da, Đ= 1.31). 
3-12b (110 mg, 0.54 mmol), 3-1d (54 mg, 0.23 mmol) and NMP (5 mg, 0.015 mmol) were 
polymerized to get 3-12c (GPC (PMMA/THF): Mn= 12K Da, Đ= 1.64).  
3-13b (340 mg, 1.08 mmol), 3-1d (108 mg, 0.46 mmol) and NMP (10 mg, 0.031 mmol) 
were polymerized to get 3-13c (GPC (PMMA/THF): Mn= 12K Da, Đ= 1.16). 
3-14b (185 mg, 0.54 mmol), 3-1d (54 mg, 0.23 mmol) and NMP (5 mg, 0.015 mmol) were 
polymerized to get 3-14c (GPC (PMMA/THF): Mn= 10K Da, Đ= 1.45). 
1H NMR (400MHz, CDCl3) are shown below. 
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Synthesis of random co-polymer P3-9 - P3-14: 
DCM (2 mL) was added to dissolve the dried random co-polymer 3-9c - 3-14c. 
Trifluoroacetic acid (0.5 mL) was added to the reaction, and stirred for 12 h. The reaction 
mixture was evaporated and dried under vacuum to obtain the final product P3-9 - P3-14. 
1H NMR (400MHz, CDCl3) are shown below. 
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Synthesis of random co-polymer P4-1 
Synthesis of co-polymer P4-1 was mentioned elsewhere2 
Synthesis of random co-polymer P4-2 
Synthesis of compound 4-2a: 
Synthesis of compound 4-2a was mentioned elsewhere2 
Synthesis of polymer 4-2b: 
A mixture of the compound 4-2a (200 mg, 0.77 mmol), commercial available compound 
4-Vinylbenzyl chloride (117 mg, 0.77 mmol) and N-tert-Butyl-N-(2-methyl-1-
phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP initiator, 10 mg, 0.031 mmol) were 
degassed by three freeze/thaw cycles, sealed under argon, and heated at 125 oC under argon 
for 12 h. After the reaction cool down to room temperature, the reaction mixture was 
dissolved in DCM, and dialyzed against DCM/MeOH (v/v= 6/1) for 2 days. The solution 
was collected and dried under vacuum to yield 220 mg (70% yield) of 4-2b. GPC 
(PMMA/THF): Mn= 12K Da, Đ=1.2;  
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Synthesis of polymer 4-2c: 
Polymer precursor 4-2b was added to 2mL of Triethylphosphite in a round bottom flask 
and stirred with reflux at 110 oC for 24 h. The reaction mixture was then cooled to room 
temperature and dialyzed against DCM/MeOH (v/v= 6/1) for 2 days to remove excess 
Triethylphosphite. The solution was collected and dried under vacuum to yield 235 mg 
(85% yield) of 4-2c. 1H NMR indicates that there is a quantitative conversion from benzyl 
chloride to benzyl phosphonate functional group (based on the chemical shift of peak “g” 
and the emerging peaks “h” and “i”). 
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Synthesis of polymer P4-2: 
Polymer 4-2c was dissolved in 3 mL of DCM in a round bottom flask and stirred in an ice 
bath for 15 min. Bromotrimethylsilane (0.17 mL, 1.54 mmol) was slowly added to the 
solution. The reaction mixture was further stirred for 12 h. After the reaction, the solvent 
and excess Bromotrimethylsilane was evaporated to obtain dark yellow solids. 3 mL DCM 
was added to re-dissolve the compounds and 1M HCl aqueous solution (1 mL) was added. 
The reaction mixture was stirred at room temperature for 1 hour. After the reaction, DCM 
was evaporated and water was removed, and the residues are lyophilized to obtain 220 mg 
of the final polymer P4-2. The disappearance of peaks “h” and “i” in the precursor indicates 
that the ethyl groups were deprotected. 1H NMR (400 MHz, CDCl3) was shown below. 
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Synthesis of random co-polymer P4-3 
Synthesis of compound 4-3a: 
To a solution of THF mixed with 4-Hydroxybenzaldehyde (5.16 g, 42.22 mmol) and 
Imidazole (4.02 g, 59.11 mmol), tert-Butyldimethylsilyl chloride (8.91 g, 59.11 mmol) was 
added and stirred for 12 hours at room temperature. After the reaction, NaCl saline and 
ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The solvent was evaporated to dryness and purified by silica 
gel column chromatography (2-3% ethyl acetate in hexanes) to obtain 9.0 g (90% yield) of 
4-3a. 1H NMR (400MHz, CDCl3) δ 9.89 (s, 1H), δ 7.77-7.79 (d, 2H), δ 6.93-6.94 (d, 2H), 
δ 0.98 (s, 9H), δ 0.24 (s, 6H). ESI-MS (expected: [m+H]+= 237.1, obtained: [m+Na]+= 
259.1) 
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Synthesis of compound 4-3b: 
Methyltriphenylphosphonium bromide (12.41 g, 34.75 mmol) and Potassium tert-butoxide 
(3.90 g, 34.75 mmol) were mixed in a round bottom flask, and dry THF (20 mL) was added 
to the mixture. The mixture was stirred under argon atmosphere in an ice bath for 15 min 
to yield the bright yellow solution. 4-3a (5.47 g, 23.17 mmol) was slowly added to the 
mixture. The reaction mixture was further stirred for 5 h. After the reaction, NaCl saline 
and ethyl acetate were added for extraction. The combined organic layer was separated and 
washed with saline 3 times. The organic layer was evaporated to dryness and purified by 
silica gel column chromatography (0.5% ethyl acetate in hexanes) to afford 4.6 g (85% 
yield) of 4-3b. 1H NMR (400MHz, CDCl3) δ 7.28-7.29 (d, 2H), δ 6.78-6.80 (d, 2H), δ 6.62-
6.68 (q, 1H), δ 5.59-5.62 (d, 1H), δ 5.11-5.13 (d, 1H), δ 0.98 (s, 9H), δ 0.20 (s, 6H).  
 
Synthesis of random co-polymer 4-3c: 
A mixture of the compound 4-3b (269 mg, 1.15 mmol), 4-2a (300 mg, 1.15 mmol) and N-
tert-Butyl-N-(2-methyl-1-phenylpropyl)-O-(1-phenylethyl)hydroxylamine (NMP 
initiator, 15 mg, 0.046 mmol) were degassed by three freeze/thaw cycles, sealed under 
argon, and heated at 125 oC under argon for 12 h. After the reaction cool down to room 
temperature, the reaction mixture was dissolved in minimal amount of DCM, and 
precipitated 3 times in the MeOH. The precipitate was collected and dried under vacuum 
to yield 430 mg (75% yield) of 4-3c. GPC (PMMA/THF): Mn= 12K Da, Đ= 1.1. 1H NMR 
(400MHz, CDCl3) was shown below.  
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Synthesis of random co-polymer 4-3d: 
THF (3 mL) was added to dissolve the dried random co-polymer 4-3c. 
Tetrabutylammonium fluoride (5.75 mL, 1M in THF) was added to the reaction in an ice 
bath, and stirred for 12 h. The reaction mixture was evaporated and re-dissolved with 
minimal amount of DCM. Then MeOH was used to precipitate polymers 3 times. The 
product was collected and dried under vacuum to yield 200 mg (50% yield) of 4-3d. The 
disappreance of peaks “h” and “g” in the precursor indicates that the TBS was deprotected. 
1H NMR (400MHz, CDCl3) was shown below. 
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Synthesis of random co-polymer P4-3: 
THF (5 mL) was added to dissolve the dried random co-polymer 4-3d. Sodium hydride 
(0.13 g, 5.75 mmol) was added to the reaction in an ice bath, and stirred for 15 min. The 
reaction mixture was then added the 1,3-Propanesultone (0.70 g, 5.75 mmol) and stirred 
for 12 hours. After the reaction, 2 mL of H2O was added dropwise to the reaction to quench 
the NaH in the mixture in an ice bath. Then mixture was dried, and the water was removed. 
The dried sample was dialyzed against DCM/MeOH (v/v= 6/1) for 1 day. The solution was 
evaporated and dried under vacuum to obtain 130 mg of the final product P4-3. 1H NMR 
(400MHz, CDCl3) was shown below. 
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Covalent labeling reagent synthesis and characterization 
Synthesis of compound 6-1b:  
Compound 6-1a (505 mg, 3 mmol) and DABCO (336 mg, 3 mmol) were dissolved in 600 
uL of THF. Then formaldehyde (90 mg, 3 mmol) was added to the solution. The reaction 
mixture was stirred overnight. Then 2 M HCl solution (5 mL) was added to the reaction. 
The mixture was extracted with ethyl acetate for 3 times. Organic layers were collected, 
combined and dried over anhydrous sodium sulfate. The organic solution was dried and 
subjected to flash chromatography after filtration to afford compound 6-1b. Yield: 372 mg, 
63%. 1H-NMR (CDCl3): δ (ppm) 7.87-7.94 (m, 2H), 7.60-7.68 (m, 1H), 7.50-7.60 (m, 2H), 
6.44(s, 1H), 6.07 (t, 1H), 4.31 (d, 2H). 
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Synthesis of compound 6-1c:  
Compound 6-1b (170 mg, 0.86 mmol) was dissolved in 2 mL dry DCM followed by 
addition of PBr3 (116.2 mg, 0.43 mmol) at 0 °C. The reaction completed in 20 minutes. 
Compound 6-1c was obtained by flash chromatography.  Yield: 182 mg, 79%.  1H-NMR 
(CDCl3): δ (ppm) 7.87-7.94 (m, 2H), 7.63-7.70 (m, 1H), 7.54-7.60 (m, 2H), 6.65(s, 1H), 
6.26(q, 1H), 4.11 (d, 2H). 
 
Synthesis of compound Reagent 6-1: 
Compound 6-1c (26 mg, 0.1 mmol) was added with TEA (10.2 mg, 0.1 mmol). The 
reaction was kept for 30 minutes. Then the precipitate was washed with THF for 3 times. 
The precipitate was collected and dried to afford Reagent 6-1. Yield: 31 mg, 86%. 1H-
NMR (D2O): δ (ppm) 7.95-8.00 (m, 2H), 7.82-7.87 (m, 1H), 7.68-7.75 (m, 2H), 6.98 (d, 
1H), 6.70 (d, 1H), 4.15 (s, 1H), 3.36 (q, 6 H), 1.33 (t, 9H). ESI-MS: [m-Br]+ = 282.3 
 
 
Synthesis of compound 6-2b:  
Compound 6-2a (2.0 g, 17.23 mmol) was dissolved in 20 mL of dry DCM and cooled to 0 
°C in ice bath. PBr3 (2.332 g, 8.615 mmol) was added slowly to the solution. Then the 
reaction mixture was stirred at room temperature. The completion of reaction was 
monitored by TLC. The reaction was then quenched by the addition of ice. The reaction 
solution was neutralized by sodium bicarbonate solution and then extracted with DCM 
three times. Organic layers were collected and dried over anhydrous sodium sulfate, then 
concentrated. Compound 6-2b was obtained by flash chromatography. Yield: 2.52 g, 82%. 
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1H-NMR (400 MHz, CDCl3): δ (ppm) 6.34 (s, 1H), 5.96 (s, 1H), 4.18 (s, 2H), 3.82 (s, 3H). 
13C-NMR (125 MHz, CDCl3): δ (ppm) 165.4, 165.0, 140.5, 138.7, 131.5, 129.2, 118.6, 
84.2, 75.8, 66.7, 37.9, 20.1. 
 
Synthesis of Reagent 6-2:  
Compound 6-2b (50 mg, 0.28 mmol) was dissolved in 200 uL of dry THF. To the solution, 
triethylamine (57 mg, 0.56 mmol) was added. The reaction was allowed to stirred at room 
temperature for 2 hours. Then mixture was concentrated and precipitated in dry diethyl 
ether for 3 times. The precipitate was collected and dried to afford Reagent 6-2. Yield: 65 
mg, 83%. 1H-NMR (400 MHz, MeOH-d4): δ (ppm) 6.90 (s, H), 6.40 (s, H), 4.23 (s, 2H), 
3.85 (s, 3H), 3.30 (q, J=7.2 Hz, 6H), 1.37 (t, J=7.2 Hz, 9H). 13C-NMR (100 MHz, MeOH-
d4): δ (ppm) 167.42, 140.52, 130.66, 56.97, 54.30, 53.44, 8.08. ESI-MS: [m-Br]+ = 200.4 
 
 
Synthesis of Reagent 6-3:  
Compound 6-2b (25 mg, 0.14 mmol) was weighed to glass vial. To the vial, tripropylamine 
(40 mg, 0.28 mmol) was added. The reaction was kept for 2 hours at room temperature. 
Then the white precipitate was washed with diethyl ether for three times. The precipitate 
was collected and dried to achieve Reagent 6-3. Yield: 32 mg, 70%. 1H-NMR (MeOH-
d4): δ (ppm) 6.90 (s, 1H), 6.36 (s, 1H), 4.27 (s, 2H), 3.85 (s, 3H), 3.16 (m, 6H), 1.81 (m, 
6H), 0.99 (t, 9H). ESI-MS: [m-Br]+ = 242.3 
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Synthesis of Reagent 6-4:  
Compound 6-2b (25 mg, 0.14 mmol) was weighed to glass vial. To the vial, N, N-
diisopropylethylamine (36.2 mg, 0.28 mmol) was added. The reaction was kept for 2 hours 
at room temperature. Then the white precipitate was washed with diethyl ether for three 
times. The precipitate was collected and dried to achieve Reagent 6-4. Yield: 32 mg, 75%. 
1H-NMR (MeOH-d4): δ (ppm) 6.83 (s, 1H), 6.45 (s, 1H), 4.23 (s, 2H), 4.16 (m, 2H), 3.87 
(s, 3H), 3.45 (q, 2H), 1.50 (m, 12H), 1.40 (t, 3H). ESI-MS: [m-Br]+ = 228.4 
 
Synthesis of Reagent 6-5:  
4-(dimethylamino)pyridine (24.4 mg, 0.2 mmol) was dissolved in 100 uL of dry THF. To 
the solution, compound 6-2b (50 mg, 0.28 mmol) was added. The reaction was kept for 2 
hours at room temperature. Then the white precipitate was washed with diethyl ether for 
three times. The precipitate was collected and dried to achieve Reagent 6-5. Yield: 53.2 
mg, 89%. 1H-NMR (400 MHz, MeOH-d4): δ (ppm) 8.16 (d, 2H), 6.99 (d, 2H), 6.52 (s, 
1H), 6.08 (s, 1H), 5.02 (s, 2H), 3.76 (s, 3H), 3.26 (s, 6H). 13C-NMR (100 MHz, MeOH-
d4): δ (ppm) 166.53, 158.10, 143.43, 136.17, 132.28, 108.76, 58.93, 52.87, 40.36. ESI-
MS: [m-Br]+ = 221.3 
 
Synthesis of Reagent 6-6:  
Compound 6-2a (116 mg, 1 mmol) was dissolved in 5 mL of THF with 4-nitrophenyl 
isocyanate (164.1 mg, 1 mmol) and 2,6-Di-tert-butyl-4-methylphenol (2.2 mg, 0.01 mmol). 
The reaction mixture was heated at 60 °C under argon atmosphere. The completion of 
reaction was followed by TLC. Reagent 6-6 was obtained by flash chromatography. Yield: 
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134 mg, 48%. 1H-NMR (400 MHz, MeOH-d4): δ (ppm) 8.19 (d, 2H), 7.67 (d, 2H), 6.37 
(d, 1H), 5.98 (d, 1H), 4.91 (s, 2H), 3.79 (s, 3H). ESI-MS: [m+Na]+ = 303.1 
 
Synthesis of compound 6-7a:  
Compound 6-2a (3.48 g, 30 mmol) was dissolved in 50 mL of dry THF with imidazole 
(2.250 g, 33 mmol). TBDPSCl (9.070 g, 33 mmol) was added to the solution dropwise at 
0 °C. The reaction was stirred overnight at room temperature. Then, precipitate was 
removed by filtration to achieve clear solution which was further extracted with saturated 
sodium bicarbonate solution, water and brine. The organic layers were combined and dried 
over anhydrous sodium sulfate. The solution was collected, concentrated and subjected to 
flash chromatography to afford compound 6-7a.  Yield, 6.99 g, 66%. 1H-NMR (400 MHz, 
CDCl3): δ (ppm) 7.64-7.69 (m, 4H), 7.34-7.47 (m, 6H), 6.33 (q, 1H), 6.11 (q, 1H), 4.42 (t, 
2H), 3.70 (s, 3H), 1.08 (s, 9H). 
 
Synthesis of compound 6-7b:  
Compound 6-7a (5g, 14.15 mmol) was dissolved in 50 mL of THF/H2O mixture (1:1). 
Lithium hydroxide (1.015 g, 42.45 mmol) in 2 mL of water was added to the solution.  The 
reaction was stirred overnight. Then, the solution was acidified with 2M HCl solution to 
pH 3 and extracted with DCM. Organic layers were collected and dried over anhydrous 
sodium sulfate. The organic layer was further concentrated to obtain crude product, 
compound 6-7b which was subjected for reaction without further purification. Yield: 3.925 
g, 82%.  
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Synthesis of compound 6-7c:  
To 50 mL of compound 6-7b (2.620 g, 8.13 mmol) solution in THF, thionyl chloride (19.4 
g, 160.26 mmol) was added. The mixture was refluxed for 3 hours. Then volatiles were 
removed under vacuum. The residue was dissolved in 10 mL of dry DCM in a round bottom 
flask. To the flask, a solution of methylamine (4.13 mL 2M THF solution, 8.13 mmol) and 
TEA (0.828 g, 8.13 mmol) in 10 mL DCM was added dropwise at 0 °C.  The reaction was 
stirred overnight at room temperature. The white precipitate was removed by filtration. 
Solvent was removed and the residue was extracted with sodium bicarbonate, and water 
using ethyl acetate.  The organic layers were combined and dried over anhydrous sodium 
sulfate. The solution was collected and dried for flash chromatography. Pure compound 6-
7c was obtained after purification. Yield: 2.60 g, 95%. 1H-NMR (400 MHz, CDCl3): δ 
(ppm) 7.62-7.69 (m, 4H), 7.36-7.48 (m, 6H), 6.84 (bs, NH), 5.98 (s, 1H), 5.36 (q, 1H), 4.41 
(s. 2H), 2.89 (d, 3H), 1.07 (s, 9H). 
 
Synthesis of compound 6-7d:  
To 10 mL of compound 6-7c (2.50 g, 7.08 mmol) solution, 7.79 mL of TBAF solution (1M 
in THF) was added dropwise at 0 °C. The reaction completed in 20 minutes. Compound 6-
7d was obtained by flash chromatography. 1H-NMR (400 MHz, MeOH-d4): δ(ppm) 5.80 
(q, 1H), 5.58 (q, 1H), 4.27 (s, 2H), 2.79 (s, 3H). Yield: 513 mg, 63%.  
 
Synthesis of compound 6-7e:  
To the solution of compound 6-7d (230 mg, 2 mmol) in 5 mL of dry DCM, PBr3 (270 mg, 
1 mmol) was added slowly at 0 °C. The reaction was stirred at room temperature after 
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addition. The completion of reaction was followed by TLC. Then reaction was quenched 
by addition of 2 M sodium bicarbonate solution. The solution was further extracted with 
DCM and water for two more times, and organic layers were combined and dried over 
anhydrous sodium sulfate. The solution was collected and dried to afford compound 6-7e 
for further reaction.  
 
Synthesis of Reagent 6-7:  
Compound 6-7e (35.6 mg, 0.2 mmol) was weighed into a small glass vial.  To the vial, 
triethylamine (44.48 mg, 0.44 mmol) was added. The reaction was kept for 2 hours at room 
temperature. Then the white precipitate was washed with diethyl ether for three times. The 
precipitate was collected and dried to achieve Reagent 6-7. Yield: 42 mg, 75%. 1H-NMR 
(400 MHz, MeOH-d4): δ (ppm) 6.24 (s, 1H), 6.07 (s, 1H), 4.19 (s, 2H), 3.26 (q, 6H), 2.83 
(s, 3H), 1.34 (t, 9H). ESI-MS: [m-Br]+ = 199.4 
 
Synthesis of Reagent 6-8:  
Compound 6-8a (190 mg, 1 mmol) in 200 uL of THF was added with triethylamine (101.2 
mg, 1 mmol). The precipitate was washed with THF (5 mL) for three time after 2 hours. 
The collected solid was then dried to achieve Reagent 6-8. Yield: 206 mg, 70%. 1H-NMR 
(400 MHz, MeOH-d4): δ (ppm) 6.90 (s, 1H), 6.41 (s, 1H), 4.31 (q, 2H), 4.24 (s, 2H), 3.32 
(m, 6H), 1.37 (m, 12H). ESI-MS: [m-Br]+ = 214.3 
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Synthesis of compound 6-9a:  
Solution of compound 6-7b (644 mg, 2 mmol) in 5 mL dry DCM was added with DCC 
(412 mg, 2 mmol). DMAP (244 mg, 2 mmol) and EtOH-d5 (208 mg, 4 mmol) was then 
added to the reaction solution after 10 minutes. The reaction solution was stirred overnight. 
The precipitate was removed by filtration. The filtrate was then dried and subjected to flash 
chromatography to obtained compound 6-9a.  Yield: 350 mg, 49%. 1H-NMR (CDCl3): δ 
(ppm) 7.62-7.72 (m, 4H), 7.34-7.48 (m, 6H), 6.32 (q, 1H), 6.10 (q, 1H), 4.43 (t, 2H), 1.08 
(s, 9H). 
 
Synthesis of compound 6-9b:  
To 3 mL of compound 6-9a (330 mg, 0.93 mmol) solution in THF, 1 mL of TBAF solution 
(1 M in THF) was added dropwise at 0 °C. The reaction completed in 20 minutes. 
Compound 6-9b was obtained by flash chromatography. Yield: 105 mg, 84%. 1H-NMR 
(CDCl3): δ (ppm) 7.62-7.72 (m, 4H), 7.34-7.48 (m, 6H), 6.32 (q, 1H), 6.10 (q, 1H), 4.43 
(t, 2H), 1.08 (s, 9H). 
 
Synthesis of compound 6-9c:  
To a solution of compound 6-9b (90 mg, 0.667 mmol) in 1 mL of dry DCM, PBr3(90.2 mg, 
0.333 mmol) was added at at 0 °C. The reaction was stirred at room temperature after 
addition. The completion of reaction was followed by TLC. Then reaction was quenched 
by addition of 2 M sodium bicarbonate solution. The solution was further extracted with 
DCM and water for two more times, and organic layers were combined and dried over 
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anhydrous sodium sulfate. The solution was collected and dried to afford compound 6-9c 
for further reaction. 
 
Synthesis of Reagent 6-9:  
Compound 6-9c (19.8 mg, 0.1 mmol) was added with triethylamine (20.2mg, 0.02 mmol). 
The precipitate was washed with THF (5 mL) for three time after 2 hours. The collected 
solid was then dried to achieve the Reagent 6-9. Yield: 21 mg, 70%. 1H-NMR (MeOH-
d4): δ (ppm) 6.88 (s, 1H), 6.38 (s, 1H), 4.22 (s, 2H), 3.30 (m, 6H), 1.37 (t, 9H). ESI-MS: 
[m-Br]+ = 219.3 
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